name,code
alimentary tract and metabolism,A
stomatological preparations,A01
stomatological preparations,A01A
antiinfectives and antiseptics for local oral treatment,A01AB
hydrogen peroxide,A01AB02
chlorhexidine,A01AB03
amphotericin b,A01AB04
polynoxylin,A01AB05
domiphen,A01AB06
oxyquinoline,A01AB07
neomycin,A01AB08
miconazole,A01AB09
natamycin,A01AB10
various,A01AB11
hexetidine,A01AB12
tetracycline,A01AB13
benzoxonium chloride,A01AB14
tibezonium iodide,A01AB15
mepartricin,A01AB16
metronidazole,A01AB17
clotrimazole,A01AB18
sodium perborate,A01AB19
chlortetracycline,A01AB21
doxycycline,A01AB22
minocycline,A01AB23
corticosteroids for local oral treatment,A01AC
triamcinolone,A01AC01
dexamethasone,A01AC02
hydrocortisone,A01AC03
"prednisolone, combinations",A01AC54
other agents for local oral treatment,A01AD
epinephrine,A01AD01
benzydamine,A01AD02
acetylsalicylic acid,A01AD05
adrenalone,A01AD06
amlexanox,A01AD07
becaplermin,A01AD08
various,A01AD11
caries prophylactic agents,A01AA
sodium fluoride,A01AA01
sodium monofluorophosphate,A01AA02
olaflur,A01AA03
stannous fluoride,A01AA04
combinations,A01AA30
"sodium fluoride, combinations",A01AA51
drugs for acid related disorders,A02
antacids,A02A
aluminium compounds,A02AB
aluminium hydroxide,A02AB01
algeldrate,A02AB02
aluminium phosphate,A02AB03
dihydroxialumini sodium carbonate,A02AB04
aluminium acetoacetate,A02AB05
aloglutamol,A02AB06
aluminium glycinate,A02AB07
combinations,A02AB10
calcium compounds,A02AC
calcium carbonate,A02AC01
calcium silicate,A02AC02
combinations,A02AC10
"combinations and complexes of aluminium, calcium and magnesium compounds",A02AD
ordinary salt combinations,A02AD01
magaldrate,A02AD02
almagate,A02AD03
hydrotalcite,A02AD04
almasilate,A02AD05
antacids with antiflatulents,A02AF
magaldrate and antiflatulents,A02AF01
ordinary salt combinations and antiflatulents,A02AF02
antacids with antispasmodics,A02AG
antacids with sodium bicarbonate,A02AH
"antacids, other combinations",A02AX
drugs for peptic ulcer and gastro-oesophageal reflux disease (gord),A02B
h<n>2</n>-receptor antagonists,A02BA
cimetidine,A02BA01
ranitidine,A02BA02
famotidine,A02BA03
nizatidine,A02BA04
niperotidine,A02BA05
roxatidine,A02BA06
ranitidine bismuth citrate,A02BA07
lafutidine,A02BA08
"cimetidine, combinations",A02BA51
"famotidine, combinations",A02BA53
prostaglandins,A02BB
misoprostol,A02BB01
enprostil,A02BB02
proton pump inhibitors,A02BC
omeprazole,A02BC01
pantoprazole,A02BC02
lansoprazole,A02BC03
rabeprazole,A02BC04
esomeprazole,A02BC05
dexlansoprazole,A02BC06
dexrabeprazole,A02BC07
vonoprazan,A02BC08
"lansoprazole, combinations",A02BC53
"rabeprazole, combinations",A02BC54
combinations for eradication of helicobacter pylori,A02BD
"omeprazole, amoxicillin and metronidazole",A02BD01
"lansoprazole, tetracycline and metronidazole",A02BD02
"lansoprazole, amoxicillin and metronidazole",A02BD03
"pantoprazole, amoxicillin and clarithromycin",A02BD04
"omeprazole, amoxicillin and clarithromycin",A02BD05
"esomeprazole, amoxicillin and clarithromycin",A02BD06
"lansoprazole, amoxicillin and clarithromycin",A02BD07
"bismuth subcitrate, tetracycline and metronidazole",A02BD08
"lansoprazole, clarithromycin and tinidazole",A02BD09
"lansoprazole, amoxicillin and levofloxacin",A02BD10
"pantoprazole, amoxicillin, clarithromycin and metronidazole",A02BD11
"rabeprazole, amoxicillin and clarithromycin",A02BD12
"rabeprazole, amoxicillin and metronidazole",A02BD13
"vonoprazan, amoxicillin and clarithromycin",A02BD14
"vonoprazan, amoxicillin and metronidazole",A02BD15
other drugs for peptic ulcer and gastro-oesophageal reflux disease (gord),A02BX
carbenoxolone,A02BX01
sucralfate,A02BX02
pirenzepine,A02BX03
methiosulfonium chloride,A02BX04
bismuth subcitrate,A02BX05
proglumide,A02BX06
gefarnate,A02BX07
sulglicotide,A02BX08
acetoxolone,A02BX09
zolimidine,A02BX10
troxipide,A02BX11
bismuth subnitrate,A02BX12
alginic acid,A02BX13
rebamipide,A02BX14
"carbenoxolone, combinations excl. psycholeptics",A02BX51
"carbenoxolone, combinations with psycholeptics",A02BX71
"gefarnate, combinations with psycholeptics",A02BX77
other drugs for acid related disorders,A02X
magnesium compounds,A02AA
magnesium carbonate,A02AA01
magnesium oxide,A02AA02
magnesium peroxide,A02AA03
magnesium hydroxide,A02AA04
magnesium silicate,A02AA05
combinations,A02AA10
drugs for functional gastrointestinal disorders,A03
drugs for functional gastrointestinal disorders,A03A
"synthetic anticholinergics, quaternary ammonium compounds",A03AB
benzilone,A03AB01
glycopyrronium bromide,A03AB02
oxyphenonium,A03AB03
penthienate,A03AB04
propantheline,A03AB05
otilonium bromide,A03AB06
methantheline,A03AB07
tridihexethyl,A03AB08
isopropamide,A03AB09
hexocyclium,A03AB10
poldine,A03AB11
mepenzolate,A03AB12
bevonium,A03AB13
pipenzolate,A03AB14
diphemanil,A03AB15
(2-benzhydryloxyethyl)diethyl-methylammonium iodide,A03AB16
tiemonium iodide,A03AB17
prifinium bromide,A03AB18
timepidium bromide,A03AB19
fenpiverinium,A03AB21
"oxyphenonium, combinations",A03AB53
"synthetic antispasmodics, amides with tertiary amines",A03AC
dimethylaminopropionylphenothiazine,A03AC02
nicofetamide,A03AC04
tiropramide,A03AC05
papaverine and derivatives,A03AD
papaverine,A03AD01
drotaverine,A03AD02
moxaverine,A03AD30
serotonin receptor antagonists,A03AE
alosetron,A03AE01
cilansetron,A03AE03
other drugs for functional gastrointestinal disorders,A03AX
fenpiprane,A03AX01
diisopromine,A03AX02
chlorbenzoxamine,A03AX03
pinaverium,A03AX04
fenoverine,A03AX05
idanpramine,A03AX06
proxazole,A03AX07
alverine,A03AX08
trepibutone,A03AX09
isometheptene,A03AX10
caroverine,A03AX11
phloroglucinol,A03AX12
silicones,A03AX13
valethamate,A03AX14
menthae piperitae aetheroleum,A03AX15
trimethyldiphenylpropylamine,A03AX30
"alverine, combinations",A03AX58
"belladonna and derivatives, plain",A03B
"belladonna alkaloids, tertiary amines",A03BA
atropine,A03BA01
hyoscyamine,A03BA03
belladonna total alkaloids,A03BA04
"belladonna alkaloids, semisynthetic, quaternary ammonium compounds",A03BB
butylscopolamine,A03BB01
methylatropine,A03BB02
methylscopolamine,A03BB03
fentonium,A03BB04
cimetropium bromide,A03BB05
homatropine methylbromide,A03BB06
antispasmodics in combination with psycholeptics,A03C
synthetic anticholinergic agents in combination with psycholeptics,A03CA
isopropamide and psycholeptics,A03CA01
clidinium and psycholeptics,A03CA02
oxyphencyclimine and psycholeptics,A03CA03
otilonium bromide and psycholeptics,A03CA04
glycopyrronium bromide and psycholeptics,A03CA05
bevonium and psycholeptics,A03CA06
ambutonium and psycholeptics,A03CA07
diphemanil and psycholeptics,A03CA08
pipenzolate and psycholeptics,A03CA09
emepronium and psycholeptics,A03CA30
propantheline and psycholeptics,A03CA34
belladonna and derivatives in combination with psycholeptics,A03CB
methylscopolamine and psycholeptics,A03CB01
belladonna total alkaloids and psycholeptics,A03CB02
atropine and psycholeptics,A03CB03
homatropine methylbromide and psycholeptics,A03CB04
hyoscyamine and psycholeptics,A03CB31
other antispasmodics in combination with psycholeptics,A03CC
antispasmodics in combination with analgesics,A03D
synthetic anticholinergic agents in combination with analgesics,A03DA
tropenzilone and analgesics,A03DA01
pitofenone and analgesics,A03DA02
bevonium and analgesics,A03DA03
ciclonium and analgesics,A03DA04
camylofin and analgesics,A03DA05
trospium and analgesics,A03DA06
tiemonium iodide and analgesics,A03DA07
belladonna and derivatives in combination with analgesics,A03DB
butylscopolamine and analgesics,A03DB04
other antispasmodics in combination with analgesics,A03DC
antispasmodics and anticholinergics in combination with other drugs,A03E
"antispasmodics, psycholeptics and analgesics in combination",A03EA
antispasmodics in combination with other drugs,A03ED
propulsives,A03F
propulsives,A03FA
metoclopramide,A03FA01
cisapride,A03FA02
domperidone,A03FA03
bromopride,A03FA04
alizapride,A03FA05
clebopride,A03FA06
itopride,A03FA07
cinitapride,A03FA08
mosapride,A03FA09
"synthetic anticholinergics, esters with tertiary amino group",A03AA
oxyphencyclimine,A03AA01
camylofin,A03AA03
mebeverine,A03AA04
trimebutine,A03AA05
rociverine,A03AA06
dicycloverine,A03AA07
dihexyverine,A03AA08
difemerine,A03AA09
piperidolate,A03AA30
antiemetics and antinauseants,A04
antiemetics and antinauseants,A04A
other antiemetics,A04AD
scopolamine,A04AD01
cerium oxalate,A04AD02
chlorobutanol,A04AD04
metopimazine,A04AD05
dronabinol,A04AD10
nabilone,A04AD11
aprepitant,A04AD12
casopitant,A04AD13
rolapitant,A04AD14
"scopolamine, combinations",A04AD51
"chlorobutanol, combinations",A04AD54
serotonin (5ht<n>3</n>) antagonists,A04AA
ondansetron,A04AA01
granisetron,A04AA02
tropisetron,A04AA03
dolasetron,A04AA04
palonosetron,A04AA05
"palonosetron, combinations",A04AA55
bile and liver therapy,A05
bile therapy,A05A
preparations for biliary tract therapy,A05AB
nicotinyl methylamide,A05AB01
other drugs for bile therapy,A05AX
piprozolin,A05AX01
hymecromone,A05AX02
cyclobutyrol,A05AX03
"liver therapy, lipotropics",A05B
liver therapy,A05BA
arginine glutamate,A05BA01
silymarin,A05BA03
citiolone,A05BA04
epomediol,A05BA05
ornithine oxoglurate,A05BA06
tidiacic arginine,A05BA07
glycyrrhizic acid,A05BA08
metadoxine,A05BA09
drugs for bile therapy and lipotropics in combination,A05C
bile acids and derivatives,A05AA
chenodeoxycholic acid,A05AA01
ursodeoxycholic acid,A05AA02
cholic acid,A05AA03
obeticholic acid,A05AA04
drugs for constipation,A06
drugs for constipation,A06A
contact laxatives,A06AB
oxyphenisatine,A06AB01
bisacodyl,A06AB02
dantron,A06AB03
phenolphthalein,A06AB04
castor oil,A06AB05
senna glycosides,A06AB06
cascara,A06AB07
sodium picosulfate,A06AB08
bisoxatin,A06AB09
contact laxatives in combination,A06AB20
contact laxatives in combination with belladonna alkaloids,A06AB30
"bisacodyl, combinations",A06AB52
"dantron, combinations",A06AB53
"senna glycosides, combinations",A06AB56
"cascara, combinations",A06AB57
"sodium picosulfate, combinations",A06AB58
bulk-forming laxatives,A06AC
ispaghula (psylla seeds),A06AC01
ethulose,A06AC02
sterculia,A06AC03
linseed,A06AC05
methylcellulose,A06AC06
triticum (wheat fibre),A06AC07
polycarbophil calcium,A06AC08
"ispaghula, combinations",A06AC51
"sterculia, combinations",A06AC53
"linseed, combinations",A06AC55
osmotically acting laxatives,A06AD
magnesium carbonate,A06AD01
magnesium oxide,A06AD02
magnesium peroxide,A06AD03
magnesium sulfate,A06AD04
mineral salts in combination,A06AD10
lactulose,A06AD11
lactitol,A06AD12
sodium sulfate,A06AD13
pentaerithrityl,A06AD14
macrogol,A06AD15
mannitol,A06AD16
sodium phosphate,A06AD17
sorbitol,A06AD18
magnesium citrate,A06AD19
sodium tartrate,A06AD21
"lactulose, combinations",A06AD61
"macrogol, combinations",A06AD65
enemas,A06AG
sodium phosphate,A06AG01
bisacodyl,A06AG02
"dantron, incl. combinations",A06AG03
glycerol,A06AG04
oil,A06AG06
sorbitol,A06AG07
"docusate sodium, incl. combinations",A06AG10
"sodium lauryl sulfoacetate, incl. combinations",A06AG11
combinations,A06AG20
peripheral opioid receptor antagonists,A06AH
methylnaltrexone bromide,A06AH01
alvimopan,A06AH02
naloxegol,A06AH03
naloxone,A06AH04
naldemedine,A06AH05
other drugs for constipation,A06AX
glycerol,A06AX01
carbon dioxide producing drugs,A06AX02
lubiprostone,A06AX03
linaclotide,A06AX04
prucalopride,A06AX05
tegaserod,A06AX06
plecanatide,A06AX07
tenapanor,A06AX08
"softeners, emollients",A06AA
liquid paraffin,A06AA01
docusate sodium,A06AA02
"liquid paraffin, combinations",A06AA51
"antidiarrheals, intestinal antiinflammatory/antiinfective agents",A07
intestinal antiinfectives,A07A
sulfonamides,A07AB
phthalylsulfathiazole,A07AB02
sulfaguanidine,A07AB03
succinylsulfathiazole,A07AB04
imidazole derivatives,A07AC
miconazole,A07AC01
other intestinal antiinfectives,A07AX
broxyquinoline,A07AX01
acetarsol,A07AX02
nifuroxazide,A07AX03
nifurzide,A07AX04
intestinal adsorbents,A07B
charcoal preparations,A07BA
medicinal charcoal,A07BA01
"medicinal charcoal, combinations",A07BA51
bismuth preparations,A07BB
other intestinal adsorbents,A07BC
pectin,A07BC01
kaolin,A07BC02
crospovidone,A07BC03
attapulgite,A07BC04
diosmectite,A07BC05
combinations,A07BC30
"attapulgite, combinations",A07BC54
electrolytes with carbohydrates,A07C
oral rehydration salt formulations,A07CA
antipropulsives,A07D
antipropulsives,A07DA
diphenoxylate,A07DA01
opium,A07DA02
loperamide,A07DA03
difenoxin,A07DA04
loperamide oxide,A07DA05
eluxadoline,A07DA06
"morphine, combinations",A07DA52
"loperamide, combinations",A07DA53
intestinal antiinflammatory agents,A07E
corticosteroids acting locally,A07EA
prednisolone,A07EA01
hydrocortisone,A07EA02
prednisone,A07EA03
betamethasone,A07EA04
tixocortol,A07EA05
budesonide,A07EA06
beclometasone,A07EA07
"antiallergic agents, excl. corticosteroids",A07EB
cromoglicic acid,A07EB01
aminosalicylic acid and similar agents,A07EC
sulfasalazine,A07EC01
mesalazine,A07EC02
olsalazine,A07EC03
balsalazide,A07EC04
antidiarrheal microorganisms,A07F
antidiarrheal microorganisms,A07FA
lactic acid producing organisms,A07FA01
saccharomyces boulardii,A07FA02
"lactic acid producing organisms, combinations",A07FA51
other antidiarrheals,A07X
other antidiarrheals,A07XA
albumin tannate,A07XA01
ceratonia,A07XA02
calcium compounds,A07XA03
racecadotril,A07XA04
crofelemer,A07XA06
"albumin tannate, combinations",A07XA51
antibiotics,A07AA
neomycin,A07AA01
nystatin,A07AA02
natamycin,A07AA03
streptomycin,A07AA04
polymyxin b,A07AA05
paromomycin,A07AA06
amphotericin b,A07AA07
kanamycin,A07AA08
vancomycin,A07AA09
colistin,A07AA10
rifaximin,A07AA11
fidaxomicin,A07AA12
rifamycin,A07AA13
"neomycin, combinations",A07AA51
"streptomycin, combinations",A07AA54
"antiobesity preparations, excl. diet products",A08
"antiobesity preparations, excl. diet products",A08A
peripherally acting antiobesity products,A08AB
orlistat,A08AB01
other antiobesity drugs,A08AX
rimonabant,A08AX01
centrally acting antiobesity products,A08AA
phentermine,A08AA01
fenfluramine,A08AA02
amfepramone,A08AA03
dexfenfluramine,A08AA04
mazindol,A08AA05
etilamfetamine,A08AA06
cathine,A08AA07
clobenzorex,A08AA08
mefenorex,A08AA09
sibutramine,A08AA10
lorcaserin,A08AA11
"ephedrine, combinations",A08AA56
bupropion and naltrexone,A08AA62
"digestives, incl. enzymes",A09
"digestives, incl. enzymes",A09A
acid preparations,A09AB
glutamic acid hydrochloride,A09AB01
betaine hydrochloride,A09AB02
hydrochloric acid,A09AB03
citric acid,A09AB04
"enzyme and acid preparations, combinations",A09AC
pepsin and acid preparations,A09AC01
multienzymes and acid preparations,A09AC02
enzyme preparations,A09AA
diastase,A09AA01
"multienzymes (lipase, protease etc.)",A09AA02
pepsin,A09AA03
tilactase,A09AA04
drugs used in diabetes,A10
insulins and analogues,A10A
"insulins and analogues for injection, fast-acting",A10AB
insulin (human),A10AB01
insulin (beef),A10AB02
insulin (pork),A10AB03
insulin lispro,A10AB04
insulin aspart,A10AB05
insulin glulisine,A10AB06
combinations,A10AB30
"insulins and analogues for injection, intermediate-acting",A10AC
insulin (human),A10AC01
insulin (beef),A10AC02
insulin (pork),A10AC03
insulin lispro,A10AC04
combinations,A10AC30
"insulins and analogues for injection, intermediate- or long-acting combined with fast-acting",A10AD
insulin (human),A10AD01
insulin (beef),A10AD02
insulin (pork),A10AD03
insulin lispro,A10AD04
insulin aspart,A10AD05
insulin degludec and insulin aspart,A10AD06
combinations,A10AD30
"insulins and analogues for injection, long-acting",A10AE
insulin (human),A10AE01
insulin (beef),A10AE02
insulin (pork),A10AE03
insulin glargine,A10AE04
insulin detemir,A10AE05
insulin degludec,A10AE06
combinations,A10AE30
insulin glargine and lixisenatide,A10AE54
insulin degludec and liraglutide,A10AE56
insulins and analogues for inhalation,A10AF
insulin (human),A10AF01
"blood glucose lowering drugs, excl. insulins",A10B
biguanides,A10BA
phenformin,A10BA01
metformin,A10BA02
buformin,A10BA03
sulfonylureas,A10BB
glibenclamide,A10BB01
chlorpropamide,A10BB02
tolbutamide,A10BB03
glibornuride,A10BB04
tolazamide,A10BB05
carbutamide,A10BB06
glipizide,A10BB07
gliquidone,A10BB08
gliclazide,A10BB09
metahexamide,A10BB10
glisoxepide,A10BB11
glimepiride,A10BB12
acetohexamide,A10BB31
sulfonamides (heterocyclic),A10BC
glymidine,A10BC01
combinations of oral blood glucose lowering drugs,A10BD
phenformin and sulfonylureas,A10BD01
metformin and sulfonylureas,A10BD02
metformin and rosiglitazone,A10BD03
glimepiride and rosiglitazone,A10BD04
metformin and pioglitazone,A10BD05
glimepiride and pioglitazone,A10BD06
metformin and sitagliptin,A10BD07
metformin and vildagliptin,A10BD08
pioglitazone and alogliptin,A10BD09
metformin and saxagliptin,A10BD10
metformin and linagliptin,A10BD11
pioglitazone and sitagliptin,A10BD12
metformin and alogliptin,A10BD13
metformin and repaglinide,A10BD14
metformin and dapagliflozin,A10BD15
metformin and canagliflozin,A10BD16
metformin and acarbose,A10BD17
metformin and gemigliptin,A10BD18
linagliptin and empagliflozin,A10BD19
metformin and empagliflozin,A10BD20
saxagliptin and dapagliflozin,A10BD21
metformin and evogliptin,A10BD22
metformin and ertugliflozin,A10BD23
sitagliptin and ertugliflozin,A10BD24
"metformin, saxagliptin and dapagliflozin",A10BD25
metformin and lobeglitazone,A10BD26
alpha glucosidase inhibitors,A10BF
acarbose,A10BF01
miglitol,A10BF02
voglibose,A10BF03
thiazolidinediones,A10BG
troglitazone,A10BG01
rosiglitazone,A10BG02
pioglitazone,A10BG03
lobeglitazone,A10BG04
dipeptidyl peptidase 4 (dpp-4) inhibitors,A10BH
sitagliptin,A10BH01
vildagliptin,A10BH02
saxagliptin,A10BH03
alogliptin,A10BH04
linagliptin,A10BH05
gemigliptin,A10BH06
evogliptin,A10BH07
teneligliptin,A10BH08
sitagliptin and simvastatin,A10BH51
gemigliptin and rosuvastatin,A10BH52
glucagon-like peptide-1 (glp-1) analogues,A10BJ
exenatide,A10BJ01
liraglutide,A10BJ02
lixisenatide,A10BJ03
albiglutide,A10BJ04
dulaglutide,A10BJ05
semaglutide,A10BJ06
beinaglutide,A10BJ07
sodium-glucose co-transporter 2 (sglt2) inhibitors,A10BK
dapagliflozin,A10BK01
canagliflozin,A10BK02
empagliflozin,A10BK03
ertugliflozin,A10BK04
ipragliflozin,A10BK05
sotagliflozin,A10BK06
luseogliflozin,A10BK07
"other blood glucose lowering drugs, excl. insulins",A10BX
guar gum,A10BX01
repaglinide,A10BX02
nateglinide,A10BX03
pramlintide,A10BX05
benfluorex,A10BX06
mitiglinide,A10BX08
other drugs used in diabetes,A10X
aldose reductase inhibitors,A10XA
tolrestat,A10XA01
vitamins,A11
"multivitamins, combinations",A11A
"multivitamins, other combinations",A11AB
"multivitamins, plain",A11B
"multivitamins, plain",A11BA
"vitamin a and d, incl. combinations of the two",A11C
"vitamin a, plain",A11CA
retinol (vit a),A11CA01
betacarotene,A11CA02
vitamin a and d in combination,A11CB
vitamin d and analogues,A11CC
ergocalciferol,A11CC01
dihydrotachysterol,A11CC02
alfacalcidol,A11CC03
calcitriol,A11CC04
colecalciferol,A11CC05
calcifediol,A11CC06
combinations,A11CC20
"colecalciferol, combinations",A11CC55
"vitamin b<n>1</n>, plain and in combination with vitamin b<n>6</n> and b<n>12</n>",A11D
"vitamin b<n>1</n>, plain",A11DA
thiamine (vit b<n>1</n>),A11DA01
sulbutiamine,A11DA02
benfotiamine,A11DA03
vitamin b<n>1</n> in combination with vitamin b<n>6</n> and/or vitamin b<n>12</n>,A11DB
"vitamin b-complex, incl. combinations",A11E
"vitamin b-complex, plain",A11EA
vitamin b-complex with vitamin c,A11EB
vitamin b-complex with minerals,A11EC
vitamin b-complex with anabolic steroids,A11ED
"vitamin b-complex, other combinations",A11EX
"ascorbic acid (vitamin c), incl. combinations",A11G
"ascorbic acid (vitamin c), plain",A11GA
ascorbic acid (vit c),A11GA01
"ascorbic acid (vitamin c), combinations",A11GB
ascorbic acid (vit c) and calcium,A11GB01
other plain vitamin preparations,A11H
other plain vitamin preparations,A11HA
nicotinamide,A11HA01
pyridoxine (vit b<n>6</n>),A11HA02
tocopherol (vit e),A11HA03
riboflavin (vit b<n>2</n>),A11HA04
biotin,A11HA05
pyridoxal phosphate,A11HA06
inositol,A11HA07
tocofersolan,A11HA08
dexpanthenol,A11HA30
calcium pantothenate,A11HA31
pantethine,A11HA32
"other vitamin products, combinations",A11J
combinations of vitamins,A11JA
vitamins with minerals,A11JB
"vitamins, other combinations",A11JC
multivitamins with minerals,A11AA
multivitamins and iron,A11AA01
multivitamins and calcium,A11AA02
"multivitamins and other minerals, incl. combinations",A11AA03
multivitamins and trace elements,A11AA04
mineral supplements,A12
calcium,A12A
"calcium, combinations with vitamin d and/or other drugs",A12AX
potassium,A12B
potassium,A12BA
potassium chloride,A12BA01
potassium citrate,A12BA02
potassium hydrogentartrate,A12BA03
potassium hydrogencarbonate,A12BA04
potassium gluconate,A12BA05
potassium (different salts in combination),A12BA30
"potassium chloride, combinations",A12BA51
other mineral supplements,A12C
sodium,A12CA
sodium chloride,A12CA01
sodium sulfate,A12CA02
zinc,A12CB
zinc sulfate,A12CB01
zinc gluconate,A12CB02
zinc protein complex,A12CB03
magnesium,A12CC
magnesium chloride,A12CC01
magnesium sulfate,A12CC02
magnesium gluconate,A12CC03
magnesium citrate,A12CC04
magnesium aspartate,A12CC05
magnesium lactate,A12CC06
magnesium levulinate,A12CC07
magnesium pidolate,A12CC08
magnesium orotate,A12CC09
magnesium oxide,A12CC10
magnesium (different salts in combination),A12CC30
fluoride,A12CD
sodium fluoride,A12CD01
sodium monofluorophosphate,A12CD02
"fluoride, combinations",A12CD51
selenium,A12CE
sodium selenate,A12CE01
sodium selenite,A12CE02
other mineral products,A12CX
calcium,A12AA
calcium phosphate,A12AA01
calcium glubionate,A12AA02
calcium gluconate,A12AA03
calcium carbonate,A12AA04
calcium lactate,A12AA05
calcium lactate gluconate,A12AA06
calcium chloride,A12AA07
calcium glycerylphosphate,A12AA08
calcium citrate lysine complex,A12AA09
calcium glucoheptonate,A12AA10
calcium pangamate,A12AA11
calcium citrate,A12AA13
calcium (different salts in combination),A12AA20
calcium laevulate,A12AA30
tonics,A13
tonics,A13A
anabolic agents for systemic use,A14
anabolic steroids,A14A
estren derivatives,A14AB
nandrolone,A14AB01
ethylestrenol,A14AB02
oxabolone cipionate,A14AB03
other anabolic agents,A14B
androstan derivatives,A14AA
androstanolone,A14AA01
stanozolol,A14AA02
metandienone,A14AA03
metenolone,A14AA04
oxymetholone,A14AA05
quinbolone,A14AA06
prasterone,A14AA07
oxandrolone,A14AA08
norethandrolone,A14AA09
appetite stimulants,A15
other alimentary tract and metabolism products,A16
other alimentary tract and metabolism products,A16A
enzymes,A16AB
alglucerase,A16AB01
imiglucerase,A16AB02
agalsidase alfa,A16AB03
agalsidase beta,A16AB04
laronidase,A16AB05
sacrosidase,A16AB06
alglucosidase alfa,A16AB07
galsulfase,A16AB08
idursulfase,A16AB09
velaglucerase alfa,A16AB10
taliglucerase alfa,A16AB11
elosulfase alfa,A16AB12
asfotase alfa,A16AB13
sebelipase alfa,A16AB14
velmanase alfa,A16AB15
idursulfase beta,A16AB16
cerliponase alfa,A16AB17
vestronidase alfa,A16AB18
pegvaliase,A16AB19
various alimentary tract and metabolism products,A16AX
thioctic acid,A16AX01
anethole trithione,A16AX02
sodium phenylbutyrate,A16AX03
nitisinone,A16AX04
zinc acetate,A16AX05
miglustat,A16AX06
sapropterin,A16AX07
teduglutide,A16AX08
glycerol phenylbutyrate,A16AX09
eliglustat,A16AX10
sodium benzoate,A16AX11
trientine,A16AX12
uridine triacetate,A16AX13
migalastat,A16AX14
telotristat,A16AX15
givosiran,A16AX16
triheptanoin,A16AX17
lumasiran,A16AX18
sodium benzoate and sodium phenylacetate,A16AX30
amino acids and derivatives,A16AA
levocarnitine,A16AA01
ademetionine,A16AA02
glutamine,A16AA03
mercaptamine,A16AA04
carglumic acid,A16AA05
betaine,A16AA06
metreleptin,A16AA07
blood and blood forming organs,B
antithrombotic agents,B01
antithrombotic agents,B01A
heparin group,B01AB
heparin,B01AB01
antithrombin iii,B01AB02
dalteparin,B01AB04
enoxaparin,B01AB05
nadroparin,B01AB06
parnaparin,B01AB07
reviparin,B01AB08
danaparoid,B01AB09
tinzaparin,B01AB10
sulodexide,B01AB11
bemiparin,B01AB12
"heparin, combinations",B01AB51
platelet aggregation inhibitors excl. heparin,B01AC
ditazole,B01AC01
cloricromen,B01AC02
picotamide,B01AC03
clopidogrel,B01AC04
ticlopidine,B01AC05
acetylsalicylic acid,B01AC06
dipyridamole,B01AC07
carbasalate calcium,B01AC08
epoprostenol,B01AC09
indobufen,B01AC10
iloprost,B01AC11
abciximab,B01AC13
aloxiprin,B01AC15
eptifibatide,B01AC16
tirofiban,B01AC17
triflusal,B01AC18
beraprost,B01AC19
treprostinil,B01AC21
prasugrel,B01AC22
cilostazol,B01AC23
ticagrelor,B01AC24
cangrelor,B01AC25
vorapaxar,B01AC26
selexipag,B01AC27
combinations,B01AC30
"acetylsalicylic acid, combinations with proton pump inhibitors",B01AC56
enzymes,B01AD
streptokinase,B01AD01
alteplase,B01AD02
anistreplase,B01AD03
urokinase,B01AD04
fibrinolysin,B01AD05
brinase,B01AD06
reteplase,B01AD07
saruplase,B01AD08
ancrod,B01AD09
drotrecogin alfa (activated),B01AD10
tenecteplase,B01AD11
protein c,B01AD12
direct thrombin inhibitors,B01AE
desirudin,B01AE01
lepirudin,B01AE02
argatroban,B01AE03
melagatran,B01AE04
ximelagatran,B01AE05
bivalirudin,B01AE06
dabigatran etexilate,B01AE07
direct factor xa inhibitors,B01AF
rivaroxaban,B01AF01
apixaban,B01AF02
edoxaban,B01AF03
betrixaban,B01AF04
other antithrombotic agents,B01AX
defibrotide,B01AX01
dermatan sulfate,B01AX04
fondaparinux,B01AX05
caplacizumab,B01AX07
vitamin k antagonists,B01AA
dicoumarol,B01AA01
phenindione,B01AA02
warfarin,B01AA03
phenprocoumon,B01AA04
acenocoumarol,B01AA07
ethyl biscoumacetate,B01AA08
clorindione,B01AA09
diphenadione,B01AA10
tioclomarol,B01AA11
fluindione,B01AA12
antihemorrhagics,B02
antifibrinolytics,B02A
proteinase inhibitors,B02AB
aprotinin,B02AB01
alfa1 antitrypsin,B02AB02
camostat,B02AB04
ulinastatin,B02AB05
vitamin k and other hemostatics,B02B
vitamin k,B02BA
phytomenadione,B02BA01
menadione,B02BA02
fibrinogen,B02BB
"fibrinogen, human",B02BB01
local hemostatics,B02BC
absorbable gelatin sponge,B02BC01
oxidized cellulose,B02BC02
tetragalacturonic acid hydroxymethylester,B02BC03
adrenalone,B02BC05
thrombin,B02BC06
collagen,B02BC07
calcium alginate,B02BC08
epinephrine,B02BC09
combinations,B02BC30
blood coagulation factors,B02BD
"coagulation factor ix, ii, vii and x in combination",B02BD01
coagulation factor viii,B02BD02
factor viii inhibitor bypassing activity,B02BD03
coagulation factor ix,B02BD04
coagulation factor vii,B02BD05
von willebrand factor and coagulation factor viii in combination,B02BD06
coagulation factor xiii,B02BD07
coagulation factor viia,B02BD08
von willebrand factor,B02BD10
catridecacog,B02BD11
coagulation factor x,B02BD13
susoctocog alfa,B02BD14
thrombin,B02BD30
other systemic hemostatics,B02BX
etamsylate,B02BX01
carbazochrome,B02BX02
batroxobin,B02BX03
romiplostim,B02BX04
eltrombopag,B02BX05
emicizumab,B02BX06
lusutrombopag,B02BX07
avatrombopag,B02BX08
fostamatinib,B02BX09
amino acids,B02AA
aminocaproic acid,B02AA01
tranexamic acid,B02AA02
aminomethylbenzoic acid,B02AA03
antianemic preparations,B03
iron preparations,B03A
"iron trivalent, oral preparations",B03AB
ferric sodium citrate,B03AB01
saccharated iron oxide,B03AB02
sodium feredetate,B03AB03
ferric hydroxide,B03AB04
ferric oxide polymaltose complexes,B03AB05
chondroitin sulfate-iron complex,B03AB07
ferric acetyl transferrin,B03AB08
ferric proteinsuccinylate,B03AB09
ferric maltol,B03AB10
"iron, parenteral preparations",B03AC
iron in combination with folic acid,B03AD
ferrous amino acid complex,B03AD01
ferrous fumarate,B03AD02
ferrous sulfate,B03AD03
ferric oxide polymaltose complexes,B03AD04
ferrous gluconate,B03AD05
iron in other combinations,B03AE
"iron, vitamin b<n>12</n> and folic acid",B03AE01
"iron, multivitamins and folic acid",B03AE02
iron and multivitamins,B03AE03
"iron, multivitamins and minerals",B03AE04
various combinations,B03AE10
vitamin b<n>12</n> and folic acid,B03B
vitamin b<n>12</n> (cyanocobalamin and analogues),B03BA
cyanocobalamin,B03BA01
cyanocobalamin tannin complex,B03BA02
hydroxocobalamin,B03BA03
cobamamide,B03BA04
mecobalamin,B03BA05
"cyanocobalamin, combinations",B03BA51
"hydroxocobalamin, combinations",B03BA53
folic acid and derivatives,B03BB
folic acid,B03BB01
"folic acid, combinations",B03BB51
other antianemic preparations,B03X
other antianemic preparations,B03XA
erythropoietin,B03XA01
darbepoetin alfa,B03XA02
methoxy polyethylene glycol-epoetin beta,B03XA03
peginesatide,B03XA04
roxadustat,B03XA05
luspatercept,B03XA06
"iron bivalent, oral preparations",B03AA
ferrous glycine sulfate,B03AA01
ferrous fumarate,B03AA02
ferrous gluconate,B03AA03
ferrous carbonate,B03AA04
ferrous chloride,B03AA05
ferrous succinate,B03AA06
ferrous sulfate,B03AA07
ferrous tartrate,B03AA08
ferrous aspartate,B03AA09
ferrous ascorbate,B03AA10
ferrous iodine,B03AA11
ferrous sodium citrate,B03AA12
blood substitutes and perfusion solutions,B05
blood and related products,B05A
other blood products,B05AX
erythrocytes,B05AX01
thrombocytes,B05AX02
blood plasma,B05AX03
stem cells from umbilical cord blood,B05AX04
i.v. solutions,B05B
solutions for parenteral nutrition,B05BA
amino acids,B05BA01
fat emulsions,B05BA02
carbohydrates,B05BA03
protein hydrolysates,B05BA04
combinations,B05BA10
solutions affecting the electrolyte balance,B05BB
electrolytes,B05BB01
electrolytes with carbohydrates,B05BB02
trometamol,B05BB03
electrolytes in combination with other drugs,B05BB04
solutions producing osmotic diuresis,B05BC
mannitol,B05BC01
carbamide,B05BC02
irrigating solutions,B05C
antiinfectives,B05CA
cetylpyridinium,B05CA01
chlorhexidine,B05CA02
nitrofural,B05CA03
sulfamethizole,B05CA04
taurolidine,B05CA05
mandelic acid,B05CA06
noxytiolin,B05CA07
ethacridine lactate,B05CA08
neomycin,B05CA09
combinations,B05CA10
salt solutions,B05CB
sodium chloride,B05CB01
sodium citrate,B05CB02
magnesium citrate,B05CB03
sodium bicarbonate,B05CB04
combinations,B05CB10
other irrigating solutions,B05CX
glucose,B05CX01
sorbitol,B05CX02
glycine,B05CX03
mannitol,B05CX04
combinations,B05CX10
peritoneal dialytics,B05D
isotonic solutions,B05DA
hypertonic solutions,B05DB
i.v. solution additives,B05X
electrolyte solutions,B05XA
potassium chloride,B05XA01
sodium bicarbonate,B05XA02
sodium chloride,B05XA03
ammonium chloride,B05XA04
magnesium sulfate,B05XA05
"potassium phosphate, incl. combinations with other potassium salts",B05XA06
calcium chloride,B05XA07
sodium acetate,B05XA08
sodium phosphate,B05XA09
magnesium phosphate,B05XA10
magnesium chloride,B05XA11
zinc chloride,B05XA12
hydrochloric acid,B05XA13
sodium glycerophosphate,B05XA14
potassium lactate,B05XA15
cardioplegia solutions,B05XA16
potassium acetate,B05XA17
zinc sulfate,B05XA18
combinations of electrolytes,B05XA30
electrolytes in combination with other drugs,B05XA31
amino acids,B05XB
arginine hydrochloride,B05XB01
alanyl glutamine,B05XB02
lysine,B05XB03
vitamins,B05XC
other i.v. solution additives,B05XX
trometamol,B05XX02
hemodialytics and hemofiltrates,B05Z
"hemodialytics, concentrates",B05ZA
hemofiltrates,B05ZB
blood substitutes and plasma protein fractions,B05AA
albumin,B05AA01
other plasma protein fractions,B05AA02
fluorocarbon blood substitutes,B05AA03
dextran,B05AA05
gelatin agents,B05AA06
hydroxyethylstarch,B05AA07
hemoglobin crosfumaril,B05AA08
hemoglobin raffimer,B05AA09
hemoglobin glutamer (bovine),B05AA10
other hematological agents,B06
other hematological agents,B06A
heme products,B06AB
hemin,B06AB01
drugs used in hereditary angioedema,B06AC
"c1-inhibitor, plasma derived",B06AC01
icatibant,B06AC02
ecallantide,B06AC03
conestat alfa,B06AC04
lanadelumab,B06AC05
other hematological agents,B06AX
crizanlizumab,B06AX01
betibeglogene autotemcel,B06AX02
enzymes,B06AA
fibrinolysin and desoxyribonuclease,B06AA02
hyaluronidase,B06AA03
chymotrypsin,B06AA04
trypsin,B06AA07
desoxyribonuclease,B06AA10
"streptokinase, combinations",B06AA55
cardiovascular system,C
cardiac therapy,C01
cardiac glycosides,C01A
scilla glycosides,C01AB
proscillaridin,C01AB01
"proscillaridin, combinations",C01AB51
strophanthus glycosides,C01AC
g-strophanthin,C01AC01
cymarin,C01AC03
other cardiac glycosides,C01AX
peruvoside,C01AX02
"antiarrhythmics, class i and iii",C01B
"antiarrhythmics, class ia",C01BA
quinidine,C01BA01
procainamide,C01BA02
disopyramide,C01BA03
sparteine,C01BA04
ajmaline,C01BA05
prajmaline,C01BA08
lorajmine,C01BA12
hydroquinidine,C01BA13
"quinidine, combinations excl. psycholeptics",C01BA51
"quinidine, combinations with psycholeptics",C01BA71
"antiarrhythmics, class ib",C01BB
lidocaine,C01BB01
mexiletine,C01BB02
tocainide,C01BB03
aprindine,C01BB04
"antiarrhythmics, class ic",C01BC
propafenone,C01BC03
flecainide,C01BC04
lorcainide,C01BC07
encainide,C01BC08
ethacizine,C01BC09
"antiarrhythmics, class iii",C01BD
amiodarone,C01BD01
bretylium tosilate,C01BD02
bunaftine,C01BD03
dofetilide,C01BD04
ibutilide,C01BD05
tedisamil,C01BD06
dronedarone,C01BD07
"other antiarrhythmics, class i and iii",C01BG
moracizine,C01BG01
cibenzoline,C01BG07
vernakalant,C01BG11
cardiac stimulants excl. cardiac glycosides,C01C
adrenergic and dopaminergic agents,C01CA
etilefrine,C01CA01
isoprenaline,C01CA02
norepinephrine,C01CA03
dopamine,C01CA04
norfenefrine,C01CA05
phenylephrine,C01CA06
dobutamine,C01CA07
oxedrine,C01CA08
metaraminol,C01CA09
methoxamine,C01CA10
mephentermine,C01CA11
dimetofrine,C01CA12
prenalterol,C01CA13
dopexamine,C01CA14
gepefrine,C01CA15
ibopamine,C01CA16
midodrine,C01CA17
octopamine,C01CA18
fenoldopam,C01CA19
cafedrine,C01CA21
arbutamine,C01CA22
theodrenaline,C01CA23
epinephrine,C01CA24
amezinium metilsulfate,C01CA25
ephedrine,C01CA26
droxidopa,C01CA27
combinations,C01CA30
"etilefrine, combinations",C01CA51
phosphodiesterase inhibitors,C01CE
amrinone,C01CE01
milrinone,C01CE02
enoximone,C01CE03
bucladesine,C01CE04
other cardiac stimulants,C01CX
angiotensinamide,C01CX06
xamoterol,C01CX07
levosimendan,C01CX08
angiotensin ii,C01CX09
vasodilators used in cardiac diseases,C01D
organic nitrates,C01DA
glyceryl trinitrate,C01DA02
methylpropylpropanediol dinitrate,C01DA04
pentaerithrityl tetranitrate,C01DA05
propatylnitrate,C01DA07
isosorbide dinitrate,C01DA08
trolnitrate,C01DA09
eritrityl tetranitrate,C01DA13
isosorbide mononitrate,C01DA14
organic nitrates in combination,C01DA20
tenitramine,C01DA38
"glyceryl trinitrate, combinations",C01DA52
"methylpropylpropanediol dinitrate, combinations",C01DA54
"pentaerithrityl tetranitrate, combinations",C01DA55
"propatylnitrate, combinations",C01DA57
"isosorbide dinitrate, combinations",C01DA58
"trolnitrate, combinations",C01DA59
"eritrityl tetranitrate, combinations",C01DA63
organic nitrates in combination with psycholeptics,C01DA70
quinolone vasodilators,C01DB
flosequinan,C01DB01
other vasodilators used in cardiac diseases,C01DX
itramin tosilate,C01DX01
prenylamine,C01DX02
oxyfedrine,C01DX03
benziodarone,C01DX04
carbocromen,C01DX05
hexobendine,C01DX06
etafenone,C01DX07
heptaminol,C01DX08
imolamine,C01DX09
dilazep,C01DX10
trapidil,C01DX11
molsidomine,C01DX12
efloxate,C01DX13
cinepazet,C01DX14
cloridarol,C01DX15
nicorandil,C01DX16
linsidomine,C01DX18
nesiritide,C01DX19
serelaxin,C01DX21
vericiguat,C01DX22
"itramin tosilate, combinations",C01DX51
"prenylamine, combinations",C01DX52
"oxyfedrine, combinations",C01DX53
"benziodarone, combinations",C01DX54
other cardiac preparations,C01E
prostaglandins,C01EA
alprostadil,C01EA01
other cardiac preparations,C01EB
camphora,C01EB02
indometacin,C01EB03
crataegus glycosides,C01EB04
creatinolfosfate,C01EB05
fosfocreatine,C01EB06
"fructose 1,6-diphosphate",C01EB07
ubidecarenone,C01EB09
adenosine,C01EB10
tiracizine,C01EB11
acadesine,C01EB13
trimetazidine,C01EB15
ibuprofen,C01EB16
ivabradine,C01EB17
ranolazine,C01EB18
regadenoson,C01EB21
meldonium,C01EB22
tiazotic acid,C01EB23
other cardiac combination products,C01EX
digitalis glycosides,C01AA
acetyldigitoxin,C01AA01
acetyldigoxin,C01AA02
digitalis leaves,C01AA03
digitoxin,C01AA04
digoxin,C01AA05
lanatoside c,C01AA06
deslanoside,C01AA07
metildigoxin,C01AA08
gitoformate,C01AA09
"acetyldigoxin, combinations",C01AA52
antihypertensives,C02
"antiadrenergic agents, centrally acting",C02A
methyldopa,C02AB
methyldopa (levorotatory),C02AB01
methyldopa (racemic),C02AB02
imidazoline receptor agonists,C02AC
clonidine,C02AC01
guanfacine,C02AC02
tolonidine,C02AC04
moxonidine,C02AC05
rilmenidine,C02AC06
"antiadrenergic agents, ganglion-blocking",C02B
sulfonium derivatives,C02BA
trimetaphan,C02BA01
secondary and tertiary amines,C02BB
mecamylamine,C02BB01
bisquaternary ammonium compounds,C02BC
"antiadrenergic agents, peripherally acting",C02C
alpha-adrenoreceptor antagonists,C02CA
prazosin,C02CA01
indoramin,C02CA02
trimazosin,C02CA03
doxazosin,C02CA04
urapidil,C02CA06
guanidine derivatives,C02CC
betanidine,C02CC01
guanethidine,C02CC02
guanoxan,C02CC03
debrisoquine,C02CC04
guanoclor,C02CC05
guanazodine,C02CC06
guanoxabenz,C02CC07
"arteriolar smooth muscle, agents acting on",C02D
thiazide derivatives,C02DA
diazoxide,C02DA01
hydrazinophthalazine derivatives,C02DB
dihydralazine,C02DB01
hydralazine,C02DB02
endralazine,C02DB03
cadralazine,C02DB04
pyrimidine derivatives,C02DC
minoxidil,C02DC01
nitroferricyanide derivatives,C02DD
nitroprusside,C02DD01
guanidine derivatives,C02DG
pinacidil,C02DG01
other antihypertensives,C02K
"alkaloids, excl. rauwolfia",C02KA
veratrum,C02KA01
tyrosine hydroxylase inhibitors,C02KB
metirosine,C02KB01
mao inhibitors,C02KC
pargyline,C02KC01
serotonin antagonists,C02KD
ketanserin,C02KD01
antihypertensives for pulmonary arterial hypertension,C02KX
bosentan,C02KX01
ambrisentan,C02KX02
sitaxentan,C02KX03
macitentan,C02KX04
riociguat,C02KX05
ambrisentan and tadalafil,C02KX52
antihypertensives and diuretics in combination,C02L
rauwolfia alkaloids and diuretics in combination,C02LA
reserpine and diuretics,C02LA01
rescinnamine and diuretics,C02LA02
deserpidine and diuretics,C02LA03
methoserpidine and diuretics,C02LA04
bietaserpine and diuretics,C02LA07
"rauwolfia alkaloids, whole root and diuretics",C02LA08
syrosingopine and diuretics,C02LA09
combination of rauwolfia alkaloids and diuretics incl. other combinations,C02LA50
"reserpine and diuretics, combinations with other drugs",C02LA51
"rescinnamine and diuretics, combinations with other drugs",C02LA52
"reserpine and diuretics, combinations with psycholeptics",C02LA71
methyldopa and diuretics in combination,C02LB
methyldopa (levorotatory) and diuretics,C02LB01
imidazoline receptor agonists in combination with diuretics,C02LC
clonidine and diuretics,C02LC01
moxonidine and diuretics,C02LC05
"clonidine and diuretics, combinations with other drugs",C02LC51
alpha-adrenoreceptor antagonists and diuretics,C02LE
prazosin and diuretics,C02LE01
guanidine derivatives and diuretics,C02LF
guanethidine and diuretics,C02LF01
hydrazinophthalazine derivatives and diuretics,C02LG
dihydralazine and diuretics,C02LG01
hydralazine and diuretics,C02LG02
picodralazine and diuretics,C02LG03
"dihydralazine and diuretics, combinations with other drugs",C02LG51
"picodralazine and diuretics, combinations with psycholeptics",C02LG73
"alkaloids, excl. rauwolfia, in combination with diuretics",C02LK
veratrum and diuretics,C02LK01
mao inhibitors and diuretics,C02LL
pargyline and diuretics,C02LL01
serotonin antagonists and diuretics,C02LN
other antihypertensives and diuretics,C02LX
pinacidil and diuretics,C02LX01
combinations of antihypertensives in atc-gr. c02,C02N
rauwolfia alkaloids,C02AA
rescinnamine,C02AA01
reserpine,C02AA02
combinations of rauwolfia alkaloids,C02AA03
"rauwolfia alkaloids, whole root",C02AA04
deserpidine,C02AA05
methoserpidine,C02AA06
bietaserpine,C02AA07
"reserpine, combinations",C02AA52
"combinations of rauwolfia alkoloids, combinations",C02AA53
"bietaserpine, combinations",C02AA57
diuretics,C03
"low-ceiling diuretics, thiazides",C03A
thiazides and potassium in combination,C03AB
bendroflumethiazide and potassium,C03AB01
hydroflumethiazide and potassium,C03AB02
hydrochlorothiazide and potassium,C03AB03
chlorothiazide and potassium,C03AB04
polythiazide and potassium,C03AB05
trichlormethiazide and potassium,C03AB06
cyclopenthiazide and potassium,C03AB07
methyclothiazide and potassium,C03AB08
cyclothiazide and potassium,C03AB09
"thiazides, combinations with psycholeptics and/or analgesics",C03AH
"chlorothiazide, combinations",C03AH01
"hydroflumethiazide, combinations",C03AH02
"thiazides, combinations with other drugs",C03AX
"hydrochlorothiazide, combinations",C03AX01
"low-ceiling diuretics, excl. thiazides",C03B
"sulfonamides, plain",C03BA
quinethazone,C03BA02
clopamide,C03BA03
chlortalidone,C03BA04
mefruside,C03BA05
clofenamide,C03BA07
metolazone,C03BA08
meticrane,C03BA09
xipamide,C03BA10
indapamide,C03BA11
clorexolone,C03BA12
fenquizone,C03BA13
"clorexolone, combinations with psycholeptics",C03BA82
sulfonamides and potassium in combination,C03BB
quinethazone and potassium,C03BB02
clopamide and potassium,C03BB03
chlortalidone and potassium,C03BB04
mefruside and potassium,C03BB05
clofenamide and potassium,C03BB07
mercurial diuretics,C03BC
mersalyl,C03BC01
xanthine derivatives,C03BD
theobromine,C03BD01
"sulfonamides, combinations with other drugs",C03BK
other low-ceiling diuretics,C03BX
cicletanine,C03BX03
high-ceiling diuretics,C03C
"sulfonamides, plain",C03CA
furosemide,C03CA01
bumetanide,C03CA02
piretanide,C03CA03
torasemide,C03CA04
sulfonamides and potassium in combination,C03CB
furosemide and potassium,C03CB01
bumetanide and potassium,C03CB02
aryloxyacetic acid derivatives,C03CC
etacrynic acid,C03CC01
tienilic acid,C03CC02
pyrazolone derivatives,C03CD
muzolimine,C03CD01
other high-ceiling diuretics,C03CX
etozolin,C03CX01
potassium-sparing agents,C03D
aldosterone antagonists,C03DA
spironolactone,C03DA01
potassium canrenoate,C03DA02
canrenone,C03DA03
eplerenone,C03DA04
other potassium-sparing agents,C03DB
amiloride,C03DB01
triamterene,C03DB02
diuretics and potassium-sparing agents in combination,C03E
low-ceiling diuretics and potassium-sparing agents,C03EA
hydrochlorothiazide and potassium-sparing agents,C03EA01
trichlormethiazide and potassium-sparing agents,C03EA02
epitizide and potassium-sparing agents,C03EA03
altizide and potassium-sparing agents,C03EA04
mebutizide and potassium-sparing agents,C03EA05
chlortalidone and potassium-sparing agents,C03EA06
cyclopenthiazide and potassium-sparing agents,C03EA07
metolazone and potassium-sparing agents,C03EA12
bendroflumethiazide and potassium-sparing agents,C03EA13
butizide and potassium-sparing agents,C03EA14
high-ceiling diuretics and potassium-sparing agents,C03EB
furosemide and potassium-sparing agents,C03EB01
bumetanide and potassium-sparing agents,C03EB02
other diuretics,C03X
vasopressin antagonists,C03XA
tolvaptan,C03XA01
conivaptan,C03XA02
"thiazides, plain",C03AA
bendroflumethiazide,C03AA01
hydroflumethiazide,C03AA02
hydrochlorothiazide,C03AA03
chlorothiazide,C03AA04
polythiazide,C03AA05
trichlormethiazide,C03AA06
cyclopenthiazide,C03AA07
methyclothiazide,C03AA08
cyclothiazide,C03AA09
mebutizide,C03AA13
peripheral vasodilators,C04
peripheral vasodilators,C04A
imidazoline derivatives,C04AB
phentolamine,C04AB01
tolazoline,C04AB02
nicotinic acid and derivatives,C04AC
nicotinic acid,C04AC01
nicotinyl alcohol (pyridylcarbinol),C04AC02
inositol nicotinate,C04AC03
ciclonicate,C04AC07
purine derivatives,C04AD
pentifylline,C04AD01
xantinol nicotinate,C04AD02
pentoxifylline,C04AD03
etofylline nicotinate,C04AD04
ergot alkaloids,C04AE
ergoloid mesylates,C04AE01
nicergoline,C04AE02
dihydroergocristine,C04AE04
"ergoloid mesylates, combinations",C04AE51
"dihydroergocristine, combinations",C04AE54
enzymes,C04AF
kallidinogenase,C04AF01
other peripheral vasodilators,C04AX
cyclandelate,C04AX01
phenoxybenzamine,C04AX02
vincamine,C04AX07
moxisylyte,C04AX10
bencyclane,C04AX11
vinburnine,C04AX17
suloctidil,C04AX19
buflomedil,C04AX20
naftidrofuryl,C04AX21
butalamine,C04AX23
visnadine,C04AX24
cetiedil,C04AX26
cinepazide,C04AX27
ifenprodil,C04AX28
azapetine,C04AX30
fasudil,C04AX32
2-amino-1-phenylethanol derivatives,C04AA
isoxsuprine,C04AA01
buphenine,C04AA02
bamethan,C04AA31
vasoprotectives,C05
agents for treatment of hemorrhoids and anal fissures for topical use,C05A
antibiotics,C05AB
local anesthetics,C05AD
lidocaine,C05AD01
tetracaine,C05AD02
benzocaine,C05AD03
cinchocaine,C05AD04
procaine,C05AD05
oxetacaine,C05AD06
pramocaine,C05AD07
muscle relaxants,C05AE
glyceryl trinitrate,C05AE01
isosorbide dinitrate,C05AE02
diltiazem,C05AE03
other agents for treatment of hemorrhoids and anal fissures for topical use,C05AX
aluminium preparations,C05AX01
"bismuth preparations, combinations",C05AX02
"other preparations, combinations",C05AX03
zinc preparations,C05AX04
tribenoside,C05AX05
antivaricose therapy,C05B
heparins or heparinoids for topical use,C05BA
organo-heparinoid,C05BA01
sodium apolate,C05BA02
heparin,C05BA03
pentosan polysulfate sodium,C05BA04
"heparinoid, combinations",C05BA51
"heparin, combinations",C05BA53
sclerosing agents for local injection,C05BB
monoethanolamine oleate,C05BB01
polidocanol,C05BB02
invert sugar,C05BB03
sodium tetradecyl sulfate,C05BB04
phenol,C05BB05
"glucose, combinations",C05BB56
other sclerosing agents,C05BX
calcium dobesilate,C05BX01
"calcium dobesilate, combinations",C05BX51
capillary stabilizing agents,C05C
bioflavonoids,C05CA
rutoside,C05CA01
monoxerutin,C05CA02
diosmin,C05CA03
troxerutin,C05CA04
hidrosmin,C05CA05
"rutoside, combinations",C05CA51
"diosmin, combinations",C05CA53
"troxerutin, combinations",C05CA54
other capillary stabilizing agents,C05CX
tribenoside,C05CX01
naftazone,C05CX02
hippocastani semen,C05CX03
corticosteroids,C05AA
hydrocortisone,C05AA01
prednisolone,C05AA04
betamethasone,C05AA05
fluorometholone,C05AA06
fluocortolone,C05AA08
dexamethasone,C05AA09
fluocinolone acetonide,C05AA10
fluocinonide,C05AA11
triamcinolone,C05AA12
beta blocking agents,C07
beta blocking agents,C07A
"beta blocking agents, selective",C07AB
practolol,C07AB01
metoprolol,C07AB02
atenolol,C07AB03
acebutolol,C07AB04
betaxolol,C07AB05
bevantolol,C07AB06
bisoprolol,C07AB07
celiprolol,C07AB08
esmolol,C07AB09
epanolol,C07AB10
s-atenolol,C07AB11
nebivolol,C07AB12
talinolol,C07AB13
landiolol,C07AB14
alpha and beta blocking agents,C07AG
labetalol,C07AG01
carvedilol,C07AG02
beta blocking agents and thiazides,C07B
"beta blocking agents, non-selective, and thiazides",C07BA
oxprenolol and thiazides,C07BA02
propranolol and thiazides,C07BA05
timolol and thiazides,C07BA06
sotalol and thiazides,C07BA07
nadolol and thiazides,C07BA12
"metipranolol and thiazides, combinations",C07BA68
"beta blocking agents, selective, and thiazides",C07BB
metoprolol and thiazides,C07BB02
atenolol and thiazides,C07BB03
acebutolol and thiazides,C07BB04
bevantolol and thiazides,C07BB06
bisoprolol and thiazides,C07BB07
nebivolol and thiazides,C07BB12
"metoprolol and thiazides, combinations",C07BB52
alpha and beta blocking agents and thiazides,C07BG
labetalol and thiazides,C07BG01
beta blocking agents and other diuretics,C07C
"beta blocking agents, non-selective, and other diuretics",C07CA
oxprenolol and other diuretics,C07CA02
pindolol and other diuretics,C07CA03
bopindolol and other diuretics,C07CA17
penbutolol and other diuretics,C07CA23
"beta blocking agents, selective, and other diuretics",C07CB
metoprolol and other diuretics,C07CB02
atenolol and other diuretics,C07CB03
"atenolol and other diuretics, combinations",C07CB53
alpha and beta blocking agents and other diuretics,C07CG
labetalol and other diuretics,C07CG01
"beta blocking agents, thiazides and other diuretics",C07D
"beta blocking agents, non-selective, thiazides and other diuretics",C07DA
"timolol, thiazides and other diuretics",C07DA06
"beta blocking agents, selective, thiazides and other diuretics",C07DB
"atenolol, thiazides and other diuretics",C07DB01
beta blocking agents and vasodilators,C07E
"beta blocking agents, non-selective, and vasodilators",C07EA
"beta blocking agents, selective, and vasodilators",C07EB
"beta blocking agents, other combinations",C07F
beta blocking agents and calcium channel blockers,C07FB
metoprolol and felodipine,C07FB02
atenolol and nifedipine,C07FB03
bisoprolol and amlodipine,C07FB07
nebivolol and amlodipine,C07FB12
metoprolol and amlodipine,C07FB13
"beta blocking agents, other combinations",C07FX
propranolol and other combinations,C07FX01
sotalol and acetylsalicylic acid,C07FX02
metoprolol and acetylsalicylic acid,C07FX03
bisoprolol and acetylsalicylic acid,C07FX04
metoprolol and ivabradine,C07FX05
carvedilol and ivabradine,C07FX06
"beta blocking agents, non-selective",C07AA
alprenolol,C07AA01
oxprenolol,C07AA02
pindolol,C07AA03
propranolol,C07AA05
timolol,C07AA06
sotalol,C07AA07
nadolol,C07AA12
mepindolol,C07AA14
carteolol,C07AA15
tertatolol,C07AA16
bopindolol,C07AA17
bupranolol,C07AA19
penbutolol,C07AA23
cloranolol,C07AA27
calcium channel blockers,C08
selective calcium channel blockers with mainly vascular effects,C08C
dihydropyridine derivatives,C08CA
amlodipine,C08CA01
felodipine,C08CA02
isradipine,C08CA03
nicardipine,C08CA04
nifedipine,C08CA05
nimodipine,C08CA06
nisoldipine,C08CA07
nitrendipine,C08CA08
lacidipine,C08CA09
nilvadipine,C08CA10
manidipine,C08CA11
barnidipine,C08CA12
lercanidipine,C08CA13
cilnidipine,C08CA14
benidipine,C08CA15
clevidipine,C08CA16
amlodipine and celecoxib,C08CA51
"nifedipine, combinations",C08CA55
other selective calcium channel blockers with mainly vascular effects,C08CX
mibefradil,C08CX01
selective calcium channel blockers with direct cardiac effects,C08D
phenylalkylamine derivatives,C08DA
verapamil,C08DA01
gallopamil,C08DA02
"verapamil, combinations",C08DA51
benzothiazepine derivatives,C08DB
diltiazem,C08DB01
non-selective calcium channel blockers,C08E
phenylalkylamine derivatives,C08EA
fendiline,C08EA01
bepridil,C08EA02
other non-selective calcium channel blockers,C08EX
lidoflazine,C08EX01
perhexiline,C08EX02
calcium channel blockers and diuretics,C08G
calcium channel blockers and diuretics,C08GA
nifedipine and diuretics,C08GA01
amlodipine and diuretics,C08GA02
agents acting on the renin-angiotensin system,C09
"ace inhibitors, plain",C09A
"ace inhibitors, combinations",C09B
ace inhibitors and diuretics,C09BA
captopril and diuretics,C09BA01
enalapril and diuretics,C09BA02
lisinopril and diuretics,C09BA03
perindopril and diuretics,C09BA04
ramipril and diuretics,C09BA05
quinapril and diuretics,C09BA06
benazepril and diuretics,C09BA07
cilazapril and diuretics,C09BA08
fosinopril and diuretics,C09BA09
delapril and diuretics,C09BA12
moexipril and diuretics,C09BA13
zofenopril and diuretics,C09BA15
ace inhibitors and calcium channel blockers,C09BB
enalapril and lercanidipine,C09BB02
lisinopril and amlodipine,C09BB03
perindopril and amlodipine,C09BB04
ramipril and felodipine,C09BB05
enalapril and nitrendipine,C09BB06
ramipril and amlodipine,C09BB07
trandolapril and verapamil,C09BB10
delapril and manidipine,C09BB12
"ace inhibitors, other combinations",C09BX
"perindopril, amlodipine and indapamide",C09BX01
perindopril and bisoprolol,C09BX02
"ramipril, amlodipine and hydrochlorothiazide",C09BX03
"perindopril, bisoprolol and amlodipine",C09BX04
ramipril and bisoprolol,C09BX05
"angiotensin ii receptor blockers (arbs), plain",C09C
"angiotensin ii receptor blockers (arbs), plain",C09CA
losartan,C09CA01
eprosartan,C09CA02
valsartan,C09CA03
irbesartan,C09CA04
tasosartan,C09CA05
candesartan,C09CA06
telmisartan,C09CA07
olmesartan medoxomil,C09CA08
azilsartan medoxomil,C09CA09
fimasartan,C09CA10
"angiotensin ii receptor blockers (arbs), combinations",C09D
angiotensin ii receptor blockers (arbs) and diuretics,C09DA
losartan and diuretics,C09DA01
eprosartan and diuretics,C09DA02
valsartan and diuretics,C09DA03
irbesartan and diuretics,C09DA04
candesartan and diuretics,C09DA06
telmisartan and diuretics,C09DA07
olmesartan medoxomil and diuretics,C09DA08
azilsartan medoxomil and diuretics,C09DA09
fimasartan and diuretics,C09DA10
angiotensin ii receptor blockers (arbs) and calcium channel blockers,C09DB
valsartan and amlodipine,C09DB01
olmesartan medoxomil and amlodipine,C09DB02
telmisartan and amlodipine,C09DB04
irbesartan and amlodipine,C09DB05
losartan and amlodipine,C09DB06
candesartan and amlodipine,C09DB07
valsartan and lercanidipine,C09DB08
fimasartan and amlodipine,C09DB09
"angiotensin ii receptor blockers (arbs), other combinations",C09DX
"valsartan, amlodipine and hydrochlorothiazide",C09DX01
valsartan and aliskiren,C09DX02
"olmesartan medoxomil, amlodipine and hydrochlorothiazide",C09DX03
valsartan and sacubitril,C09DX04
valsartan and nebivolol,C09DX05
"candesartan, amlodipine and hydrochlorothiazide",C09DX06
"irbesartan, amlodipine and hydrochlorothiazide",C09DX07
other agents acting on the renin-angiotensin system,C09X
renin-inhibitors,C09XA
remikiren,C09XA01
aliskiren,C09XA02
aliskiren and hydrochlorothiazide,C09XA52
aliskiren and amlodipine,C09XA53
"aliskiren, amlodipine and hydrochlorothiazide",C09XA54
"ace inhibitors, plain",C09AA
captopril,C09AA01
enalapril,C09AA02
lisinopril,C09AA03
perindopril,C09AA04
ramipril,C09AA05
quinapril,C09AA06
benazepril,C09AA07
cilazapril,C09AA08
fosinopril,C09AA09
trandolapril,C09AA10
spirapril,C09AA11
delapril,C09AA12
moexipril,C09AA13
temocapril,C09AA14
zofenopril,C09AA15
imidapril,C09AA16
lipid modifying agents,C10
"lipid modifying agents, plain",C10A
fibrates,C10AB
clofibrate,C10AB01
bezafibrate,C10AB02
aluminium clofibrate,C10AB03
gemfibrozil,C10AB04
fenofibrate,C10AB05
simfibrate,C10AB06
ronifibrate,C10AB07
ciprofibrate,C10AB08
etofibrate,C10AB09
clofibride,C10AB10
choline fenofibrate,C10AB11
bile acid sequestrants,C10AC
colestyramine,C10AC01
colestipol,C10AC02
colextran,C10AC03
colesevelam,C10AC04
nicotinic acid and derivatives,C10AD
niceritrol,C10AD01
nicotinic acid,C10AD02
nicofuranose,C10AD03
aluminium nicotinate,C10AD04
nicotinyl alcohol (pyridylcarbinol),C10AD05
acipimox,C10AD06
"nicotinic acid, combinations",C10AD52
other lipid modifying agents,C10AX
dextrothyroxine,C10AX01
probucol,C10AX02
tiadenol,C10AX03
meglutol,C10AX05
omega-3-triglycerides incl. other esters and acids,C10AX06
magnesium pyridoxal 5-phosphate glutamate,C10AX07
policosanol,C10AX08
ezetimibe,C10AX09
alipogene tiparvovec,C10AX10
mipomersen,C10AX11
lomitapide,C10AX12
evolocumab,C10AX13
alirocumab,C10AX14
bempedoic acid,C10AX15
inclisiran,C10AX16
"lipid modifying agents, combinations",C10B
combinations of various lipid modifying agents,C10BA
lovastatin and nicotinic acid,C10BA01
simvastatin and ezetimibe,C10BA02
pravastatin and fenofibrate,C10BA03
simvastatin and fenofibrate,C10BA04
atorvastatin and ezetimibe,C10BA05
rosuvastatin and ezetimibe,C10BA06
rosuvastatin and omega-3 fatty acids,C10BA07
atorvastatin and omega-3 fatty acids,C10BA08
rosuvastatin and fenofibrate,C10BA09
bempedoic acid and ezetimibe,C10BA10
lipid modifying agents in combination with other drugs,C10BX
simvastatin and acetylsalicylic acid,C10BX01
pravastatin and acetylsalicylic acid,C10BX02
atorvastatin and amlodipine,C10BX03
"simvastatin, acetylsalicylic acid and ramipril",C10BX04
rosuvastatin and acetylsalicylic acid,C10BX05
"atorvastatin, acetylsalicylic acid and ramipril",C10BX06
"rosuvastatin, amlodipine and lisinopril",C10BX07
atorvastatin and acetylsalicylic acid,C10BX08
rosuvastatin and amlodipine,C10BX09
rosuvastatin and valsartan,C10BX10
"atorvastatin, amlodipine and perindopril",C10BX11
"atorvastatin, acetylsalicylic acid and perindopril",C10BX12
"rosuvastatin, perindopril and indapamide",C10BX13
"rosuvastatin, amlodipine and perindopril",C10BX14
atorvastatin and perindopril,C10BX15
rosuvastatin and fimasartan,C10BX16
rosuvastatin and ramipril,C10BX17
"atorvastatin, amlodipine and ramipril",C10BX18
hmg coa reductase inhibitors,C10AA
simvastatin,C10AA01
lovastatin,C10AA02
pravastatin,C10AA03
fluvastatin,C10AA04
atorvastatin,C10AA05
cerivastatin,C10AA06
rosuvastatin,C10AA07
pitavastatin,C10AA08
dermatologicals,D
antifungals for dermatological use,D01
antifungals for topical use,D01A
imidazole and triazole derivatives,D01AC
clotrimazole,D01AC01
miconazole,D01AC02
econazole,D01AC03
chlormidazole,D01AC04
isoconazole,D01AC05
tiabendazole,D01AC06
tioconazole,D01AC07
ketoconazole,D01AC08
sulconazole,D01AC09
bifonazole,D01AC10
oxiconazole,D01AC11
fenticonazole,D01AC12
omoconazole,D01AC13
sertaconazole,D01AC14
fluconazole,D01AC15
flutrimazole,D01AC16
eberconazole,D01AC17
luliconazole,D01AC18
efinaconazole,D01AC19
imidazoles/triazoles in combination with corticosteroids,D01AC20
"miconazole, combinations",D01AC52
"bifonazole, combinations",D01AC60
other antifungals for topical use,D01AE
bromochlorosalicylanilide,D01AE01
methylrosaniline,D01AE02
tribromometacresol,D01AE03
undecylenic acid,D01AE04
polynoxylin,D01AE05
2-(4-chlorphenoxy)-ethanol,D01AE06
chlorphenesin,D01AE07
ticlatone,D01AE08
sulbentine,D01AE09
ethyl hydroxybenzoate,D01AE10
haloprogin,D01AE11
salicylic acid,D01AE12
selenium sulfide,D01AE13
ciclopirox,D01AE14
terbinafine,D01AE15
amorolfine,D01AE16
dimazole,D01AE17
tolnaftate,D01AE18
tolciclate,D01AE19
combinations,D01AE20
flucytosine,D01AE21
naftifine,D01AE22
butenafine,D01AE23
tavaborole,D01AE24
"undecylenic acid, combinations",D01AE54
antifungals for systemic use,D01B
antifungals for systemic use,D01BA
griseofulvin,D01BA01
terbinafine,D01BA02
fosravuconazole,D01BA03
antibiotics,D01AA
nystatin,D01AA01
natamycin,D01AA02
hachimycin,D01AA03
pecilocin,D01AA04
mepartricin,D01AA06
pyrrolnitrin,D01AA07
griseofulvin,D01AA08
combinations,D01AA20
emollients and protectives,D02
emollients and protectives,D02A
zinc products,D02AB
soft paraffin and fat products,D02AC
liquid plasters,D02AD
carbamide products,D02AE
carbamide,D02AE01
"carbamide, combinations",D02AE51
salicylic acid preparations,D02AF
other emollients and protectives,D02AX
protectives against uv-radiation,D02B
protectives against uv-radiation for topical use,D02BA
aminobenzoic acid,D02BA01
octinoxate,D02BA02
protectives against uv-radiation for systemic use,D02BB
betacarotene,D02BB01
afamelanotide,D02BB02
silicone products,D02AA
preparations for treatment of wounds and ulcers,D03
cicatrizants,D03A
other cicatrizants,D03AX
cadexomer iodine,D03AX01
dextranomer,D03AX02
dexpanthenol,D03AX03
calcium pantothenate,D03AX04
hyaluronic acid,D03AX05
becaplermin,D03AX06
crilanomer,D03AX09
enoxolone,D03AX10
sodium chlorite,D03AX11
trolamine,D03AX12
betulae cortex,D03AX13
centella asiatica herba,D03AX14
enzymes,D03B
proteolytic enzymes,D03BA
trypsin,D03BA01
collagenase,D03BA02
bromelains,D03BA03
"collagenase, combinations",D03BA52
cod-liver oil ointments,D03AA
"antipruritics, incl. antihistamines, anesthetics, etc.",D04
"antipruritics, incl. antihistamines, anesthetics, etc.",D04A
anesthetics for topical use,D04AB
lidocaine,D04AB01
cinchocaine,D04AB02
oxybuprocaine,D04AB03
benzocaine,D04AB04
quinisocaine,D04AB05
tetracaine,D04AB06
pramocaine,D04AB07
other antipruritics,D04AX
doxepin,D04AX01
antihistamines for topical use,D04AA
thonzylamine,D04AA01
mepyramine,D04AA02
thenalidine,D04AA03
tripelennamine,D04AA04
chloropyramine,D04AA09
promethazine,D04AA10
tolpropamine,D04AA12
dimetindene,D04AA13
clemastine,D04AA14
bamipine,D04AA15
pheniramine,D04AA16
isothipendyl,D04AA22
diphenhydramine,D04AA32
diphenhydramine methylbromide,D04AA33
chlorphenoxamine,D04AA34
antipsoriatics,D05
antipsoriatics for topical use,D05A
antracen derivatives,D05AC
dithranol,D05AC01
"dithranol, combinations",D05AC51
psoralens for topical use,D05AD
trioxysalen,D05AD01
methoxsalen,D05AD02
other antipsoriatics for topical use,D05AX
fumaric acid,D05AX01
calcipotriol,D05AX02
calcitriol,D05AX03
tacalcitol,D05AX04
tazarotene,D05AX05
"calcipotriol, combinations",D05AX52
tazarotene and ulobetasol,D05AX55
antipsoriatics for systemic use,D05B
psoralens for systemic use,D05BA
trioxysalen,D05BA01
methoxsalen,D05BA02
bergapten,D05BA03
retinoids for treatment of psoriasis,D05BB
etretinate,D05BB01
acitretin,D05BB02
other antipsoriatics for systemic use,D05BX
"fumaric acid derivatives, combinations",D05BX51
tars,D05AA
antibiotics and chemotherapeutics for dermatological use,D06
antibiotics for topical use,D06A
other antibiotics for topical use,D06AX
fusidic acid,D06AX01
chloramphenicol,D06AX02
neomycin,D06AX04
bacitracin,D06AX05
gentamicin,D06AX07
tyrothricin,D06AX08
mupirocin,D06AX09
virginiamycin,D06AX10
rifaximin,D06AX11
amikacin,D06AX12
retapamulin,D06AX13
ozenoxacin,D06AX14
rifamycin,D06AX15
chemotherapeutics for topical use,D06B
sulfonamides,D06BA
silver sulfadiazine,D06BA01
sulfathiazole,D06BA02
mafenide,D06BA03
sulfamethizole,D06BA04
sulfanilamide,D06BA05
sulfamerazine,D06BA06
"silver sulfadiazine, combinations",D06BA51
antivirals,D06BB
idoxuridine,D06BB01
tromantadine,D06BB02
aciclovir,D06BB03
podophyllotoxin,D06BB04
inosine,D06BB05
penciclovir,D06BB06
lysozyme,D06BB07
ibacitabine,D06BB08
edoxudine,D06BB09
imiquimod,D06BB10
docosanol,D06BB11
sinecatechins,D06BB12
"aciclovir, combinations",D06BB53
other chemotherapeutics,D06BX
metronidazole,D06BX01
ingenol mebutate,D06BX02
tirbanibulin,D06BX03
"antibiotics and chemotherapeutics, combinations",D06C
tetracycline and derivatives,D06AA
demeclocycline,D06AA01
chlortetracycline,D06AA02
oxytetracycline,D06AA03
tetracycline,D06AA04
"corticosteroids, dermatological preparations",D07
"corticosteroids, plain",D07A
"corticosteroids, moderately potent (group ii)",D07AB
clobetasone,D07AB01
hydrocortisone butyrate,D07AB02
flumetasone,D07AB03
fluocortin,D07AB04
fluperolone,D07AB05
fluorometholone,D07AB06
fluprednidene,D07AB07
desonide,D07AB08
triamcinolone,D07AB09
alclometasone,D07AB10
hydrocortisone buteprate,D07AB11
dexamethasone,D07AB19
clocortolone,D07AB21
combinations of corticosteroids,D07AB30
"corticosteroids, potent (group iii)",D07AC
betamethasone,D07AC01
fluclorolone,D07AC02
desoximetasone,D07AC03
fluocinolone acetonide,D07AC04
fluocortolone,D07AC05
diflucortolone,D07AC06
fludroxycortide,D07AC07
fluocinonide,D07AC08
budesonide,D07AC09
diflorasone,D07AC10
amcinonide,D07AC11
halometasone,D07AC12
mometasone,D07AC13
methylprednisolone aceponate,D07AC14
beclometasone,D07AC15
hydrocortisone aceponate,D07AC16
fluticasone,D07AC17
prednicarbate,D07AC18
difluprednate,D07AC19
ulobetasol,D07AC21
"corticosteroids, very potent (group iv)",D07AD
clobetasol,D07AD01
halcinonide,D07AD02
"corticosteroids, combinations with antiseptics",D07B
"corticosteroids, weak, combinations with antiseptics",D07BA
prednisolone and antiseptics,D07BA01
hydrocortisone and antiseptics,D07BA04
"corticosteroids, moderately potent, combinations with antiseptics",D07BB
flumetasone and antiseptics,D07BB01
desonide and antiseptics,D07BB02
triamcinolone and antiseptics,D07BB03
hydrocortisone butyrate and antiseptics,D07BB04
"corticosteroids, potent, combinations with antiseptics",D07BC
betamethasone and antiseptics,D07BC01
fluocinolone acetonide and antiseptics,D07BC02
fluocortolone and antiseptics,D07BC03
diflucortolone and antiseptics,D07BC04
"corticosteroids, very potent, combinations with antiseptics",D07BD
"corticosteroids, combinations with antibiotics",D07C
"corticosteroids, weak, combinations with antibiotics",D07CA
hydrocortisone and antibiotics,D07CA01
methylprednisolone and antibiotics,D07CA02
prednisolone and antibiotics,D07CA03
"corticosteroids, moderately potent, combinations with antibiotics",D07CB
triamcinolone and antibiotics,D07CB01
fluprednidene and antibiotics,D07CB02
fluorometholone and antibiotics,D07CB03
dexamethasone and antibiotics,D07CB04
flumetasone and antibiotics,D07CB05
"corticosteroids, potent, combinations with antibiotics",D07CC
betamethasone and antibiotics,D07CC01
fluocinolone acetonide and antibiotics,D07CC02
fludroxycortide and antibiotics,D07CC03
beclometasone and antibiotics,D07CC04
fluocinonide and antibiotics,D07CC05
fluocortolone and antibiotics,D07CC06
"corticosteroids, very potent, combinations with antibiotics",D07CD
clobetasol and antibiotics,D07CD01
"corticosteroids, other combinations",D07X
"corticosteroids, weak, other combinations",D07XA
hydrocortisone,D07XA01
prednisolone,D07XA02
"corticosteroids, moderately potent, other combinations",D07XB
flumetasone,D07XB01
triamcinolone,D07XB02
fluprednidene,D07XB03
fluorometholone,D07XB04
dexamethasone,D07XB05
combinations of corticosteroids,D07XB30
"corticosteroids, potent, other combinations",D07XC
betamethasone,D07XC01
desoximetasone,D07XC02
mometasone,D07XC03
diflucortolone,D07XC04
fluocortolone,D07XC05
"corticosteroids, very potent, other combinations",D07XD
"corticosteroids, weak (group i)",D07AA
methylprednisolone,D07AA01
hydrocortisone,D07AA02
prednisolone,D07AA03
antiseptics and disinfectants,D08
antiseptics and disinfectants,D08A
aluminium agents,D08AB
biguanides and amidines,D08AC
dibrompropamidine,D08AC01
chlorhexidine,D08AC02
propamidine,D08AC03
hexamidine,D08AC04
polihexanide,D08AC05
"chlorhexidine, combinations",D08AC52
boric acid products,D08AD
phenol and derivatives,D08AE
hexachlorophene,D08AE01
policresulen,D08AE02
phenol,D08AE03
triclosan,D08AE04
chloroxylenol,D08AE05
biphenylol,D08AE06
nitrofuran derivatives,D08AF
nitrofural,D08AF01
iodine products,D08AG
iodine/octylphenoxypolyglycolether,D08AG01
povidone-iodine,D08AG02
iodine,D08AG03
diiodohydroxypropane,D08AG04
quinoline derivatives,D08AH
dequalinium,D08AH01
chlorquinaldol,D08AH02
oxyquinoline,D08AH03
clioquinol,D08AH30
quaternary ammonium compounds,D08AJ
benzalkonium,D08AJ01
cetrimonium,D08AJ02
cetylpyridinium,D08AJ03
cetrimide,D08AJ04
benzoxonium chloride,D08AJ05
didecyldimethylammonium chloride,D08AJ06
benzethonium chloride,D08AJ08
decamethoxine,D08AJ10
"octenidine, combinations",D08AJ57
"benzethonium chloride, combinations",D08AJ58
"dodeclonium bromide, combinations",D08AJ59
mercurial products,D08AK
mercuric amidochloride,D08AK01
phenylmercuric borate,D08AK02
mercuric chloride,D08AK03
merbromin,D08AK04
"mercury, metallic",D08AK05
thiomersal,D08AK06
mercuric iodide,D08AK30
silver compounds,D08AL
silver nitrate,D08AL01
silver,D08AL30
other antiseptics and disinfectants,D08AX
hydrogen peroxide,D08AX01
eosin,D08AX02
propanol,D08AX03
tosylchloramide sodium,D08AX04
isopropanol,D08AX05
potassium permanganate,D08AX06
sodium hypochlorite,D08AX07
ethanol,D08AX08
"propanol, combinations",D08AX53
acridine derivatives,D08AA
ethacridine lactate,D08AA01
aminoacridine,D08AA02
euflavine,D08AA03
medicated dressings,D09
medicated dressings,D09A
zinc bandages,D09AB
zinc bandage without supplements,D09AB01
zinc bandage with supplements,D09AB02
soft paraffin dressings,D09AX
medicated dressings with antiinfectives,D09AA
framycetin,D09AA01
fusidic acid,D09AA02
nitrofural,D09AA03
phenylmercuric nitrate,D09AA04
benzododecinium,D09AA05
triclosan,D09AA06
cetylpyridinium,D09AA07
aluminium chlorohydrate,D09AA08
povidone-iodine,D09AA09
clioquinol,D09AA10
benzalkonium,D09AA11
chlorhexidine,D09AA12
iodoform,D09AA13
anti-acne preparations,D10
anti-acne preparations for topical use,D10A
preparations containing sulfur,D10AB
bithionol,D10AB01
sulfur,D10AB02
tioxolone,D10AB03
mesulfen,D10AB05
retinoids for topical use in acne,D10AD
tretinoin,D10AD01
retinol,D10AD02
adapalene,D10AD03
isotretinoin,D10AD04
motretinide,D10AD05
trifarotene,D10AD06
"tretinoin, combinations",D10AD51
"adapalene, combinations",D10AD53
"isotretinoin, combinations",D10AD54
peroxides,D10AE
benzoyl peroxide,D10AE01
"benzoyl peroxide, combinations",D10AE51
antiinfectives for treatment of acne,D10AF
clindamycin,D10AF01
erythromycin,D10AF02
chloramphenicol,D10AF03
meclocycline,D10AF04
nadifloxacin,D10AF05
sulfacetamide,D10AF06
minocycline,D10AF07
"clindamycin, combinations",D10AF51
"erythromycin, combinations",D10AF52
other anti-acne preparations for topical use,D10AX
aluminium chloride,D10AX01
resorcinol,D10AX02
azelaic acid,D10AX03
aluminium oxide,D10AX04
dapsone,D10AX05
various combinations,D10AX30
anti-acne preparations for systemic use,D10B
retinoids for treatment of acne,D10BA
isotretinoin,D10BA01
other anti-acne preparations for systemic use,D10BX
ichtasol,D10BX01
"corticosteroids, combinations for treatment of acne",D10AA
fluorometholone,D10AA01
methylprednisolone,D10AA02
dexamethasone,D10AA03
other dermatological preparations,D11
other dermatological preparations,D11A
medicated shampoos,D11AC
cetrimide,D11AC01
cadmium compounds,D11AC02
selenium compounds,D11AC03
povidone-iodine,D11AC06
sulfur compounds,D11AC08
xenysalate,D11AC09
others,D11AC30
androgens for topical use,D11AE
metandienone,D11AE01
wart and anti-corn preparations,D11AF
"agents for dermatitis, excluding corticosteroids",D11AH
tacrolimus,D11AH01
pimecrolimus,D11AH02
cromoglicic acid,D11AH03
alitretinoin,D11AH04
dupilumab,D11AH05
crisaborole,D11AH06
tralokinumab,D11AH07
other dermatologicals,D11AX
minoxidil,D11AX01
gamolenic acid,D11AX02
calcium gluconate,D11AX03
lithium succinate,D11AX04
magnesium sulfate,D11AX05
mequinol,D11AX06
tiratricol,D11AX08
oxaceprol,D11AX09
finasteride,D11AX10
hydroquinone,D11AX11
pyrithione zinc,D11AX12
monobenzone,D11AX13
eflornithine,D11AX16
diclofenac,D11AX18
brimonidine,D11AX21
ivermectin,D11AX22
aminobenzoate potassium,D11AX23
deoxycholic acid,D11AX24
hydrogen peroxide,D11AX25
caffeine,D11AX26
"gamolenic acid, combinations",D11AX52
"collagen, combinations",D11AX57
antihidrotics,D11AA
glycopyrronium,D11AA01
genito urinary system and sex hormones,G
gynecological antiinfectives and antiseptics,G01
"antiinfectives and antiseptics, excl. combinations with corticosteroids",G01A
arsenic compounds,G01AB
acetarsol,G01AB01
quinoline derivatives,G01AC
diiodohydroxyquinoline,G01AC01
clioquinol,G01AC02
chlorquinaldol,G01AC03
dequalinium,G01AC05
broxyquinoline,G01AC06
oxyquinoline,G01AC30
organic acids,G01AD
lactic acid,G01AD01
acetic acid,G01AD02
ascorbic acid,G01AD03
sulfonamides,G01AE
sulfatolamide,G01AE01
combinations of sulfonamides,G01AE10
imidazole derivatives,G01AF
metronidazole,G01AF01
clotrimazole,G01AF02
miconazole,G01AF04
econazole,G01AF05
ornidazole,G01AF06
isoconazole,G01AF07
tioconazole,G01AF08
ketoconazole,G01AF11
fenticonazole,G01AF12
azanidazole,G01AF13
propenidazole,G01AF14
butoconazole,G01AF15
omoconazole,G01AF16
oxiconazole,G01AF17
flutrimazole,G01AF18
sertaconazole,G01AF19
combinations of imidazole derivatives,G01AF20
"econazole, combinations",G01AF55
triazole derivatives,G01AG
terconazole,G01AG02
other antiinfectives and antiseptics,G01AX
clodantoin,G01AX01
inosine,G01AX02
policresulen,G01AX03
nifuratel,G01AX05
furazolidone,G01AX06
methylrosaniline,G01AX09
povidone-iodine,G01AX11
ciclopirox,G01AX12
protiofate,G01AX13
lactobacillus,G01AX14
copper usnate,G01AX15
hexetidine,G01AX16
dapivirine,G01AX17
"octenidine, combinations",G01AX66
antiinfectives/antiseptics in combination with corticosteroids,G01B
antibiotics and corticosteroids,G01BA
quinoline derivatives and corticosteroids,G01BC
antiseptics and corticosteroids,G01BD
sulfonamides and corticosteroids,G01BE
imidazole derivatives and corticosteroids,G01BF
antibiotics,G01AA
nystatin,G01AA01
natamycin,G01AA02
amphotericin b,G01AA03
candicidin,G01AA04
chloramphenicol,G01AA05
hachimycin,G01AA06
oxytetracycline,G01AA07
carfecillin,G01AA08
mepartricin,G01AA09
clindamycin,G01AA10
pentamycin,G01AA11
"nystatin, combinations",G01AA51
other gynecologicals,G02
uterotonics,G02A
ergot alkaloids,G02AB
methylergometrine,G02AB01
ergot alkaloids,G02AB02
ergometrine,G02AB03
"ergot alkaloids and oxytocin incl. analogues, in combination",G02AC
methylergometrine and oxytocin,G02AC01
prostaglandins,G02AD
dinoprost,G02AD01
dinoprostone,G02AD02
gemeprost,G02AD03
carboprost,G02AD04
sulprostone,G02AD05
misoprostol,G02AD06
other uterotonics,G02AX
contraceptives for topical use,G02B
intrauterine contraceptives,G02BA
plastic iud,G02BA01
plastic iud with copper,G02BA02
plastic iud with progestogen,G02BA03
intravaginal contraceptives,G02BB
vaginal ring with progestogen and estrogen,G02BB01
vaginal ring with progestogen,G02BB02
other gynecologicals,G02C
"sympathomimetics, labour repressants",G02CA
ritodrine,G02CA01
buphenine,G02CA02
fenoterol,G02CA03
prolactine inhibitors,G02CB
bromocriptine,G02CB01
lisuride,G02CB02
cabergoline,G02CB03
quinagolide,G02CB04
metergoline,G02CB05
terguride,G02CB06
antiinflammatory products for vaginal administration,G02CC
ibuprofen,G02CC01
naproxen,G02CC02
benzydamine,G02CC03
flunoxaprofen,G02CC04
other gynecologicals,G02CX
atosiban,G02CX01
flibanserin,G02CX02
agni casti fructus,G02CX03
cimicifugae rhizoma,G02CX04
bremelanotide,G02CX05
sex hormones and modulators of the genital system,G03
hormonal contraceptives for systemic use,G03A
"progestogens and estrogens, sequential preparations",G03AB
megestrol and ethinylestradiol,G03AB01
lynestrenol and ethinylestradiol,G03AB02
levonorgestrel and ethinylestradiol,G03AB03
norethisterone and ethinylestradiol,G03AB04
desogestrel and ethinylestradiol,G03AB05
gestodene and ethinylestradiol,G03AB06
chlormadinone and ethinylestradiol,G03AB07
dienogest and estradiol,G03AB08
norgestimate and ethinylestradiol,G03AB09
progestogens,G03AC
norethisterone,G03AC01
lynestrenol,G03AC02
levonorgestrel,G03AC03
quingestanol,G03AC04
megestrol,G03AC05
medroxyprogesterone,G03AC06
norgestrienone,G03AC07
etonogestrel,G03AC08
desogestrel,G03AC09
drospirenone,G03AC10
emergency contraceptives,G03AD
levonorgestrel,G03AD01
ulipristal,G03AD02
androgens,G03B
3-oxoandrosten (4) derivatives,G03BA
fluoxymesterone,G03BA01
methyltestosterone,G03BA02
testosterone,G03BA03
5-androstanon (3) derivatives,G03BB
mesterolone,G03BB01
androstanolone,G03BB02
estrogens,G03C
"natural and semisynthetic estrogens, plain",G03CA
ethinylestradiol,G03CA01
estradiol,G03CA03
estriol,G03CA04
chlorotrianisene,G03CA06
estrone,G03CA07
promestriene,G03CA09
"estradiol, combinations",G03CA53
conjugated estrogens,G03CA57
"synthetic estrogens, plain",G03CB
dienestrol,G03CB01
diethylstilbestrol,G03CB02
methallenestril,G03CB03
moxestrol,G03CB04
"estrogens, combinations with other drugs",G03CC
dienestrol,G03CC02
methallenestril,G03CC03
estrone,G03CC04
diethylstilbestrol,G03CC05
estriol,G03CC06
conjugated estrogens and bazedoxifene,G03CC07
other estrogens,G03CX
tibolone,G03CX01
progestogens,G03D
pregnen (4) derivatives,G03DA
gestonorone,G03DA01
medroxyprogesterone,G03DA02
hydroxyprogesterone,G03DA03
progesterone,G03DA04
pregnadien derivatives,G03DB
dydrogesterone,G03DB01
megestrol,G03DB02
medrogestone,G03DB03
nomegestrol,G03DB04
demegestone,G03DB05
chlormadinone,G03DB06
promegestone,G03DB07
dienogest,G03DB08
estren derivatives,G03DC
allylestrenol,G03DC01
norethisterone,G03DC02
lynestrenol,G03DC03
ethisterone,G03DC04
etynodiol,G03DC06
methylestrenolone,G03DC31
androgens and female sex hormones in combination,G03E
androgens and estrogens,G03EA
methyltestosterone and estrogen,G03EA01
testosterone and estrogen,G03EA02
prasterone and estrogen,G03EA03
"androgen, progestogen and estrogen in combination",G03EB
androgens and female sex hormones in combination with other drugs,G03EK
methyltestosterone,G03EK01
progestogens and estrogens in combination,G03F
"progestogens and estrogens, fixed combinations",G03FA
norethisterone and estrogen,G03FA01
hydroxyprogesterone and estrogen,G03FA02
ethisterone and estrogen,G03FA03
progesterone and estrogen,G03FA04
methylnortestosterone and estrogen,G03FA05
etynodiol and estrogen,G03FA06
lynestrenol and estrogen,G03FA07
megestrol and estrogen,G03FA08
noretynodrel and estrogen,G03FA09
norgestrel and estrogen,G03FA10
levonorgestrel and estrogen,G03FA11
medroxyprogesterone and estrogen,G03FA12
norgestimate and estrogen,G03FA13
dydrogesterone and estrogen,G03FA14
dienogest and estrogen,G03FA15
trimegestone and estrogen,G03FA16
drospirenone and estrogen,G03FA17
"progestogens and estrogens, sequential preparations",G03FB
norgestrel and estrogen,G03FB01
lynestrenol and estrogen,G03FB02
chlormadinone and estrogen,G03FB03
megestrol and estrogen,G03FB04
norethisterone and estrogen,G03FB05
medroxyprogesterone and estrogen,G03FB06
medrogestone and estrogen,G03FB07
dydrogesterone and estrogen,G03FB08
levonorgestrel and estrogen,G03FB09
desogestrel and estrogen,G03FB10
trimegestone and estrogen,G03FB11
nomegestrol and estrogen,G03FB12
gonadotropins and other ovulation stimulants,G03G
gonadotropins,G03GA
chorionic gonadotrophin,G03GA01
human menopausal gonadotrophin,G03GA02
serum gonadotrophin,G03GA03
urofollitropin,G03GA04
follitropin alfa,G03GA05
follitropin beta,G03GA06
lutropin alfa,G03GA07
choriogonadotropin alfa,G03GA08
corifollitropin alfa,G03GA09
follitropin delta,G03GA10
combinations,G03GA30
"ovulation stimulants, synthetic",G03GB
cyclofenil,G03GB01
clomifene,G03GB02
epimestrol,G03GB03
antiandrogens,G03H
"antiandrogens, plain",G03HA
cyproterone,G03HA01
antiandrogens and estrogens,G03HB
cyproterone and estrogen,G03HB01
other sex hormones and modulators of the genital system,G03X
antigonadotropins and similar agents,G03XA
danazol,G03XA01
gestrinone,G03XA02
progesterone receptor modulators,G03XB
mifepristone,G03XB01
ulipristal,G03XB02
"mifepristone, combinations",G03XB51
selective estrogen receptor modulators,G03XC
raloxifene,G03XC01
bazedoxifene,G03XC02
lasofoxifene,G03XC03
ormeloxifene,G03XC04
ospemifene,G03XC05
other sex hormones and modulators of the genital system,G03XX
prasterone,G03XX01
"progestogens and estrogens, fixed combinations",G03AA
etynodiol and ethinylestradiol,G03AA01
quingestanol and ethinylestradiol,G03AA02
lynestrenol and ethinylestradiol,G03AA03
megestrol and ethinylestradiol,G03AA04
norethisterone and ethinylestradiol,G03AA05
norgestrel and ethinylestradiol,G03AA06
levonorgestrel and ethinylestradiol,G03AA07
medroxyprogesterone and ethinylestradiol,G03AA08
desogestrel and ethinylestradiol,G03AA09
gestodene and ethinylestradiol,G03AA10
norgestimate and ethinylestradiol,G03AA11
drospirenone and ethinylestradiol,G03AA12
norelgestromin and ethinylestradiol,G03AA13
nomegestrol and estradiol,G03AA14
chlormadinone and ethinylestradiol,G03AA15
dienogest and ethinylestradiol,G03AA16
medroxyprogesterone and estradiol,G03AA17
drospirenone and estetrol,G03AA18
urologicals,G04
urologicals,G04B
acidifiers,G04BA
ammonium chloride,G04BA01
calcium chloride,G04BA03
urinary concrement solvents,G04BC
drugs for urinary frequency and incontinence,G04BD
emepronium,G04BD01
flavoxate,G04BD02
meladrazine,G04BD03
oxybutynin,G04BD04
terodiline,G04BD05
propiverine,G04BD06
tolterodine,G04BD07
solifenacin,G04BD08
trospium,G04BD09
darifenacin,G04BD10
fesoterodine,G04BD11
mirabegron,G04BD12
desfesoterodine,G04BD13
drugs used in erectile dysfunction,G04BE
alprostadil,G04BE01
papaverine,G04BE02
sildenafil,G04BE03
yohimbine,G04BE04
moxisylyte,G04BE06
apomorphine,G04BE07
tadalafil,G04BE08
vardenafil,G04BE09
avanafil,G04BE10
udenafil,G04BE11
combinations,G04BE30
"papaverine, combinations",G04BE52
other urologicals,G04BX
magnesium hydroxide,G04BX01
acetohydroxamic acid,G04BX03
phenazopyridine,G04BX06
succinimide,G04BX10
collagen,G04BX11
phenyl salicylate,G04BX12
dimethyl sulfoxide,G04BX13
dapoxetine,G04BX14
pentosan polysulfate sodium,G04BX15
tiopronin,G04BX16
drugs used in benign prostatic hypertrophy,G04C
alpha-adrenoreceptor antagonists,G04CA
alfuzosin,G04CA01
tamsulosin,G04CA02
terazosin,G04CA03
silodosin,G04CA04
alfuzosin and finasteride,G04CA51
tamsulosin and dutasteride,G04CA52
tamsulosin and solifenacin,G04CA53
tamsulosin and tadalafil,G04CA54
testosterone-5-alpha reductase inhibitors,G04CB
finasteride,G04CB01
dutasteride,G04CB02
other drugs used in benign prostatic hypertrophy,G04CX
prunus africanae cortex,G04CX01
sabalis serrulatae fructus,G04CX02
mepartricin,G04CX03
fexapotide,G04CX04
"systemic hormonal preparations, excl. sex hormones and insulins",H
pituitary and hypothalamic hormones and analogues,H01
anterior pituitary lobe hormones and analogues,H01A
thyrotropin,H01AB
thyrotropin alfa,H01AB01
somatropin and somatropin agonists,H01AC
somatropin,H01AC01
somatrem,H01AC02
mecasermin,H01AC03
sermorelin,H01AC04
mecasermin rinfabate,H01AC05
tesamorelin,H01AC06
somapacitan,H01AC07
other anterior pituitary lobe hormones and analogues,H01AX
pegvisomant,H01AX01
posterior pituitary lobe hormones,H01B
vasopressin and analogues,H01BA
vasopressin (argipressin),H01BA01
desmopressin,H01BA02
lypressin,H01BA03
terlipressin,H01BA04
ornipressin,H01BA05
oxytocin and analogues,H01BB
demoxytocin,H01BB01
oxytocin,H01BB02
carbetocin,H01BB03
hypothalamic hormones,H01C
gonadotropin-releasing hormones,H01CA
gonadorelin,H01CA01
nafarelin,H01CA02
somatostatin and analogues,H01CB
somatostatin,H01CB01
octreotide,H01CB02
lanreotide,H01CB03
vapreotide,H01CB04
pasireotide,H01CB05
anti-gonadotropin-releasing hormones,H01CC
ganirelix,H01CC01
cetrorelix,H01CC02
elagolix,H01CC03
"relugolix, estradiol and norethisterone",H01CC54
acth,H01AA
corticotropin,H01AA01
tetracosactide,H01AA02
corticosteroids for systemic use,H02
"corticosteroids for systemic use, plain",H02A
glucocorticoids,H02AB
betamethasone,H02AB01
dexamethasone,H02AB02
fluocortolone,H02AB03
methylprednisolone,H02AB04
paramethasone,H02AB05
prednisolone,H02AB06
prednisone,H02AB07
triamcinolone,H02AB08
hydrocortisone,H02AB09
cortisone,H02AB10
prednylidene,H02AB11
rimexolone,H02AB12
deflazacort,H02AB13
cloprednol,H02AB14
meprednisone,H02AB15
cortivazol,H02AB17
"corticosteroids for systemic use, combinations",H02B
"corticosteroids for systemic use, combinations",H02BX
"methylprednisolone, combinations",H02BX01
antiadrenal preparations,H02C
anticorticosteroids,H02CA
trilostane,H02CA01
osilodrostat,H02CA02
ketoconazole,H02CA03
mineralocorticoids,H02AA
aldosterone,H02AA01
fludrocortisone,H02AA02
desoxycortone,H02AA03
thyroid therapy,H03
thyroid preparations,H03A
antithyroid preparations,H03B
thiouracils,H03BA
methylthiouracil,H03BA01
propylthiouracil,H03BA02
benzylthiouracil,H03BA03
sulfur-containing imidazole derivatives,H03BB
carbimazole,H03BB01
thiamazole,H03BB02
"thiamazole, combinations",H03BB52
perchlorates,H03BC
potassium perchlorate,H03BC01
other antithyroid preparations,H03BX
diiodotyrosine,H03BX01
dibromotyrosine,H03BX02
iodine therapy,H03C
iodine therapy,H03CA
thyroid hormones,H03AA
levothyroxine sodium,H03AA01
liothyronine sodium,H03AA02
combinations of levothyroxine and liothyronine,H03AA03
tiratricol,H03AA04
thyroid gland preparations,H03AA05
pancreatic hormones,H04
glycogenolytic hormones,H04A
glycogenolytic hormones,H04AA
glucagon,H04AA01
calcium homeostasis,H05
parathyroid hormones and analogues,H05A
anti-parathyroid agents,H05B
calcitonin preparations,H05BA
calcitonin (salmon synthetic),H05BA01
calcitonin (pork natural),H05BA02
calcitonin (human synthetic),H05BA03
elcatonin,H05BA04
other anti-parathyroid agents,H05BX
cinacalcet,H05BX01
paricalcitol,H05BX02
doxercalciferol,H05BX03
etelcalcetide,H05BX04
calcifediol,H05BX05
parathyroid hormones and analogues,H05AA
parathyroid gland extract,H05AA01
teriparatide,H05AA02
parathyroid hormone,H05AA03
abaloparatide,H05AA04
antiinfectives for systemic use,J
antibacterials for systemic use,J01
tetracyclines,J01A
amphenicols,J01B
amphenicols,J01BA
chloramphenicol,J01BA01
thiamphenicol,J01BA02
"thiamphenicol, combinations",J01BA52
"beta-lactam antibacterials, penicillins",J01C
penicillins with extended spectrum,J01CA
ampicillin,J01CA01
pivampicillin,J01CA02
carbenicillin,J01CA03
amoxicillin,J01CA04
carindacillin,J01CA05
bacampicillin,J01CA06
epicillin,J01CA07
pivmecillinam,J01CA08
azlocillin,J01CA09
mezlocillin,J01CA10
mecillinam,J01CA11
piperacillin,J01CA12
ticarcillin,J01CA13
metampicillin,J01CA14
talampicillin,J01CA15
sulbenicillin,J01CA16
temocillin,J01CA17
hetacillin,J01CA18
aspoxicillin,J01CA19
combinations,J01CA20
"ampicillin, combinations",J01CA51
beta-lactamase sensitive penicillins,J01CE
benzylpenicillin,J01CE01
phenoxymethylpenicillin,J01CE02
propicillin,J01CE03
azidocillin,J01CE04
pheneticillin,J01CE05
penamecillin,J01CE06
clometocillin,J01CE07
benzathine benzylpenicillin,J01CE08
procaine benzylpenicillin,J01CE09
benzathine phenoxymethylpenicillin,J01CE10
combinations,J01CE30
beta-lactamase resistant penicillins,J01CF
dicloxacillin,J01CF01
cloxacillin,J01CF02
meticillin,J01CF03
oxacillin,J01CF04
flucloxacillin,J01CF05
nafcillin,J01CF06
beta-lactamase inhibitors,J01CG
sulbactam,J01CG01
tazobactam,J01CG02
"combinations of penicillins, incl. beta-lactamase inhibitors",J01CR
ampicillin and beta-lactamase inhibitor,J01CR01
amoxicillin and beta-lactamase inhibitor,J01CR02
ticarcillin and beta-lactamase inhibitor,J01CR03
sultamicillin,J01CR04
piperacillin and beta-lactamase inhibitor,J01CR05
combinations of penicillins,J01CR50
other beta-lactam antibacterials,J01D
first-generation cephalosporins,J01DB
cefalexin,J01DB01
cefaloridine,J01DB02
cefalotin,J01DB03
cefazolin,J01DB04
cefadroxil,J01DB05
cefazedone,J01DB06
cefatrizine,J01DB07
cefapirin,J01DB08
cefradine,J01DB09
cefacetrile,J01DB10
cefroxadine,J01DB11
ceftezole,J01DB12
second-generation cephalosporins,J01DC
cefoxitin,J01DC01
cefuroxime,J01DC02
cefamandole,J01DC03
cefaclor,J01DC04
cefotetan,J01DC05
cefonicid,J01DC06
cefotiam,J01DC07
loracarbef,J01DC08
cefmetazole,J01DC09
cefprozil,J01DC10
ceforanide,J01DC11
cefminox,J01DC12
cefbuperazone,J01DC13
flomoxef,J01DC14
third-generation cephalosporins,J01DD
cefotaxime,J01DD01
ceftazidime,J01DD02
cefsulodin,J01DD03
ceftriaxone,J01DD04
cefmenoxime,J01DD05
latamoxef,J01DD06
ceftizoxime,J01DD07
cefixime,J01DD08
cefodizime,J01DD09
cefetamet,J01DD10
cefpiramide,J01DD11
cefoperazone,J01DD12
cefpodoxime,J01DD13
ceftibuten,J01DD14
cefdinir,J01DD15
cefditoren,J01DD16
cefcapene,J01DD17
cefteram,J01DD18
cefotaxime and beta-lactamase inhibitor,J01DD51
ceftazidime and beta-lactamase inhibitor,J01DD52
"ceftriaxone, combinations",J01DD54
cefoperazone and beta-lactamase inhibitor,J01DD62
ceftriaxone and beta-lactamase inhibitor,J01DD63
cefpodoxime and beta-lactamase inhibitor,J01DD64
fourth-generation cephalosporins,J01DE
cefepime,J01DE01
cefpirome,J01DE02
cefozopran,J01DE03
monobactams,J01DF
aztreonam,J01DF01
carumonam,J01DF02
carbapenems,J01DH
meropenem,J01DH02
ertapenem,J01DH03
doripenem,J01DH04
biapenem,J01DH05
tebipenem pivoxil,J01DH06
imipenem and cilastatin,J01DH51
meropenem and vaborbactam,J01DH52
panipenem and betamipron,J01DH55
"imipenem, cilastatin and relebactam",J01DH56
other cephalosporins and penems,J01DI
ceftobiprole medocaril,J01DI01
ceftaroline fosamil,J01DI02
faropenem,J01DI03
cefiderocol,J01DI04
ceftolozane and beta-lactamase inhibitor,J01DI54
sulfonamides and trimethoprim,J01E
trimethoprim and derivatives,J01EA
trimethoprim,J01EA01
brodimoprim,J01EA02
iclaprim,J01EA03
short-acting sulfonamides,J01EB
sulfaisodimidine,J01EB01
sulfamethizole,J01EB02
sulfadimidine,J01EB03
sulfapyridine,J01EB04
sulfafurazole,J01EB05
sulfanilamide,J01EB06
sulfathiazole,J01EB07
sulfathiourea,J01EB08
combinations,J01EB20
intermediate-acting sulfonamides,J01EC
sulfamethoxazole,J01EC01
sulfadiazine,J01EC02
sulfamoxole,J01EC03
combinations,J01EC20
long-acting sulfonamides,J01ED
sulfadimethoxine,J01ED01
sulfalene,J01ED02
sulfametomidine,J01ED03
sulfametoxydiazine,J01ED04
sulfamethoxypyridazine,J01ED05
sulfaperin,J01ED06
sulfamerazine,J01ED07
sulfaphenazole,J01ED08
sulfamazone,J01ED09
combinations,J01ED20
"combinations of sulfonamides and trimethoprim, incl. derivatives",J01EE
sulfamethoxazole and trimethoprim,J01EE01
sulfadiazine and trimethoprim,J01EE02
sulfametrole and trimethoprim,J01EE03
sulfamoxole and trimethoprim,J01EE04
sulfadimidine and trimethoprim,J01EE05
sulfadiazine and tetroxoprim,J01EE06
sulfamerazine and trimethoprim,J01EE07
"macrolides, lincosamides and streptogramins",J01F
macrolides,J01FA
erythromycin,J01FA01
spiramycin,J01FA02
midecamycin,J01FA03
oleandomycin,J01FA05
roxithromycin,J01FA06
josamycin,J01FA07
troleandomycin,J01FA08
clarithromycin,J01FA09
azithromycin,J01FA10
miocamycin,J01FA11
rokitamycin,J01FA12
dirithromycin,J01FA13
flurithromycin,J01FA14
telithromycin,J01FA15
solithromycin,J01FA16
lincosamides,J01FF
clindamycin,J01FF01
lincomycin,J01FF02
streptogramins,J01FG
pristinamycin,J01FG01
quinupristin/dalfopristin,J01FG02
aminoglycoside antibacterials,J01G
streptomycins,J01GA
streptomycin,J01GA01
streptoduocin,J01GA02
other aminoglycosides,J01GB
tobramycin,J01GB01
gentamicin,J01GB03
kanamycin,J01GB04
neomycin,J01GB05
amikacin,J01GB06
netilmicin,J01GB07
sisomicin,J01GB08
dibekacin,J01GB09
ribostamycin,J01GB10
isepamicin,J01GB11
arbekacin,J01GB12
bekanamycin,J01GB13
plazomicin,J01GB14
quinolone antibacterials,J01M
fluoroquinolones,J01MA
ofloxacin,J01MA01
ciprofloxacin,J01MA02
pefloxacin,J01MA03
enoxacin,J01MA04
temafloxacin,J01MA05
norfloxacin,J01MA06
lomefloxacin,J01MA07
fleroxacin,J01MA08
sparfloxacin,J01MA09
rufloxacin,J01MA10
grepafloxacin,J01MA11
levofloxacin,J01MA12
trovafloxacin,J01MA13
moxifloxacin,J01MA14
gemifloxacin,J01MA15
gatifloxacin,J01MA16
prulifloxacin,J01MA17
pazufloxacin,J01MA18
garenoxacin,J01MA19
sitafloxacin,J01MA21
tosufloxacin,J01MA22
delafloxacin,J01MA23
levonadifloxacin,J01MA24
lascufloxacin,J01MA25
other quinolones,J01MB
rosoxacin,J01MB01
nalidixic acid,J01MB02
piromidic acid,J01MB03
pipemidic acid,J01MB04
oxolinic acid,J01MB05
cinoxacin,J01MB06
flumequine,J01MB07
nemonoxacin,J01MB08
combinations of antibacterials,J01R
combinations of antibacterials,J01RA
"penicillins, combinations with other antibacterials",J01RA01
"sulfonamides, combinations with other antibacterials (excl. trimethoprim)",J01RA02
cefuroxime and metronidazole,J01RA03
spiramycin and metronidazole,J01RA04
levofloxacin and ornidazole,J01RA05
cefepime and amikacin,J01RA06
"azithromycin, fluconazole and secnidazole",J01RA07
tetracycline and oleandomycin,J01RA08
ofloxacin and ornidazole,J01RA09
ciprofloxacin and metronidazole,J01RA10
ciprofloxacin and tinidazole,J01RA11
ciprofloxacin and ornidazole,J01RA12
norfloxacin and tinidazole,J01RA13
other antibacterials,J01X
glycopeptide antibacterials,J01XA
vancomycin,J01XA01
teicoplanin,J01XA02
telavancin,J01XA03
dalbavancin,J01XA04
oritavancin,J01XA05
polymyxins,J01XB
colistin,J01XB01
polymyxin b,J01XB02
steroid antibacterials,J01XC
fusidic acid,J01XC01
imidazole derivatives,J01XD
metronidazole,J01XD01
tinidazole,J01XD02
ornidazole,J01XD03
nitrofuran derivatives,J01XE
nitrofurantoin,J01XE01
nifurtoinol,J01XE02
furazidin,J01XE03
"nitrofurantoin, combinations",J01XE51
other antibacterials,J01XX
fosfomycin,J01XX01
xibornol,J01XX02
clofoctol,J01XX03
spectinomycin,J01XX04
methenamine,J01XX05
mandelic acid,J01XX06
nitroxoline,J01XX07
linezolid,J01XX08
daptomycin,J01XX09
bacitracin,J01XX10
tedizolid,J01XX11
lefamulin,J01XX12
tetracyclines,J01AA
demeclocycline,J01AA01
doxycycline,J01AA02
chlortetracycline,J01AA03
lymecycline,J01AA04
metacycline,J01AA05
oxytetracycline,J01AA06
tetracycline,J01AA07
minocycline,J01AA08
rolitetracycline,J01AA09
penimepicycline,J01AA10
clomocycline,J01AA11
tigecycline,J01AA12
eravacycline,J01AA13
sarecycline,J01AA14
omadacycline,J01AA15
combinations of tetracyclines,J01AA20
"oxytetracycline, combinations",J01AA56
antimycotics for systemic use,J02
antimycotics for systemic use,J02A
imidazole derivatives,J02AB
miconazole,J02AB01
ketoconazole,J02AB02
triazole derivatives,J02AC
fluconazole,J02AC01
itraconazole,J02AC02
voriconazole,J02AC03
posaconazole,J02AC04
isavuconazole,J02AC05
other antimycotics for systemic use,J02AX
flucytosine,J02AX01
caspofungin,J02AX04
micafungin,J02AX05
anidulafungin,J02AX06
antibiotics,J02AA
amphotericin b,J02AA01
hachimycin,J02AA02
antimycobacterials,J04
drugs for treatment of tuberculosis,J04A
antibiotics,J04AB
cycloserine,J04AB01
rifampicin,J04AB02
rifamycin,J04AB03
rifabutin,J04AB04
rifapentine,J04AB05
enviomycin,J04AB06
capreomycin,J04AB30
hydrazides,J04AC
isoniazid,J04AC01
"isoniazid, combinations",J04AC51
thiocarbamide derivatives,J04AD
protionamide,J04AD01
tiocarlide,J04AD02
ethionamide,J04AD03
other drugs for treatment of tuberculosis,J04AK
pyrazinamide,J04AK01
ethambutol,J04AK02
terizidone,J04AK03
morinamide,J04AK04
bedaquiline,J04AK05
delamanid,J04AK06
thioacetazone,J04AK07
pretomanid,J04AK08
combinations of drugs for treatment of tuberculosis,J04AM
streptomycin and isoniazid,J04AM01
rifampicin and isoniazid,J04AM02
ethambutol and isoniazid,J04AM03
thioacetazone and isoniazid,J04AM04
"rifampicin, pyrazinamide and isoniazid",J04AM05
"rifampicin, pyrazinamide, ethambutol and isoniazid",J04AM06
"rifampicin, ethambutol and isoniazid",J04AM07
"isoniazid, sulfamethoxazole, trimethoprim and pyridoxine",J04AM08
drugs for treatment of lepra,J04B
drugs for treatment of lepra,J04BA
clofazimine,J04BA01
dapsone,J04BA02
aldesulfone sodium,J04BA03
aminosalicylic acid and derivatives,J04AA
4-aminosalicylic acid,J04AA01
sodium aminosalicylate,J04AA02
calcium aminosalicylate,J04AA03
antivirals for systemic use,J05
direct acting antivirals,J05A
nucleosides and nucleotides excl. reverse transcriptase inhibitors,J05AB
aciclovir,J05AB01
idoxuridine,J05AB02
vidarabine,J05AB03
ganciclovir,J05AB06
famciclovir,J05AB09
valaciclovir,J05AB11
cidofovir,J05AB12
penciclovir,J05AB13
valganciclovir,J05AB14
brivudine,J05AB15
cyclic amines,J05AC
rimantadine,J05AC02
tromantadine,J05AC03
phosphonic acid derivatives,J05AD
foscarnet,J05AD01
fosfonet,J05AD02
protease inhibitors,J05AE
saquinavir,J05AE01
indinavir,J05AE02
ritonavir,J05AE03
nelfinavir,J05AE04
amprenavir,J05AE05
fosamprenavir,J05AE07
atazanavir,J05AE08
tipranavir,J05AE09
darunavir,J05AE10
nucleoside and nucleotide reverse transcriptase inhibitors,J05AF
zidovudine,J05AF01
didanosine,J05AF02
zalcitabine,J05AF03
stavudine,J05AF04
lamivudine,J05AF05
abacavir,J05AF06
tenofovir disoproxil,J05AF07
adefovir dipivoxil,J05AF08
emtricitabine,J05AF09
entecavir,J05AF10
telbivudine,J05AF11
clevudine,J05AF12
tenofovir alafenamide,J05AF13
non-nucleoside reverse transcriptase inhibitors,J05AG
nevirapine,J05AG01
delavirdine,J05AG02
efavirenz,J05AG03
etravirine,J05AG04
rilpivirine,J05AG05
doravirine,J05AG06
neuraminidase inhibitors,J05AH
zanamivir,J05AH01
oseltamivir,J05AH02
peramivir,J05AH03
laninamivir,J05AH04
integrase inhibitors,J05AJ
raltegravir,J05AJ01
elvitegravir,J05AJ02
dolutegravir,J05AJ03
cabotegravir,J05AJ04
antivirals for treatment of hcv infections,J05AP
ribavirin,J05AP01
telaprevir,J05AP02
boceprevir,J05AP03
faldaprevir,J05AP04
simeprevir,J05AP05
asunaprevir,J05AP06
daclatasvir,J05AP07
sofosbuvir,J05AP08
dasabuvir,J05AP09
elbasvir,J05AP10
grazoprevir,J05AP11
sofosbuvir and ledipasvir,J05AP51
"dasabuvir, ombitasvir, paritaprevir and ritonavir",J05AP52
"ombitasvir, paritaprevir and ritonavir",J05AP53
elbasvir and grazoprevir,J05AP54
sofosbuvir and velpatasvir,J05AP55
"sofosbuvir, velpatasvir and voxilaprevir",J05AP56
glecaprevir and pibrentasvir,J05AP57
"daclatasvir, asunaprevir and beclabuvir",J05AP58
"antivirals for treatment of hiv infections, combinations",J05AR
zidovudine and lamivudine,J05AR01
lamivudine and abacavir,J05AR02
tenofovir disoproxil and emtricitabine,J05AR03
"zidovudine, lamivudine and abacavir",J05AR04
"zidovudine, lamivudine and nevirapine",J05AR05
"emtricitabine, tenofovir disoproxil and efavirenz",J05AR06
"stavudine, lamivudine and nevirapine",J05AR07
"emtricitabine, tenofovir disoproxil and rilpivirine",J05AR08
"emtricitabine, tenofovir disoproxil, elvitegravir and cobicistat",J05AR09
lopinavir and ritonavir,J05AR10
"lamivudine, tenofovir disoproxil and efavirenz",J05AR11
lamivudine and tenofovir disoproxil,J05AR12
"lamivudine, abacavir and dolutegravir",J05AR13
darunavir and cobicistat,J05AR14
atazanavir and cobicistat,J05AR15
lamivudine and raltegravir,J05AR16
emtricitabine and tenofovir alafenamide,J05AR17
"emtricitabine, tenofovir alafenamide, elvitegravir and cobicistat",J05AR18
"emtricitabine, tenofovir alafenamide and rilpivirine",J05AR19
"emtricitabine, tenofovir alafenamide and bictegravir",J05AR20
dolutegravir and rilpivirine,J05AR21
"emtricitabine, tenofovir alafenamide, darunavir and cobicistat",J05AR22
atazanavir and ritonavir,J05AR23
"lamivudine, tenofovir disoproxil and doravirine",J05AR24
lamivudine and dolutegravir,J05AR25
darunavir and ritonavir,J05AR26
"lamivudine, tenofovir disoproxil and dolutegravir",J05AR27
other antivirals,J05AX
moroxydine,J05AX01
lysozyme,J05AX02
inosine pranobex,J05AX05
pleconaril,J05AX06
enfuvirtide,J05AX07
maraviroc,J05AX09
maribavir,J05AX10
umifenovir,J05AX13
enisamium iodide,J05AX17
letermovir,J05AX18
tilorone,J05AX19
pentanedioic acid imidazolyl ethanamide,J05AX21
ibalizumab,J05AX23
tecovirimat,J05AX24
baloxavir marboxil,J05AX25
amenamevir,J05AX26
favipiravir,J05AX27
bulevirtide,J05AX28
fostemsavir,J05AX29
thiosemicarbazones,J05AA
metisazone,J05AA01
immune sera and immunoglobulins,J06
immune sera,J06A
immunoglobulins,J06B
"immunoglobulins, normal human",J06BA
"immunoglobulins, normal human, for extravascular adm.",J06BA01
"immunoglobulins, normal human, for intravascular adm.",J06BA02
specific immunoglobulins,J06BB
anti-d (rh) immunoglobulin,J06BB01
tetanus immunoglobulin,J06BB02
varicella/zoster immunoglobulin,J06BB03
hepatitis b immunoglobulin,J06BB04
rabies immunoglobulin,J06BB05
rubella immunoglobulin,J06BB06
vaccinia immunoglobulin,J06BB07
staphylococcus immunoglobulin,J06BB08
cytomegalovirus immunoglobulin,J06BB09
diphtheria immunoglobulin,J06BB10
hepatitis a immunoglobulin,J06BB11
"encephalitis, tick borne immunoglobulin",J06BB12
pertussis immunoglobulin,J06BB13
measles immunoglobulin,J06BB14
mumps immunoglobulin,J06BB15
palivizumab,J06BB16
motavizumab,J06BB17
raxibacumab,J06BB18
anthrax immunoglobulin,J06BB19
bezlotoxumab,J06BB21
obiltoxaximab,J06BB22
combinations,J06BB30
other immunoglobulins,J06BC
nebacumab,J06BC01
immune sera,J06AA
diphtheria antitoxin,J06AA01
tetanus antitoxin,J06AA02
snake venom antiserum,J06AA03
botulinum antitoxin,J06AA04
gas-gangrene sera,J06AA05
rabies serum,J06AA06
vaccines,J07
bacterial vaccines,J07A
anthrax vaccines,J07AC
anthrax antigen,J07AC01
brucellosis vaccines,J07AD
brucella antigen,J07AD01
cholera vaccines,J07AE
"cholera, inactivated, whole cell",J07AE01
"cholera, live attenuated",J07AE02
"cholera, combinations with typhoid vaccine, inactivated, whole cell",J07AE51
diphtheria vaccines,J07AF
diphtheria toxoid,J07AF01
haemophilus influenzae b vaccines,J07AG
"haemophilus influenzae b, purified antigen conjugated",J07AG01
"haemophilus influenzae b, combinations with toxoids",J07AG51
"haemophilus influenzae b, combinations with pertussis and toxoids",J07AG52
"haemophilus influenzae b, combinations with meningococcus c, conjugated",J07AG53
meningococcal vaccines,J07AH
"meningococcus a, purified polysaccharides antigen",J07AH01
other meningococcal monovalent purified polysaccharides antigen,J07AH02
"meningococcus a,c, bivalent purified polysaccharides antigen",J07AH03
"meningococcus a,c,y,w-135, tetravalent purified polysaccharides antigen",J07AH04
other meningococcal polyvalent purified polysaccharides antigen,J07AH05
"meningococcus b, outer membrane vesicle vaccine",J07AH06
"meningococcus c, purified polysaccharides antigen conjugated",J07AH07
"meningococcus a,c,y,w-135, tetravalent purified polysaccharides antigen conjugated",J07AH08
"meningococcus b, multicomponent vaccine",J07AH09
"meningococcus a, purified polysaccharides antigen conjugated",J07AH10
pertussis vaccines,J07AJ
"pertussis, inactivated, whole cell",J07AJ01
"pertussis, purified antigen",J07AJ02
"pertussis, inactivated, whole cell, combinations with toxoids",J07AJ51
"pertussis, purified antigen, combinations with toxoids",J07AJ52
plague vaccines,J07AK
"plague, inactivated, whole cell",J07AK01
pneumococcal vaccines,J07AL
"pneumococcus, purified polysaccharides antigen",J07AL01
"pneumococcus, purified polysaccharides antigen conjugated",J07AL02
"pneumococcus purified polysaccharides antigen and haemophilus influenzae, conjugated",J07AL52
tetanus vaccines,J07AM
tetanus toxoid,J07AM01
"tetanus toxoid, combinations with diphtheria toxoid",J07AM51
"tetanus toxoid, combinations with tetanus immunoglobulin",J07AM52
tuberculosis vaccines,J07AN
"tuberculosis, live attenuated",J07AN01
typhoid vaccines,J07AP
"typhoid, oral, live attenuated",J07AP01
"typhoid, inactivated, whole cell",J07AP02
"typhoid, purified polysaccharide antigen",J07AP03
"typhoid, combinations with paratyphi types",J07AP10
typhus (exanthematicus) vaccines,J07AR
"typhus exanthematicus, inactivated, whole cell",J07AR01
other bacterial vaccines,J07AX
viral vaccines,J07B
encephalitis vaccines,J07BA
"encephalitis, tick borne, inactivated, whole virus",J07BA01
"encephalitis, japanese, inactivated, whole virus",J07BA02
"encephalitis, japanese, live attenuated",J07BA03
influenza vaccines,J07BB
"influenza, inactivated, whole virus",J07BB01
"influenza, inactivated, split virus or surface antigen",J07BB02
"influenza, live attenuated",J07BB03
"influenza, virus like particles",J07BB04
hepatitis vaccines,J07BC
"hepatitis b, purified antigen",J07BC01
"hepatitis a, inactivated, whole virus",J07BC02
combinations,J07BC20
measles vaccines,J07BD
"measles, live attenuated",J07BD01
"measles, combinations with mumps, live attenuated",J07BD51
"measles, combinations with mumps and rubella, live attenuated",J07BD52
"measles, combinations with rubella, live attenuated",J07BD53
"measles, combinations with mumps, rubella and varicella, live attenuated",J07BD54
mumps vaccines,J07BE
"mumps, live attenuated",J07BE01
poliomyelitis vaccines,J07BF
"poliomyelitis oral, monovalent, live attenuated",J07BF01
"poliomyelitis oral, trivalent, live attenuated",J07BF02
"poliomyelitis, trivalent, inactivated, whole virus",J07BF03
"poliomyelitis oral, bivalent, live attenuated",J07BF04
rabies vaccines,J07BG
"rabies, inactivated, whole virus",J07BG01
rota virus diarrhea vaccines,J07BH
"rota virus, live attenuated",J07BH01
"rota virus, pentavalent, live, reassorted",J07BH02
rubella vaccines,J07BJ
"rubella, live attenuated",J07BJ01
"rubella, combinations with mumps, live attenuated",J07BJ51
varicella zoster vaccines,J07BK
"varicella, live attenuated",J07BK01
"zoster, live attenuated",J07BK02
"zoster, purified antigen",J07BK03
yellow fever vaccines,J07BL
"yellow fever, live attenuated",J07BL01
papillomavirus vaccines,J07BM
"papillomavirus (human types 6, 11, 16, 18)",J07BM01
"papillomavirus (human types 16, 18)",J07BM02
"papillomavirus (human types 6, 11, 16, 18, 31, 33, 45, 52, 58)",J07BM03
other viral vaccines,J07BX
smallpox vaccines,J07BX01
ebola vaccines,J07BX02
"bacterial and viral vaccines, combined",J07C
"bacterial and viral vaccines, combined",J07CA
diphtheria-poliomyelitis-tetanus,J07CA01
diphtheria-pertussis-poliomyelitis-tetanus,J07CA02
diphtheria-rubella-tetanus,J07CA03
haemophilus influenzae b and poliomyelitis,J07CA04
diphtheria-hepatitis b-pertussis-tetanus,J07CA05
diphtheria-haemophilus influenzae b-pertussis-poliomyelitis-tetanus,J07CA06
diphtheria-hepatitis b-tetanus,J07CA07
haemophilus influenzae b and hepatitis b,J07CA08
diphtheria-haemophilus influenzae b-pertussis-poliomyelitis-tetanus-hepatitis b,J07CA09
typhoid-hepatitis a,J07CA10
diphtheria-haemophilus influenzae b-pertussis-tetanus-hepatitis b,J07CA11
diphtheria-pertussis-poliomyelitis-tetanus-hepatitis b,J07CA12
diphtheria-haemophilus influenzae b-pertussis-tetanus-hepatitis b-meningococcus a + c,J07CA13
other vaccines,J07X
antineoplastic and immunomodulating agents,L
antineoplastic agents,L01
alkylating agents,L01A
alkyl sulfonates,L01AB
busulfan,L01AB01
treosulfan,L01AB02
mannosulfan,L01AB03
ethylene imines,L01AC
thiotepa,L01AC01
triaziquone,L01AC02
carboquone,L01AC03
nitrosoureas,L01AD
carmustine,L01AD01
lomustine,L01AD02
semustine,L01AD03
streptozocin,L01AD04
fotemustine,L01AD05
nimustine,L01AD06
ranimustine,L01AD07
uramustine,L01AD08
epoxides,L01AG
etoglucid,L01AG01
other alkylating agents,L01AX
mitobronitol,L01AX01
pipobroman,L01AX02
temozolomide,L01AX03
dacarbazine,L01AX04
antimetabolites,L01B
folic acid analogues,L01BA
methotrexate,L01BA01
raltitrexed,L01BA03
pemetrexed,L01BA04
pralatrexate,L01BA05
purine analogues,L01BB
mercaptopurine,L01BB02
tioguanine,L01BB03
cladribine,L01BB04
fludarabine,L01BB05
clofarabine,L01BB06
nelarabine,L01BB07
pyrimidine analogues,L01BC
cytarabine,L01BC01
fluorouracil,L01BC02
tegafur,L01BC03
carmofur,L01BC04
gemcitabine,L01BC05
capecitabine,L01BC06
azacitidine,L01BC07
decitabine,L01BC08
floxuridine,L01BC09
"fluorouracil, combinations",L01BC52
"tegafur, combinations",L01BC53
"trifluridine, combinations",L01BC59
plant alkaloids and other natural products,L01C
vinca alkaloids and analogues,L01CA
vinblastine,L01CA01
vincristine,L01CA02
vindesine,L01CA03
vinorelbine,L01CA04
vinflunine,L01CA05
vintafolide,L01CA06
podophyllotoxin derivatives,L01CB
etoposide,L01CB01
teniposide,L01CB02
colchicine derivatives,L01CC
demecolcine,L01CC01
taxanes,L01CD
paclitaxel,L01CD01
docetaxel,L01CD02
paclitaxel poliglumex,L01CD03
cabazitaxel,L01CD04
topoisomerase 1 (top1) inhibitors,L01CE
topotecan,L01CE01
irinotecan,L01CE02
etirinotecan pegol,L01CE03
belotecan,L01CE04
other plant alkaloids and natural products,L01CX
trabectedin,L01CX01
cytotoxic antibiotics and related substances,L01D
actinomycines,L01DA
dactinomycin,L01DA01
anthracyclines and related substances,L01DB
doxorubicin,L01DB01
daunorubicin,L01DB02
epirubicin,L01DB03
aclarubicin,L01DB04
zorubicin,L01DB05
idarubicin,L01DB06
mitoxantrone,L01DB07
pirarubicin,L01DB08
valrubicin,L01DB09
amrubicin,L01DB10
pixantrone,L01DB11
other cytotoxic antibiotics,L01DC
bleomycin,L01DC01
plicamycin,L01DC02
mitomycin,L01DC03
ixabepilone,L01DC04
protein kinase inhibitors,L01E
bcr-abl tyrosine kinase inhibitors,L01EA
imatinib,L01EA01
dasatinib,L01EA02
nilotinib,L01EA03
bosutinib,L01EA04
ponatinib,L01EA05
epidermal growth factor receptor (egfr) tyrosine kinase inhibitors,L01EB
gefitinib,L01EB01
erlotinib,L01EB02
afatinib,L01EB03
osimertinib,L01EB04
rociletinib,L01EB05
olmutinib,L01EB06
dacomitinib,L01EB07
icotinib,L01EB08
b-raf serine-threonine kinase (braf) inhibitors,L01EC
vemurafenib,L01EC01
dabrafenib,L01EC02
encorafenib,L01EC03
anaplastic lymphoma kinase (alk) inhibitors,L01ED
crizotinib,L01ED01
ceritinib,L01ED02
alectinib,L01ED03
brigatinib,L01ED04
lorlatinib,L01ED05
mitogen-activated protein kinase (mek) inhibitors,L01EE
trametinib,L01EE01
cobimetinib,L01EE02
binimetinib,L01EE03
selumetinib,L01EE04
cyclin-dependent kinase (cdk) inhibitors,L01EF
palbociclib,L01EF01
ribociclib,L01EF02
abemaciclib,L01EF03
mammalian target of rapamycin (mtor) kinase inhibitors,L01EG
temsirolimus,L01EG01
everolimus,L01EG02
ridaforolimus,L01EG03
human epidermal growth factor receptor 2 (her2) tyrosine kinase inhibitors,L01EH
lapatinib,L01EH01
neratinib,L01EH02
tucatinib,L01EH03
janus-associated kinase (jak) inhibitors,L01EJ
ruxolitinib,L01EJ01
fedratinib,L01EJ02
vascular endothelial growth factor receptor (vegfr) tyrosine kinase inhibitors,L01EK
axitinib,L01EK01
cediranib,L01EK02
tivozanib,L01EK03
bruton's tyrosine kinase (btk) inhibitors,L01EL
ibrutinib,L01EL01
acalabrutinib,L01EL02
zanubrutinib,L01EL03
phosphatidylinositol-3-kinase (pi3k) inhibitors,L01EM
idelalisib,L01EM01
copanlisib,L01EM02
alpelisib,L01EM03
duvelisib,L01EM04
other protein kinase inhibitors,L01EX
sunitinib,L01EX01
sorafenib,L01EX02
pazopanib,L01EX03
vandetanib,L01EX04
regorafenib,L01EX05
masitinib,L01EX06
cabozantinib,L01EX07
lenvatinib,L01EX08
nintedanib,L01EX09
midostaurin,L01EX10
quizartinib,L01EX11
larotrectinib,L01EX12
gilteritinib,L01EX13
entrectinib,L01EX14
pexidartinib,L01EX15
erdafitinib,L01EX16
capmatinib,L01EX17
avapritinib,L01EX18
ripretinib,L01EX19
pemigatinib,L01EX20
tepotinib,L01EX21
other antineoplastic agents,L01X
platinum compounds,L01XA
cisplatin,L01XA01
carboplatin,L01XA02
oxaliplatin,L01XA03
satraplatin,L01XA04
polyplatillen,L01XA05
methylhydrazines,L01XB
procarbazine,L01XB01
monoclonal antibodies,L01XC
edrecolomab,L01XC01
rituximab,L01XC02
trastuzumab,L01XC03
gemtuzumab ozogamicin,L01XC05
cetuximab,L01XC06
bevacizumab,L01XC07
panitumumab,L01XC08
catumaxomab,L01XC09
ofatumumab,L01XC10
ipilimumab,L01XC11
brentuximab vedotin,L01XC12
pertuzumab,L01XC13
trastuzumab emtansine,L01XC14
obinutuzumab,L01XC15
dinutuximab beta,L01XC16
nivolumab,L01XC17
pembrolizumab,L01XC18
blinatumomab,L01XC19
ramucirumab,L01XC21
necitumumab,L01XC22
elotuzumab,L01XC23
daratumumab,L01XC24
mogamulizumab,L01XC25
inotuzumab ozogamicin,L01XC26
olaratumab,L01XC27
durvalumab,L01XC28
bermekimab,L01XC29
avelumab,L01XC31
atezolizumab,L01XC32
cemiplimab,L01XC33
moxetumomab pasudotox,L01XC34
tafasitamab,L01XC35
enfortumab vedotin,L01XC36
polatuzumab vedotin,L01XC37
isatuximab,L01XC38
belantamab mafodotin,L01XC39
dostarlimab,L01XC40
trastuzumab deruxtecan,L01XC41
sensitizers used in photodynamic/radiation therapy,L01XD
porfimer sodium,L01XD01
methyl aminolevulinate,L01XD03
aminolevulinic acid,L01XD04
temoporfin,L01XD05
efaproxiral,L01XD06
padeliporfin,L01XD07
retinoids for cancer treatment,L01XF
tretinoin,L01XF01
alitretinoin,L01XF02
bexarotene,L01XF03
proteasome inhibitors,L01XG
bortezomib,L01XG01
carfilzomib,L01XG02
ixazomib,L01XG03
histone deacetylase (hdac) inhibitors,L01XH
vorinostat,L01XH01
romidepsin,L01XH02
panobinostat,L01XH03
belinostat,L01XH04
entinostat,L01XH05
hedgehog pathway inhibitors,L01XJ
vismodegib,L01XJ01
sonidegib,L01XJ02
glasdegib,L01XJ03
poly (adp-ribose) polymerase (parp) inhibitors,L01XK
olaparib,L01XK01
niraparib,L01XK02
rucaparib,L01XK03
talazoparib,L01XK04
veliparib,L01XK05
other antineoplastic agents,L01XX
amsacrine,L01XX01
asparaginase,L01XX02
altretamine,L01XX03
hydroxycarbamide,L01XX05
lonidamine,L01XX07
pentostatin,L01XX08
masoprocol,L01XX10
estramustine,L01XX11
mitoguazone,L01XX16
tiazofurine,L01XX18
mitotane,L01XX23
pegaspargase,L01XX24
arsenic trioxide,L01XX27
denileukin diftitox,L01XX29
celecoxib,L01XX33
anagrelide,L01XX35
oblimersen,L01XX36
sitimagene ceradenovec,L01XX37
omacetaxine mepesuccinate,L01XX40
eribulin,L01XX41
aflibercept,L01XX44
talimogene laherparepvec,L01XX51
venetoclax,L01XX52
vosaroxin,L01XX53
plitidepsin,L01XX57
epacadostat,L01XX58
enasidenib,L01XX59
ivosidenib,L01XX62
selinexor,L01XX66
tagraxofusp,L01XX67
lurbinectedin,L01XX69
axicabtagene ciloleucel,L01XX70
tisagenlecleucel,L01XX71
combinations of antineoplastic agents,L01XY
cytarabine and daunorubicin,L01XY01
pertuzumab and trastuzumab,L01XY02
nitrogen mustard analogues,L01AA
cyclophosphamide,L01AA01
chlorambucil,L01AA02
melphalan,L01AA03
chlormethine,L01AA05
ifosfamide,L01AA06
trofosfamide,L01AA07
prednimustine,L01AA08
bendamustine,L01AA09
endocrine therapy,L02
hormones and related agents,L02A
progestogens,L02AB
megestrol,L02AB01
medroxyprogesterone,L02AB02
gestonorone,L02AB03
gonadotropin releasing hormone analogues,L02AE
buserelin,L02AE01
leuprorelin,L02AE02
goserelin,L02AE03
triptorelin,L02AE04
histrelin,L02AE05
leuprorelin and bicalutamide,L02AE51
other hormones,L02AX
hormone antagonists and related agents,L02B
anti-estrogens,L02BA
tamoxifen,L02BA01
toremifene,L02BA02
fulvestrant,L02BA03
anti-androgens,L02BB
flutamide,L02BB01
nilutamide,L02BB02
bicalutamide,L02BB03
enzalutamide,L02BB04
apalutamide,L02BB05
darolutamide,L02BB06
aromatase inhibitors,L02BG
aminoglutethimide,L02BG01
formestane,L02BG02
anastrozole,L02BG03
letrozole,L02BG04
vorozole,L02BG05
exemestane,L02BG06
other hormone antagonists and related agents,L02BX
abarelix,L02BX01
degarelix,L02BX02
abiraterone,L02BX03
estrogens,L02AA
diethylstilbestrol,L02AA01
polyestradiol phosphate,L02AA02
ethinylestradiol,L02AA03
fosfestrol,L02AA04
immunostimulants,L03
immunostimulants,L03A
interferons,L03AB
interferon alfa natural,L03AB01
interferon beta natural,L03AB02
interferon gamma,L03AB03
interferon alfa-2a,L03AB04
interferon alfa-2b,L03AB05
interferon alfa-n1,L03AB06
interferon beta-1a,L03AB07
interferon beta-1b,L03AB08
interferon alfacon-1,L03AB09
peginterferon alfa-2b,L03AB10
peginterferon alfa-2a,L03AB11
albinterferon alfa-2b,L03AB12
peginterferon beta-1a,L03AB13
cepeginterferon alfa-2b,L03AB14
ropeginterferon alfa-2b,L03AB15
"peginterferon alfa-2b, combinations",L03AB60
"peginterferon alfa-2a, combinations",L03AB61
interleukins,L03AC
aldesleukin,L03AC01
oprelvekin,L03AC02
other immunostimulants,L03AX
lentinan,L03AX01
roquinimex,L03AX02
bcg vaccine,L03AX03
pegademase,L03AX04
pidotimod,L03AX05
poly i:c,L03AX07
poly iclc,L03AX08
thymopentin,L03AX09
immunocyanin,L03AX10
tasonermin,L03AX11
melanoma vaccine,L03AX12
glatiramer acetate,L03AX13
histamine dihydrochloride,L03AX14
mifamurtide,L03AX15
plerixafor,L03AX16
sipuleucel-t,L03AX17
cridanimod,L03AX18
dasiprotimut-t,L03AX19
elapegademase,L03AX21
colony stimulating factors,L03AA
filgrastim,L03AA02
molgramostim,L03AA03
sargramostim,L03AA09
lenograstim,L03AA10
ancestim,L03AA12
pegfilgrastim,L03AA13
lipegfilgrastim,L03AA14
balugrastim,L03AA15
empegfilgrastim,L03AA16
pegteograstim,L03AA17
immunosuppressants,L04
immunosuppressants,L04A
tumor necrosis factor alpha (tnf-alpha) inhibitors,L04AB
etanercept,L04AB01
infliximab,L04AB02
afelimomab,L04AB03
adalimumab,L04AB04
certolizumab pegol,L04AB05
golimumab,L04AB06
opinercept,L04AB07
interleukin inhibitors,L04AC
daclizumab,L04AC01
basiliximab,L04AC02
anakinra,L04AC03
rilonacept,L04AC04
ustekinumab,L04AC05
tocilizumab,L04AC07
canakinumab,L04AC08
briakinumab,L04AC09
secukinumab,L04AC10
siltuximab,L04AC11
brodalumab,L04AC12
ixekizumab,L04AC13
sarilumab,L04AC14
sirukumab,L04AC15
guselkumab,L04AC16
tildrakizumab,L04AC17
risankizumab,L04AC18
satralizumab,L04AC19
calcineurin inhibitors,L04AD
ciclosporin,L04AD01
tacrolimus,L04AD02
voclosporin,L04AD03
other immunosuppressants,L04AX
azathioprine,L04AX01
thalidomide,L04AX02
methotrexate,L04AX03
lenalidomide,L04AX04
pirfenidone,L04AX05
pomalidomide,L04AX06
dimethyl fumarate,L04AX07
darvadstrocel,L04AX08
selective immunosuppressants,L04AA
muromonab-cd3,L04AA02
antilymphocyte immunoglobulin (horse),L04AA03
antithymocyte immunoglobulin (rabbit),L04AA04
mycophenolic acid,L04AA06
sirolimus,L04AA10
leflunomide,L04AA13
alefacept,L04AA15
everolimus,L04AA18
gusperimus,L04AA19
efalizumab,L04AA21
abetimus,L04AA22
natalizumab,L04AA23
abatacept,L04AA24
eculizumab,L04AA25
belimumab,L04AA26
fingolimod,L04AA27
belatacept,L04AA28
tofacitinib,L04AA29
teriflunomide,L04AA31
apremilast,L04AA32
vedolizumab,L04AA33
alemtuzumab,L04AA34
begelomab,L04AA35
ocrelizumab,L04AA36
baricitinib,L04AA37
ozanimod,L04AA38
emapalumab,L04AA39
cladribine,L04AA40
imlifidase,L04AA41
siponimod,L04AA42
ravulizumab,L04AA43
upadacitinib,L04AA44
filgotinib,L04AA45
itacitinib,L04AA46
inebilizumab,L04AA47
musculo-skeletal system,M
antiinflammatory and antirheumatic products,M01
"antiinflammatory and antirheumatic products, non-steroids",M01A
acetic acid derivatives and related substances,M01AB
indometacin,M01AB01
sulindac,M01AB02
tolmetin,M01AB03
zomepirac,M01AB04
diclofenac,M01AB05
alclofenac,M01AB06
bumadizone,M01AB07
etodolac,M01AB08
lonazolac,M01AB09
fentiazac,M01AB10
acemetacin,M01AB11
difenpiramide,M01AB12
oxametacin,M01AB13
proglumetacin,M01AB14
ketorolac,M01AB15
aceclofenac,M01AB16
bufexamac,M01AB17
"indometacin, combinations",M01AB51
"diclofenac, combinations",M01AB55
oxicams,M01AC
piroxicam,M01AC01
tenoxicam,M01AC02
droxicam,M01AC04
lornoxicam,M01AC05
meloxicam,M01AC06
"meloxicam, combinations",M01AC56
propionic acid derivatives,M01AE
ibuprofen,M01AE01
naproxen,M01AE02
ketoprofen,M01AE03
fenoprofen,M01AE04
fenbufen,M01AE05
benoxaprofen,M01AE06
suprofen,M01AE07
pirprofen,M01AE08
flurbiprofen,M01AE09
indoprofen,M01AE10
tiaprofenic acid,M01AE11
oxaprozin,M01AE12
ibuproxam,M01AE13
dexibuprofen,M01AE14
flunoxaprofen,M01AE15
alminoprofen,M01AE16
dexketoprofen,M01AE17
naproxcinod,M01AE18
"ibuprofen, combinations",M01AE51
naproxen and esomeprazole,M01AE52
"ketoprofen, combinations",M01AE53
naproxen and misoprostol,M01AE56
fenamates,M01AG
mefenamic acid,M01AG01
tolfenamic acid,M01AG02
flufenamic acid,M01AG03
meclofenamic acid,M01AG04
coxibs,M01AH
celecoxib,M01AH01
rofecoxib,M01AH02
valdecoxib,M01AH03
parecoxib,M01AH04
etoricoxib,M01AH05
lumiracoxib,M01AH06
polmacoxib,M01AH07
"other antiinflammatory and antirheumatic agents, non-steroids",M01AX
nabumetone,M01AX01
niflumic acid,M01AX02
azapropazone,M01AX04
glucosamine,M01AX05
benzydamine,M01AX07
glucosaminoglycan polysulfate,M01AX12
proquazone,M01AX13
orgotein,M01AX14
nimesulide,M01AX17
feprazone,M01AX18
diacerein,M01AX21
morniflumate,M01AX22
tenidap,M01AX23
oxaceprol,M01AX24
chondroitin sulfate,M01AX25
"avocado and soyabean oil, unsaponifiables",M01AX26
"feprazone, combinations",M01AX68
antiinflammatory/antirheumatic agents in combination,M01B
antiinflammatory/antirheumatic agents in combination with corticosteroids,M01BA
phenylbutazone and corticosteroids,M01BA01
dipyrocetyl and corticosteroids,M01BA02
acetylsalicylic acid and corticosteroids,M01BA03
other antiinflammatory/antirheumatic agents in combination with other drugs,M01BX
specific antirheumatic agents,M01C
quinolines,M01CA
oxycinchophen,M01CA03
gold preparations,M01CB
sodium aurothiomalate,M01CB01
sodium aurotiosulfate,M01CB02
auranofin,M01CB03
aurothioglucose,M01CB04
aurotioprol,M01CB05
penicillamine and similar agents,M01CC
penicillamine,M01CC01
bucillamine,M01CC02
other specific antirheumatic agents,M01CX
butylpyrazolidines,M01AA
phenylbutazone,M01AA01
mofebutazone,M01AA02
oxyphenbutazone,M01AA03
clofezone,M01AA05
kebuzone,M01AA06
topical products for joint and muscular pain,M02
topical products for joint and muscular pain,M02A
capsaicin and similar agents,M02AB
capsaicin,M02AB01
zucapsaicin,M02AB02
preparations with salicylic acid derivatives,M02AC
other topical products for joint and muscular pain,M02AX
tolazoline,M02AX02
dimethyl sulfoxide,M02AX03
idrocilamide,M02AX05
tolperisone,M02AX06
various,M02AX10
"antiinflammatory preparations, non-steroids for topical use",M02AA
phenylbutazone,M02AA01
mofebutazone,M02AA02
clofezone,M02AA03
oxyphenbutazone,M02AA04
benzydamine,M02AA05
etofenamate,M02AA06
piroxicam,M02AA07
felbinac,M02AA08
bufexamac,M02AA09
ketoprofen,M02AA10
bendazac,M02AA11
naproxen,M02AA12
ibuprofen,M02AA13
fentiazac,M02AA14
diclofenac,M02AA15
feprazone,M02AA16
niflumic acid,M02AA17
meclofenamic acid,M02AA18
flurbiprofen,M02AA19
tolmetin,M02AA21
suxibuzone,M02AA22
indometacin,M02AA23
nifenazone,M02AA24
aceclofenac,M02AA25
nimesulide,M02AA26
dexketoprofen,M02AA27
piketoprofen,M02AA28
esflurbiprofen,M02AA29
muscle relaxants,M03
"muscle relaxants, peripherally acting agents",M03A
choline derivatives,M03AB
suxamethonium,M03AB01
other quaternary ammonium compounds,M03AC
pancuronium,M03AC01
gallamine,M03AC02
vecuronium,M03AC03
atracurium,M03AC04
hexafluronium,M03AC05
pipecuronium bromide,M03AC06
doxacurium chloride,M03AC07
fazadinium bromide,M03AC08
rocuronium bromide,M03AC09
mivacurium chloride,M03AC10
cisatracurium,M03AC11
"other muscle relaxants, peripherally acting agents",M03AX
botulinum toxin,M03AX01
"muscle relaxants, centrally acting agents",M03B
carbamic acid esters,M03BA
phenprobamate,M03BA01
carisoprodol,M03BA02
methocarbamol,M03BA03
styramate,M03BA04
febarbamate,M03BA05
"phenprobamate, combinations excl. psycholeptics",M03BA51
"carisoprodol, combinations excl. psycholeptics",M03BA52
"methocarbamol, combinations excl. psycholeptics",M03BA53
"phenprobamate, combinations with psycholeptics",M03BA71
"carisoprodol, combinations with psycholeptics",M03BA72
"methocarbamol, combinations with psycholeptics",M03BA73
"oxazol, thiazine, and triazine derivatives",M03BB
chlormezanone,M03BB02
chlorzoxazone,M03BB03
"chlormezanone, combinations excl. psycholeptics",M03BB52
"chlorzoxazone, combinations excl. psycholeptics",M03BB53
"chlormezanone, combinations with psycholeptics",M03BB72
"chlorzoxazone, combinations with psycholeptics",M03BB73
"ethers, chemically close to antihistamines",M03BC
orphenadrine (citrate),M03BC01
"orphenadrine, combinations",M03BC51
other centrally acting agents,M03BX
baclofen,M03BX01
tizanidine,M03BX02
pridinol,M03BX03
tolperisone,M03BX04
thiocolchicoside,M03BX05
mephenesin,M03BX06
tetrazepam,M03BX07
cyclobenzaprine,M03BX08
eperisone,M03BX09
fenyramidol,M03BX30
"thiocolchicoside, combinations",M03BX55
"muscle relaxants, directly acting agents",M03C
dantrolene and derivatives,M03CA
dantrolene,M03CA01
curare alkaloids,M03AA
alcuronium,M03AA01
tubocurarine,M03AA02
dimethyltubocurarine,M03AA04
antigout preparations,M04
antigout preparations,M04A
preparations increasing uric acid excretion,M04AB
probenecid,M04AB01
sulfinpyrazone,M04AB02
benzbromarone,M04AB03
isobromindione,M04AB04
lesinurad,M04AB05
preparations with no effect on uric acid metabolism,M04AC
colchicine,M04AC01
cinchophen,M04AC02
other antigout preparations,M04AX
urate oxidase,M04AX01
pegloticase,M04AX02
preparations inhibiting uric acid production,M04AA
allopurinol,M04AA01
tisopurine,M04AA02
febuxostat,M04AA03
"allopurinol, combinations",M04AA51
drugs for treatment of bone diseases,M05
drugs affecting bone structure and mineralization,M05B
bisphosphonates,M05BA
etidronic acid,M05BA01
clodronic acid,M05BA02
pamidronic acid,M05BA03
alendronic acid,M05BA04
tiludronic acid,M05BA05
ibandronic acid,M05BA06
risedronic acid,M05BA07
zoledronic acid,M05BA08
"bisphosphonates, combinations",M05BB
"etidronic acid and calcium, sequential",M05BB01
"risedronic acid and calcium, sequential",M05BB02
alendronic acid and colecalciferol,M05BB03
"risedronic acid, calcium and colecalciferol, sequential",M05BB04
"alendronic acid, calcium and colecalciferol, sequential",M05BB05
"alendronic acid and alfacalcidol, sequential",M05BB06
risedronic acid and colecalciferol,M05BB07
"zoledronic acid, calcium and colecalciferol, sequential",M05BB08
ibandronic acid and colecalciferol,M05BB09
bone morphogenetic proteins,M05BC
dibotermin alfa,M05BC01
eptotermin alfa,M05BC02
other drugs affecting bone structure and mineralization,M05BX
ipriflavone,M05BX01
aluminium chlorohydrate,M05BX02
strontium ranelate,M05BX03
denosumab,M05BX04
burosumab,M05BX05
romosozumab,M05BX06
strontium ranelate and colecalciferol,M05BX53
other drugs for disorders of the musculo-skeletal system,M09
other drugs for disorders of the musculo-skeletal system,M09A
enzymes,M09AB
chymopapain,M09AB01
collagenase clostridium histolyticum,M09AB02
bromelains,M09AB03
"trypsin, combinations",M09AB52
other drugs for disorders of the musculo-skeletal system,M09AX
hyaluronic acid,M09AX01
"chondrocytes, autologous",M09AX02
ataluren,M09AX03
drisapersen,M09AX04
aceneuramic acid,M09AX05
eteplirsen,M09AX06
nusinersen,M09AX07
golodirsen,M09AX08
onasemnogene abeparvovec,M09AX09
risdiplam,M09AX10
palovarotene,M09AX11
quinine and derivatives,M09AA
hydroquinine,M09AA01
"quinine, combinations with psycholeptics",M09AA72
nervous system,N
anesthetics,N01
"anesthetics, general",N01A
halogenated hydrocarbons,N01AB
halothane,N01AB01
chloroform,N01AB02
enflurane,N01AB04
trichloroethylene,N01AB05
isoflurane,N01AB06
desflurane,N01AB07
sevoflurane,N01AB08
"barbiturates, plain",N01AF
methohexital,N01AF01
hexobarbital,N01AF02
thiopental,N01AF03
barbiturates in combination with other drugs,N01AG
narcobarbital,N01AG01
opioid anesthetics,N01AH
fentanyl,N01AH01
alfentanil,N01AH02
sufentanil,N01AH03
phenoperidine,N01AH04
anileridine,N01AH05
remifentanil,N01AH06
"fentanyl, combinations",N01AH51
other general anesthetics,N01AX
ketamine,N01AX03
propanidid,N01AX04
alfaxalone,N01AX05
etomidate,N01AX07
propofol,N01AX10
sodium oxybate,N01AX11
nitrous oxide,N01AX13
esketamine,N01AX14
xenon,N01AX15
"nitrous oxide, combinations",N01AX63
"anesthetics, local",N01B
esters of aminobenzoic acid,N01BA
metabutethamine,N01BA01
procaine,N01BA02
tetracaine,N01BA03
chloroprocaine,N01BA04
benzocaine,N01BA05
"procaine, combinations",N01BA52
"tetracaine, combinations",N01BA53
amides,N01BB
bupivacaine,N01BB01
lidocaine,N01BB02
mepivacaine,N01BB03
prilocaine,N01BB04
butanilicaine,N01BB05
cinchocaine,N01BB06
etidocaine,N01BB07
articaine,N01BB08
ropivacaine,N01BB09
levobupivacaine,N01BB10
combinations,N01BB20
"bupivacaine, combinations",N01BB51
"lidocaine, combinations",N01BB52
"mepivacaine, combinations",N01BB53
"prilocaine, combinations",N01BB54
"etidocaine, combinations",N01BB57
"articaine, combinations",N01BB58
bupivacaine and meloxicam,N01BB59
esters of benzoic acid,N01BC
cocaine,N01BC01
other local anesthetics,N01BX
ethyl chloride,N01BX01
dyclonine,N01BX02
phenol,N01BX03
capsaicin,N01BX04
ethers,N01AA
diethyl ether,N01AA01
vinyl ether,N01AA02
analgesics,N02
opioids,N02A
phenylpiperidine derivatives,N02AB
ketobemidone,N02AB01
pethidine,N02AB02
fentanyl,N02AB03
"pethidine, combinations excl. psycholeptics",N02AB52
"pethidine, combinations with psycholeptics",N02AB72
diphenylpropylamine derivatives,N02AC
dextromoramide,N02AC01
piritramide,N02AC03
dextropropoxyphene,N02AC04
bezitramide,N02AC05
"methadone, combinations excl. psycholeptics",N02AC52
"dextropropoxyphene, combinations excl. psycholeptics",N02AC54
"dextropropoxyphene, combinations with psycholeptics",N02AC74
benzomorphan derivatives,N02AD
pentazocine,N02AD01
phenazocine,N02AD02
oripavine derivatives,N02AE
buprenorphine,N02AE01
morphinan derivatives,N02AF
butorphanol,N02AF01
nalbuphine,N02AF02
opioids in combination with antispasmodics,N02AG
morphine and antispasmodics,N02AG01
ketobemidone and antispasmodics,N02AG02
pethidine and antispasmodics,N02AG03
hydromorphone and antispasmodics,N02AG04
opioids in combination with non-opioid analgesics,N02AJ
dihydrocodeine and paracetamol,N02AJ01
dihydrocodeine and acetylsalicylic acid,N02AJ02
dihydrocodeine and other non-opioid analgesics,N02AJ03
codeine and paracetamol,N02AJ06
codeine and acetylsalicylic acid,N02AJ07
codeine and ibuprofen,N02AJ08
codeine and other non-opioid analgesics,N02AJ09
tramadol and paracetamol,N02AJ13
tramadol and dexketoprofen,N02AJ14
tramadol and other non-opioid analgesics,N02AJ15
oxycodone and paracetamol,N02AJ17
oxycodone and acetylsalicylic acid,N02AJ18
oxycodone and ibuprofen,N02AJ19
other opioids,N02AX
tilidine,N02AX01
tramadol,N02AX02
dezocine,N02AX03
meptazinol,N02AX05
tapentadol,N02AX06
other analgesics and antipyretics,N02B
salicylic acid and derivatives,N02BA
acetylsalicylic acid,N02BA01
aloxiprin,N02BA02
choline salicylate,N02BA03
sodium salicylate,N02BA04
salicylamide,N02BA05
salsalate,N02BA06
ethenzamide,N02BA07
morpholine salicylate,N02BA08
dipyrocetyl,N02BA09
benorilate,N02BA10
diflunisal,N02BA11
potassium salicylate,N02BA12
guacetisal,N02BA14
carbasalate calcium,N02BA15
imidazole salicylate,N02BA16
"acetylsalicylic acid, combinations excl. psycholeptics",N02BA51
"salicylamide, combinations excl. psycholeptics",N02BA55
"ethenzamide, combinations excl. psycholeptics",N02BA57
"dipyrocetyl, combinations excl. psycholeptics",N02BA59
carbasalate calcium combinations excl. psycholeptics,N02BA65
"acetylsalicylic acid, combinations with psycholeptics",N02BA71
"salicylamide, combinations with psycholeptics",N02BA75
"ethenzamide, combinations with psycholeptics",N02BA77
"dipyrocetyl, combinations with psycholeptics",N02BA79
pyrazolones,N02BB
phenazone,N02BB01
metamizole sodium,N02BB02
aminophenazone,N02BB03
propyphenazone,N02BB04
nifenazone,N02BB05
"phenazone, combinations excl. psycholeptics",N02BB51
"metamizole sodium, combinations excl. psycholeptics",N02BB52
"aminophenazone, combinations excl. psycholeptics",N02BB53
"propyphenazone, combinations excl. psycholeptics",N02BB54
"phenazone, combinations with psycholeptics",N02BB71
"metamizole sodium, combinations with psycholeptics",N02BB72
"aminophenazone, combinations with psycholeptics",N02BB73
"propyphenazone, combinations with psycholeptics",N02BB74
anilides,N02BE
paracetamol,N02BE01
phenacetin,N02BE03
bucetin,N02BE04
propacetamol,N02BE05
"paracetamol, combinations excl. psycholeptics",N02BE51
"phenacetin, combinations excl. psycholeptics",N02BE53
"bucetin, combinations excl. psycholeptics",N02BE54
"paracetamol, combinations with psycholeptics",N02BE71
"phenacetin, combinations with psycholeptics",N02BE73
"bucetin, combinations with psycholeptics",N02BE74
other analgesics and antipyretics,N02BG
rimazolium,N02BG02
glafenine,N02BG03
floctafenine,N02BG04
viminol,N02BG05
nefopam,N02BG06
flupirtine,N02BG07
ziconotide,N02BG08
methoxyflurane,N02BG09
cannabinoids,N02BG10
mirogabalin,N02BG11
antimigraine preparations,N02C
ergot alkaloids,N02CA
dihydroergotamine,N02CA01
ergotamine,N02CA02
methysergide,N02CA04
lisuride,N02CA07
"dihydroergotamine, combinations",N02CA51
"ergotamine, combinations excl. psycholeptics",N02CA52
"ergotamine, combinations with psycholeptics",N02CA72
corticosteroid derivatives,N02CB
flumedroxone,N02CB01
selective serotonin (5ht<n>1</n>) agonists,N02CC
sumatriptan,N02CC01
naratriptan,N02CC02
zolmitriptan,N02CC03
rizatriptan,N02CC04
almotriptan,N02CC05
eletriptan,N02CC06
frovatriptan,N02CC07
calcitonin gene-related peptide (cgrp) antagonists,N02CD
erenumab,N02CD01
galcanezumab,N02CD02
fremanezumab,N02CD03
other antimigraine preparations,N02CX
pizotifen,N02CX01
clonidine,N02CX02
iprazochrome,N02CX03
dimetotiazine,N02CX05
oxetorone,N02CX06
natural opium alkaloids,N02AA
morphine,N02AA01
opium,N02AA02
hydromorphone,N02AA03
nicomorphine,N02AA04
oxycodone,N02AA05
dihydrocodeine,N02AA08
papaveretum,N02AA10
oxymorphone,N02AA11
"morphine, combinations",N02AA51
hydromorphone and naloxone,N02AA53
oxycodone and naloxone,N02AA55
oxycodone and naltrexone,N02AA56
"dihydrocodeine, combinations",N02AA58
"codeine, combinations excl. psycholeptics",N02AA59
"codeine, combinations with psycholeptics",N02AA79
antiepileptics,N03
antiepileptics,N03A
hydantoin derivatives,N03AB
ethotoin,N03AB01
phenytoin,N03AB02
amino(diphenylhydantoin) valeric acid,N03AB03
mephenytoin,N03AB04
fosphenytoin,N03AB05
"phenytoin, combinations",N03AB52
"mephenytoin, combinations",N03AB54
oxazolidine derivatives,N03AC
paramethadione,N03AC01
trimethadione,N03AC02
ethadione,N03AC03
succinimide derivatives,N03AD
ethosuximide,N03AD01
phensuximide,N03AD02
mesuximide,N03AD03
"ethosuximide, combinations",N03AD51
benzodiazepine derivatives,N03AE
clonazepam,N03AE01
carboxamide derivatives,N03AF
carbamazepine,N03AF01
oxcarbazepine,N03AF02
rufinamide,N03AF03
eslicarbazepine,N03AF04
fatty acid derivatives,N03AG
valproic acid,N03AG01
valpromide,N03AG02
aminobutyric acid,N03AG03
vigabatrin,N03AG04
progabide,N03AG05
tiagabine,N03AG06
other antiepileptics,N03AX
sultiame,N03AX03
phenacemide,N03AX07
lamotrigine,N03AX09
felbamate,N03AX10
topiramate,N03AX11
gabapentin,N03AX12
pheneturide,N03AX13
levetiracetam,N03AX14
zonisamide,N03AX15
pregabalin,N03AX16
stiripentol,N03AX17
lacosamide,N03AX18
carisbamate,N03AX19
retigabine,N03AX21
perampanel,N03AX22
brivaracetam,N03AX23
cannabidiol,N03AX24
cenobamate,N03AX25
fenfluramine,N03AX26
beclamide,N03AX30
barbiturates and derivatives,N03AA
methylphenobarbital,N03AA01
phenobarbital,N03AA02
primidone,N03AA03
barbexaclone,N03AA04
metharbital,N03AA30
anti-parkinson drugs,N04
anticholinergic agents,N04A
ethers chemically close to antihistamines,N04AB
etanautine,N04AB01
orphenadrine (chloride),N04AB02
ethers of tropine or tropine derivatives,N04AC
benzatropine,N04AC01
etybenzatropine,N04AC30
dopaminergic agents,N04B
dopa and dopa derivatives,N04BA
levodopa,N04BA01
levodopa and decarboxylase inhibitor,N04BA02
"levodopa, decarboxylase inhibitor and comt inhibitor",N04BA03
melevodopa,N04BA04
melevodopa and decarboxylase inhibitor,N04BA05
etilevodopa and decarboxylase inhibitor,N04BA06
adamantane derivatives,N04BB
amantadine,N04BB01
dopamine agonists,N04BC
bromocriptine,N04BC01
pergolide,N04BC02
dihydroergocryptine mesylate,N04BC03
ropinirole,N04BC04
pramipexole,N04BC05
cabergoline,N04BC06
apomorphine,N04BC07
piribedil,N04BC08
rotigotine,N04BC09
monoamine oxidase b inhibitors,N04BD
selegiline,N04BD01
rasagiline,N04BD02
safinamide,N04BD03
other dopaminergic agents,N04BX
tolcapone,N04BX01
entacapone,N04BX02
budipine,N04BX03
opicapone,N04BX04
other antiparkinson drugs,N04C
other antiparkinson drugs,N04CX
istradefylline,N04CX01
tertiary amines,N04AA
trihexyphenidyl,N04AA01
biperiden,N04AA02
metixene,N04AA03
procyclidine,N04AA04
profenamine,N04AA05
dexetimide,N04AA08
phenglutarimide,N04AA09
mazaticol,N04AA10
bornaprine,N04AA11
tropatepine,N04AA12
psycholeptics,N05
antipsychotics,N05A
phenothiazines with piperazine structure,N05AB
dixyrazine,N05AB01
fluphenazine,N05AB02
perphenazine,N05AB03
prochlorperazine,N05AB04
thiopropazate,N05AB05
trifluoperazine,N05AB06
acetophenazine,N05AB07
thioproperazine,N05AB08
butaperazine,N05AB09
perazine,N05AB10
phenothiazines with piperidine structure,N05AC
periciazine,N05AC01
thioridazine,N05AC02
mesoridazine,N05AC03
pipotiazine,N05AC04
butyrophenone derivatives,N05AD
haloperidol,N05AD01
trifluperidol,N05AD02
melperone,N05AD03
moperone,N05AD04
pipamperone,N05AD05
bromperidol,N05AD06
benperidol,N05AD07
droperidol,N05AD08
fluanisone,N05AD09
indole derivatives,N05AE
oxypertine,N05AE01
molindone,N05AE02
sertindole,N05AE03
ziprasidone,N05AE04
lurasidone,N05AE05
thioxanthene derivatives,N05AF
flupentixol,N05AF01
clopenthixol,N05AF02
chlorprothixene,N05AF03
tiotixene,N05AF04
zuclopenthixol,N05AF05
diphenylbutylpiperidine derivatives,N05AG
fluspirilene,N05AG01
pimozide,N05AG02
penfluridol,N05AG03
"diazepines, oxazepines, thiazepines and oxepines",N05AH
loxapine,N05AH01
clozapine,N05AH02
olanzapine,N05AH03
quetiapine,N05AH04
asenapine,N05AH05
clotiapine,N05AH06
benzamides,N05AL
sulpiride,N05AL01
sultopride,N05AL02
tiapride,N05AL03
remoxipride,N05AL04
amisulpride,N05AL05
veralipride,N05AL06
levosulpiride,N05AL07
lithium,N05AN
lithium,N05AN01
other antipsychotics,N05AX
prothipendyl,N05AX07
risperidone,N05AX08
mosapramine,N05AX10
zotepine,N05AX11
aripiprazole,N05AX12
paliperidone,N05AX13
iloperidone,N05AX14
cariprazine,N05AX15
brexpiprazole,N05AX16
pimavanserin,N05AX17
anxiolytics,N05B
benzodiazepine derivatives,N05BA
diazepam,N05BA01
chlordiazepoxide,N05BA02
medazepam,N05BA03
oxazepam,N05BA04
potassium clorazepate,N05BA05
lorazepam,N05BA06
adinazolam,N05BA07
bromazepam,N05BA08
clobazam,N05BA09
ketazolam,N05BA10
prazepam,N05BA11
alprazolam,N05BA12
halazepam,N05BA13
pinazepam,N05BA14
camazepam,N05BA15
nordazepam,N05BA16
fludiazepam,N05BA17
ethyl loflazepate,N05BA18
etizolam,N05BA19
clotiazepam,N05BA21
cloxazolam,N05BA22
tofisopam,N05BA23
bentazepam,N05BA24
"lorazepam, combinations",N05BA56
diphenylmethane derivatives,N05BB
hydroxyzine,N05BB01
captodiame,N05BB02
"hydroxyzine, combinations",N05BB51
carbamates,N05BC
meprobamate,N05BC01
emylcamate,N05BC03
mebutamate,N05BC04
"meprobamate, combinations",N05BC51
dibenzo-bicyclo-octadiene derivatives,N05BD
benzoctamine,N05BD01
azaspirodecanedione derivatives,N05BE
buspirone,N05BE01
other anxiolytics,N05BX
mephenoxalone,N05BX01
gedocarnil,N05BX02
etifoxine,N05BX03
fabomotizole,N05BX04
lavandulae aetheroleum,N05BX05
hypnotics and sedatives,N05C
"barbiturates, plain",N05CA
pentobarbital,N05CA01
amobarbital,N05CA02
butobarbital,N05CA03
barbital,N05CA04
aprobarbital,N05CA05
secobarbital,N05CA06
talbutal,N05CA07
vinylbital,N05CA08
vinbarbital,N05CA09
cyclobarbital,N05CA10
heptabarbital,N05CA11
reposal,N05CA12
methohexital,N05CA15
hexobarbital,N05CA16
thiopental,N05CA19
etallobarbital,N05CA20
allobarbital,N05CA21
proxibarbal,N05CA22
"barbiturates, combinations",N05CB
combinations of barbiturates,N05CB01
barbiturates in combination with other drugs,N05CB02
aldehydes and derivatives,N05CC
chloral hydrate,N05CC01
chloralodol,N05CC02
acetylglycinamide chloral hydrate,N05CC03
dichloralphenazone,N05CC04
paraldehyde,N05CC05
benzodiazepine derivatives,N05CD
flurazepam,N05CD01
nitrazepam,N05CD02
flunitrazepam,N05CD03
estazolam,N05CD04
triazolam,N05CD05
lormetazepam,N05CD06
temazepam,N05CD07
midazolam,N05CD08
brotizolam,N05CD09
quazepam,N05CD10
loprazolam,N05CD11
doxefazepam,N05CD12
cinolazepam,N05CD13
remimazolam,N05CD14
nimetazepam,N05CD15
piperidinedione derivatives,N05CE
glutethimide,N05CE01
methyprylon,N05CE02
pyrithyldione,N05CE03
benzodiazepine related drugs,N05CF
zopiclone,N05CF01
zolpidem,N05CF02
zaleplon,N05CF03
eszopiclone,N05CF04
melatonin receptor agonists,N05CH
melatonin,N05CH01
ramelteon,N05CH02
tasimelteon,N05CH03
other hypnotics and sedatives,N05CM
methaqualone,N05CM01
clomethiazole,N05CM02
bromisoval,N05CM03
carbromal,N05CM04
scopolamine,N05CM05
propiomazine,N05CM06
triclofos,N05CM07
ethchlorvynol,N05CM08
valerianae radix,N05CM09
hexapropymate,N05CM10
bromides,N05CM11
apronal,N05CM12
valnoctamide,N05CM13
methylpentynol,N05CM15
niaprazine,N05CM16
dexmedetomidine,N05CM18
suvorexant,N05CM19
"hypnotics and sedatives in combination, excl. barbiturates",N05CX
"meprobamate, combinations",N05CX01
"methaqualone, combinations",N05CX02
"methylpentynol, combinations",N05CX03
"clomethiazole, combinations",N05CX04
"emepronium, combinations",N05CX05
"dipiperonylaminoethanol, combinations",N05CX06
phenothiazines with aliphatic side-chain,N05AA
chlorpromazine,N05AA01
levomepromazine,N05AA02
promazine,N05AA03
acepromazine,N05AA04
triflupromazine,N05AA05
cyamemazine,N05AA06
chlorproethazine,N05AA07
psychoanaleptics,N06
antidepressants,N06A
selective serotonin reuptake inhibitors,N06AB
zimeldine,N06AB02
fluoxetine,N06AB03
citalopram,N06AB04
paroxetine,N06AB05
sertraline,N06AB06
alaproclate,N06AB07
fluvoxamine,N06AB08
etoperidone,N06AB09
escitalopram,N06AB10
"monoamine oxidase inhibitors, non-selective",N06AF
isocarboxazid,N06AF01
nialamide,N06AF02
phenelzine,N06AF03
tranylcypromine,N06AF04
iproniazide,N06AF05
iproclozide,N06AF06
monoamine oxidase a inhibitors,N06AG
moclobemide,N06AG02
toloxatone,N06AG03
other antidepressants,N06AX
oxitriptan,N06AX01
tryptophan,N06AX02
mianserin,N06AX03
nomifensine,N06AX04
trazodone,N06AX05
nefazodone,N06AX06
minaprine,N06AX07
bifemelane,N06AX08
viloxazine,N06AX09
oxaflozane,N06AX10
mirtazapine,N06AX11
bupropion,N06AX12
medifoxamine,N06AX13
tianeptine,N06AX14
pivagabine,N06AX15
venlafaxine,N06AX16
milnacipran,N06AX17
reboxetine,N06AX18
gepirone,N06AX19
duloxetine,N06AX21
agomelatine,N06AX22
desvenlafaxine,N06AX23
vilazodone,N06AX24
hyperici herba,N06AX25
vortioxetine,N06AX26
esketamine,N06AX27
"psychostimulants, agents used for adhd and nootropics",N06B
centrally acting sympathomimetics,N06BA
amfetamine,N06BA01
dexamfetamine,N06BA02
metamfetamine,N06BA03
methylphenidate,N06BA04
pemoline,N06BA05
fencamfamin,N06BA06
modafinil,N06BA07
fenozolone,N06BA08
atomoxetine,N06BA09
fenetylline,N06BA10
dexmethylphenidate,N06BA11
lisdexamfetamine,N06BA12
armodafinil,N06BA13
solriamfetol,N06BA14
xanthine derivatives,N06BC
caffeine,N06BC01
propentofylline,N06BC02
other psychostimulants and nootropics,N06BX
meclofenoxate,N06BX01
pyritinol,N06BX02
piracetam,N06BX03
deanol,N06BX04
fipexide,N06BX05
citicoline,N06BX06
oxiracetam,N06BX07
pirisudanol,N06BX08
linopirdine,N06BX09
nizofenone,N06BX10
aniracetam,N06BX11
acetylcarnitine,N06BX12
idebenone,N06BX13
prolintane,N06BX14
pipradrol,N06BX15
pramiracetam,N06BX16
adrafinil,N06BX17
vinpocetine,N06BX18
tetramethylglycoluril,N06BX21
phenibut,N06BX22
psycholeptics and psychoanaleptics in combination,N06C
antidepressants in combination with psycholeptics,N06CA
amitriptyline and psycholeptics,N06CA01
melitracen and psycholeptics,N06CA02
fluoxetine and psycholeptics,N06CA03
psychostimulants in combination with psycholeptics,N06CB
anti-dementia drugs,N06D
anticholinesterases,N06DA
tacrine,N06DA01
donepezil,N06DA02
rivastigmine,N06DA03
galantamine,N06DA04
ipidacrine,N06DA05
donepezil and memantine,N06DA52
"donepezil, memantine and ginkgo folium",N06DA53
other anti-dementia drugs,N06DX
memantine,N06DX01
ginkgo folium,N06DX02
combinations,N06DX30
non-selective monoamine reuptake inhibitors,N06AA
desipramine,N06AA01
imipramine,N06AA02
imipramine oxide,N06AA03
clomipramine,N06AA04
opipramol,N06AA05
trimipramine,N06AA06
lofepramine,N06AA07
dibenzepin,N06AA08
amitriptyline,N06AA09
nortriptyline,N06AA10
protriptyline,N06AA11
doxepin,N06AA12
iprindole,N06AA13
melitracen,N06AA14
butriptyline,N06AA15
dosulepin,N06AA16
amoxapine,N06AA17
dimetacrine,N06AA18
amineptine,N06AA19
maprotiline,N06AA21
quinupramine,N06AA23
other nervous system drugs,N07
parasympathomimetics,N07A
choline esters,N07AB
carbachol,N07AB01
bethanechol,N07AB02
other parasympathomimetics,N07AX
pilocarpine,N07AX01
choline alfoscerate,N07AX02
cevimeline,N07AX03
drugs used in addictive disorders,N07B
drugs used in nicotine dependence,N07BA
nicotine,N07BA01
varenicline,N07BA03
cytisine,N07BA04
drugs used in alcohol dependence,N07BB
disulfiram,N07BB01
calcium carbimide,N07BB02
acamprosate,N07BB03
naltrexone,N07BB04
nalmefene,N07BB05
drugs used in opioid dependence,N07BC
buprenorphine,N07BC01
methadone,N07BC02
levacetylmethadol,N07BC03
lofexidine,N07BC04
levomethadone,N07BC05
diamorphine,N07BC06
"buprenorphine, combinations",N07BC51
antivertigo preparations,N07C
antivertigo preparations,N07CA
betahistine,N07CA01
cinnarizine,N07CA02
flunarizine,N07CA03
acetylleucine,N07CA04
"cinnarizine, combinations",N07CA52
other nervous system drugs,N07X
gangliosides and ganglioside derivatives,N07XA
other nervous system drugs,N07XX
tirilazad,N07XX01
riluzole,N07XX02
xaliproden,N07XX03
sodium oxybate,N07XX04
amifampridine,N07XX05
tetrabenazine,N07XX06
fampridine,N07XX07
tafamidis,N07XX08
laquinimod,N07XX10
pitolisant,N07XX11
patisiran,N07XX12
valbenazine,N07XX13
edaravone,N07XX14
inotersen,N07XX15
"dextromethorphan, combinations",N07XX59
anticholinesterases,N07AA
neostigmine,N07AA01
pyridostigmine,N07AA02
distigmine,N07AA03
ambenonium,N07AA30
"neostigmine, combinations",N07AA51
"antiparasitic products, insecticides and repellents",P
antiprotozoals,P01
agents against amoebiasis and other protozoal diseases,P01A
nitroimidazole derivatives,P01AB
metronidazole,P01AB01
tinidazole,P01AB02
ornidazole,P01AB03
azanidazole,P01AB04
propenidazole,P01AB05
nimorazole,P01AB06
secnidazole,P01AB07
"metronidazole, combinations",P01AB51
dichloroacetamide derivatives,P01AC
diloxanide,P01AC01
clefamide,P01AC02
etofamide,P01AC03
teclozan,P01AC04
arsenic compounds,P01AR
arsthinol,P01AR01
difetarsone,P01AR02
glycobiarsol,P01AR03
"glycobiarsol, combinations",P01AR53
other agents against amoebiasis and other protozoal diseases,P01AX
chiniofon,P01AX01
emetine,P01AX02
phanquinone,P01AX04
mepacrine,P01AX05
atovaquone,P01AX06
trimetrexate,P01AX07
tenonitrozole,P01AX08
dehydroemetine,P01AX09
fumagillin,P01AX10
nitazoxanide,P01AX11
"emetine, combinations",P01AX52
antimalarials,P01B
aminoquinolines,P01BA
chloroquine,P01BA01
hydroxychloroquine,P01BA02
primaquine,P01BA03
amodiaquine,P01BA06
tafenoquine,P01BA07
biguanides,P01BB
proguanil,P01BB01
cycloguanil embonate,P01BB02
"proguanil, combinations",P01BB51
methanolquinolines,P01BC
quinine,P01BC01
mefloquine,P01BC02
diaminopyrimidines,P01BD
pyrimethamine,P01BD01
"pyrimethamine, combinations",P01BD51
"artemisinin and derivatives, plain",P01BE
artemisinin,P01BE01
artemether,P01BE02
artesunate,P01BE03
artemotil,P01BE04
artenimol,P01BE05
"artemisinin and derivatives, combinations",P01BF
artemether and lumefantrine,P01BF01
artesunate and mefloquine,P01BF02
artesunate and amodiaquine,P01BF03
"artesunate, sulfalene and pyrimethamine",P01BF04
artenimol and piperaquine,P01BF05
artesunate and pyronaridine,P01BF06
other antimalarials,P01BX
halofantrine,P01BX01
arterolane and piperaquine,P01BX02
agents against leishmaniasis and trypanosomiasis,P01C
nitroimidazole derivatives,P01CA
benznidazole,P01CA02
fexinidazole,P01CA03
antimony compounds,P01CB
meglumine antimonate,P01CB01
sodium stibogluconate,P01CB02
nitrofuran derivatives,P01CC
nifurtimox,P01CC01
nitrofural,P01CC02
arsenic compounds,P01CD
melarsoprol,P01CD01
acetarsol,P01CD02
other agents against leishmaniasis and trypanosomiasis,P01CX
pentamidine isethionate,P01CX01
suramin sodium,P01CX02
eflornithine,P01CX03
miltefosine,P01CX04
hydroxyquinoline derivatives,P01AA
broxyquinoline,P01AA01
clioquinol,P01AA02
chlorquinaldol,P01AA04
tilbroquinol,P01AA05
"clioquinol, combinations",P01AA52
anthelmintics,P02
antitrematodals,P02B
quinoline derivatives and related substances,P02BA
praziquantel,P02BA01
oxamniquine,P02BA02
organophosphorous compounds,P02BB
metrifonate,P02BB01
other antitrematodal agents,P02BX
bithionol,P02BX01
niridazole,P02BX02
stibophen,P02BX03
triclabendazole,P02BX04
antinematodal agents,P02C
benzimidazole derivatives,P02CA
mebendazole,P02CA01
tiabendazole,P02CA02
albendazole,P02CA03
ciclobendazole,P02CA04
flubendazole,P02CA05
fenbendazole,P02CA06
"mebendazole, combinations",P02CA51
piperazine and derivatives,P02CB
piperazine,P02CB01
diethylcarbamazine,P02CB02
tetrahydropyrimidine derivatives,P02CC
pyrantel,P02CC01
oxantel,P02CC02
imidazothiazole derivatives,P02CE
levamisole,P02CE01
avermectines,P02CF
ivermectin,P02CF01
other antinematodals,P02CX
pyrvinium,P02CX01
bephenium,P02CX02
moxidectin,P02CX03
anticestodals,P02D
salicylic acid derivatives,P02DA
niclosamide,P02DA01
other anticestodals,P02DX
desaspidin,P02DX01
dichlorophen,P02DX02
"ectoparasiticides, incl. scabicides, insecticides and repellents",P03
"ectoparasiticides, incl. scabicides",P03A
chlorine containing products,P03AB
clofenotane,P03AB01
lindane,P03AB02
"clofenotane, combinations",P03AB51
"pyrethrines, incl. synthetic compounds",P03AC
pyrethrum,P03AC01
bioallethrin,P03AC02
phenothrin,P03AC03
permethrin,P03AC04
"pyrethrum, combinations",P03AC51
"bioallethrin, combinations",P03AC52
"phenothrin, combinations",P03AC53
"permethrin, combinations",P03AC54
"other ectoparasiticides, incl. scabicides",P03AX
benzyl benzoate,P03AX01
copper oleinate,P03AX02
malathion,P03AX03
quassia,P03AX04
dimeticone,P03AX05
benzyl alcohol,P03AX06
insecticides and repellents,P03B
pyrethrines,P03BA
cyfluthrin,P03BA01
cypermethrin,P03BA02
decamethrin,P03BA03
tetramethrin,P03BA04
other insecticides and repellents,P03BX
diethyltoluamide,P03BX01
dimethylphthalate,P03BX02
dibutylphthalate,P03BX03
dibutylsuccinate,P03BX04
dimethylcarbate,P03BX05
etohexadiol,P03BX06
sulfur containing products,P03AA
dixanthogen,P03AA01
potassium polysulfide,P03AA02
mesulfen,P03AA03
disulfiram,P03AA04
thiram,P03AA05
"disulfiram, combinations",P03AA54
respiratory system,R
nasal preparations,R01
decongestants and other nasal preparations for topical use,R01A
"sympathomimetics, combinations excl. corticosteroids",R01AB
phenylephrine,R01AB01
naphazoline,R01AB02
tetryzoline,R01AB03
ephedrine,R01AB05
xylometazoline,R01AB06
oxymetazoline,R01AB07
tuaminoheptane,R01AB08
"antiallergic agents, excl. corticosteroids",R01AC
cromoglicic acid,R01AC01
levocabastine,R01AC02
azelastine,R01AC03
antazoline,R01AC04
spaglumic acid,R01AC05
thonzylamine,R01AC06
nedocromil,R01AC07
olopatadine,R01AC08
"cromoglicic acid, combinations",R01AC51
corticosteroids,R01AD
beclometasone,R01AD01
prednisolone,R01AD02
dexamethasone,R01AD03
flunisolide,R01AD04
budesonide,R01AD05
betamethasone,R01AD06
tixocortol,R01AD07
fluticasone,R01AD08
mometasone,R01AD09
triamcinolone,R01AD11
fluticasone furoate,R01AD12
ciclesonide,R01AD13
"prednisolone, combinations",R01AD52
"dexamethasone, combinations",R01AD53
"tixocortol, combinations",R01AD57
"fluticasone, combinations",R01AD58
"mometasone, combinations",R01AD59
"hydrocortisone, combinations",R01AD60
other nasal preparations,R01AX
calcium hexamine thiocyanate,R01AX01
retinol,R01AX02
ipratropium bromide,R01AX03
ritiometan,R01AX05
mupirocin,R01AX06
hexamidine,R01AX07
framycetin,R01AX08
hyaluronic acid,R01AX09
various,R01AX10
combinations,R01AX30
nasal decongestants for systemic use,R01B
sympathomimetics,R01BA
phenylpropanolamine,R01BA01
pseudoephedrine,R01BA02
phenylephrine,R01BA03
"phenylpropanolamine, combinations",R01BA51
"pseudoephedrine, combinations",R01BA52
"phenylephrine, combinations",R01BA53
"sympathomimetics, plain",R01AA
cyclopentamine,R01AA02
ephedrine,R01AA03
phenylephrine,R01AA04
oxymetazoline,R01AA05
tetryzoline,R01AA06
xylometazoline,R01AA07
naphazoline,R01AA08
tramazoline,R01AA09
metizoline,R01AA10
tuaminoheptane,R01AA11
fenoxazoline,R01AA12
tymazoline,R01AA13
epinephrine,R01AA14
indanazoline,R01AA15
throat preparations,R02
throat preparations,R02A
antibiotics,R02AB
neomycin,R02AB01
tyrothricin,R02AB02
fusafungine,R02AB03
bacitracin,R02AB04
gramicidin,R02AB30
"anesthetics, local",R02AD
benzocaine,R02AD01
lidocaine,R02AD02
cocaine,R02AD03
dyclonine,R02AD04
other throat preparations,R02AX
flurbiprofen,R02AX01
ibuprofen,R02AX02
benzydamine,R02AX03
antiseptics,R02AA
ambazone,R02AA01
dequalinium,R02AA02
dichlorobenzyl alcohol,R02AA03
chlorhexidine,R02AA05
cetylpyridinium,R02AA06
benzethonium,R02AA09
myristyl-benzalkonium,R02AA10
chlorquinaldol,R02AA11
hexylresorcinol,R02AA12
acriflavinium chloride,R02AA13
oxyquinoline,R02AA14
povidone-iodine,R02AA15
benzalkonium,R02AA16
cetrimonium,R02AA17
hexamidine,R02AA18
phenol,R02AA19
various,R02AA20
octenidine,R02AA21
drugs for obstructive airway diseases,R03
"adrenergics, inhalants",R03A
non-selective beta-adrenoreceptor agonists,R03AB
isoprenaline,R03AB02
orciprenaline,R03AB03
selective beta-2-adrenoreceptor agonists,R03AC
salbutamol,R03AC02
terbutaline,R03AC03
fenoterol,R03AC04
rimiterol,R03AC05
hexoprenaline,R03AC06
isoetarine,R03AC07
pirbuterol,R03AC08
tretoquinol,R03AC09
carbuterol,R03AC10
tulobuterol,R03AC11
salmeterol,R03AC12
formoterol,R03AC13
clenbuterol,R03AC14
reproterol,R03AC15
procaterol,R03AC16
bitolterol,R03AC17
indacaterol,R03AC18
olodaterol,R03AC19
combinations of adrenergics,R03AH
"adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics",R03AK
epinephrine and other drugs for obstructive airway diseases,R03AK01
isoprenaline and other drugs for obstructive airway diseases,R03AK02
salbutamol and sodium cromoglicate,R03AK04
reproterol and sodium cromoglicate,R03AK05
salmeterol and fluticasone,R03AK06
formoterol and budesonide,R03AK07
formoterol and beclometasone,R03AK08
formoterol and mometasone,R03AK09
vilanterol and fluticasone furoate,R03AK10
formoterol and fluticasone,R03AK11
salmeterol and budesonide,R03AK12
salbutamol and beclometasone,R03AK13
indacaterol and mometasone,R03AK14
adrenergics in combination with anticholinergics incl. triple combinations with corticosteroids,R03AL
fenoterol and ipratropium bromide,R03AL01
salbutamol and ipratropium bromide,R03AL02
vilanterol and umeclidinium bromide,R03AL03
indacaterol and glycopyrronium bromide,R03AL04
formoterol and aclidinium bromide,R03AL05
olodaterol and tiotropium bromide,R03AL06
formoterol and glycopyrronium bromide,R03AL07
"vilanterol, umeclidinium bromide and fluticasone furoate",R03AL08
"formoterol, glycopyrronium bromide and beclometasone",R03AL09
formoterol and tiotropium bromide,R03AL10
"formoterol, glycopyrronium bromide and budesonide",R03AL11
"indacaterol, glycopyrronium bromide and mometasone",R03AL12
"other drugs for obstructive airway diseases, inhalants",R03B
glucocorticoids,R03BA
beclometasone,R03BA01
budesonide,R03BA02
flunisolide,R03BA03
betamethasone,R03BA04
fluticasone,R03BA05
triamcinolone,R03BA06
mometasone,R03BA07
ciclesonide,R03BA08
fluticasone furoate,R03BA09
anticholinergics,R03BB
ipratropium bromide,R03BB01
oxitropium bromide,R03BB02
stramoni preparations,R03BB03
tiotropium bromide,R03BB04
aclidinium bromide,R03BB05
glycopyrronium bromide,R03BB06
umeclidinium bromide,R03BB07
revefenacin,R03BB08
"tiotropium bromide, combinations",R03BB54
"antiallergic agents, excl. corticosteroids",R03BC
cromoglicic acid,R03BC01
nedocromil,R03BC03
"other drugs for obstructive airway diseases, inhalants",R03BX
fenspiride,R03BX01
adrenergics for systemic use,R03C
alpha- and beta-adrenoreceptor agonists,R03CA
ephedrine,R03CA02
non-selective beta-adrenoreceptor agonists,R03CB
isoprenaline,R03CB01
methoxyphenamine,R03CB02
orciprenaline,R03CB03
"isoprenaline, combinations",R03CB51
"orciprenaline, combinations",R03CB53
selective beta-2-adrenoreceptor agonists,R03CC
salbutamol,R03CC02
terbutaline,R03CC03
fenoterol,R03CC04
hexoprenaline,R03CC05
isoetarine,R03CC06
pirbuterol,R03CC07
procaterol,R03CC08
tretoquinol,R03CC09
carbuterol,R03CC10
tulobuterol,R03CC11
bambuterol,R03CC12
clenbuterol,R03CC13
reproterol,R03CC14
"terbutaline, combinations",R03CC53
clenbuterol and ambroxol,R03CC63
adrenergics and other drugs for obstructive airway diseases,R03CK
other systemic drugs for obstructive airway diseases,R03D
xanthines,R03DA
diprophylline,R03DA01
choline theophyllinate,R03DA02
proxyphylline,R03DA03
theophylline,R03DA04
aminophylline,R03DA05
etamiphylline,R03DA06
theobromine,R03DA07
bamifylline,R03DA08
acefylline piperazine,R03DA09
bufylline,R03DA10
doxofylline,R03DA11
mepyramine theophyllinacetate,R03DA12
combinations of xanthines,R03DA20
"diprophylline, combinations",R03DA51
"theophylline, combinations excl. psycholeptics",R03DA54
"aminophylline, combinations",R03DA55
"theobromine, combinations",R03DA57
"theophylline, combinations with psycholeptics",R03DA74
xanthines and adrenergics,R03DB
diprophylline and adrenergics,R03DB01
choline theophyllinate and adrenergics,R03DB02
proxyphylline and adrenergics,R03DB03
theophylline and adrenergics,R03DB04
aminophylline and adrenergics,R03DB05
etamiphylline and adrenergics,R03DB06
leukotriene receptor antagonists,R03DC
zafirlukast,R03DC01
pranlukast,R03DC02
montelukast,R03DC03
ibudilast,R03DC04
"montelukast, combinations",R03DC53
other systemic drugs for obstructive airway diseases,R03DX
amlexanox,R03DX01
eprozinol,R03DX02
fenspiride,R03DX03
omalizumab,R03DX05
seratrodast,R03DX06
roflumilast,R03DX07
reslizumab,R03DX08
mepolizumab,R03DX09
benralizumab,R03DX10
alpha- and beta-adrenoreceptor agonists,R03AA
epinephrine,R03AA01
cough and cold preparations,R05
"expectorants, excl. combinations with cough suppressants",R05C
expectorants,R05CA
tyloxapol,R05CA01
potassium iodide,R05CA02
guaifenesin,R05CA03
ipecacuanha,R05CA04
althea root,R05CA05
senega,R05CA06
antimony pentasulfide,R05CA07
creosote,R05CA08
guaiacolsulfonate,R05CA09
combinations,R05CA10
levoverbenone,R05CA11
hederae helicis folium,R05CA12
cineole,R05CA13
mucolytics,R05CB
acetylcysteine,R05CB01
bromhexine,R05CB02
carbocisteine,R05CB03
eprazinone,R05CB04
mesna,R05CB05
ambroxol,R05CB06
sobrerol,R05CB07
domiodol,R05CB08
letosteine,R05CB09
combinations,R05CB10
stepronin,R05CB11
dornase alfa (desoxyribonuclease),R05CB13
neltenexine,R05CB14
erdosteine,R05CB15
mannitol,R05CB16
"cough suppressants, excl. combinations with expectorants",R05D
opium alkaloids and derivatives,R05DA
ethylmorphine,R05DA01
hydrocodone,R05DA03
codeine,R05DA04
opium alkaloids with morphine,R05DA05
normethadone,R05DA06
noscapine,R05DA07
pholcodine,R05DA08
dextromethorphan,R05DA09
thebacon,R05DA10
dimemorfan,R05DA11
acetyldihydrocodeine,R05DA12
combinations,R05DA20
other cough suppressants,R05DB
benzonatate,R05DB01
benproperine,R05DB02
clobutinol,R05DB03
isoaminile,R05DB04
pentoxyverine,R05DB05
oxolamine,R05DB07
oxeladin,R05DB09
clofedanol,R05DB10
pipazetate,R05DB11
bibenzonium bromide,R05DB12
butamirate,R05DB13
fedrilate,R05DB14
zipeprol,R05DB15
dibunate,R05DB16
droxypropine,R05DB17
prenoxdiazine,R05DB18
dropropizine,R05DB19
combinations,R05DB20
cloperastine,R05DB21
meprotixol,R05DB22
piperidione,R05DB23
tipepidine,R05DB24
morclofone,R05DB25
nepinalone,R05DB26
levodropropizine,R05DB27
dimethoxanate,R05DB28
"cough suppressants and expectorants, combinations",R05F
opium derivatives and expectorants,R05FA
opium derivatives and mucolytics,R05FA01
opium derivatives and expectorants,R05FA02
other cough suppressants and expectorants,R05FB
cough suppressants and mucolytics,R05FB01
cough suppressants and expectorants,R05FB02
other cold preparations,R05X
antihistamines for systemic use,R06
antihistamines for systemic use,R06A
substituted alkylamines,R06AB
brompheniramine,R06AB01
dexchlorpheniramine,R06AB02
dimetindene,R06AB03
chlorphenamine,R06AB04
pheniramine,R06AB05
dexbrompheniramine,R06AB06
talastine,R06AB07
"brompheniramine, combinations",R06AB51
"dexchlorpheniramine, combinations",R06AB52
"chlorphenamine, combinations",R06AB54
"dexbrompheniramine, combinations",R06AB56
substituted ethylene diamines,R06AC
mepyramine,R06AC01
histapyrrodine,R06AC02
chloropyramine,R06AC03
tripelennamine,R06AC04
methapyrilene,R06AC05
thonzylamine,R06AC06
"histapyrrodine, combinations",R06AC52
"chloropyramine, combinations",R06AC53
phenothiazine derivatives,R06AD
alimemazine,R06AD01
promethazine,R06AD02
thiethylperazine,R06AD03
methdilazine,R06AD04
hydroxyethylpromethazine,R06AD05
thiazinam,R06AD06
mequitazine,R06AD07
oxomemazine,R06AD08
isothipendyl,R06AD09
"promethazine, combinations",R06AD52
"hydroxyethylpromethazine, combinations",R06AD55
piperazine derivatives,R06AE
buclizine,R06AE01
cyclizine,R06AE03
chlorcyclizine,R06AE04
meclozine,R06AE05
oxatomide,R06AE06
cetirizine,R06AE07
levocetirizine,R06AE09
"buclizine, combinations",R06AE51
"cyclizine, combinations",R06AE53
"meclozine, combinations",R06AE55
combinations of antihistamines,R06AK
other antihistamines for systemic use,R06AX
bamipine,R06AX01
cyproheptadine,R06AX02
thenalidine,R06AX03
phenindamine,R06AX04
antazoline,R06AX05
triprolidine,R06AX07
pyrrobutamine,R06AX08
azatadine,R06AX09
astemizole,R06AX11
terfenadine,R06AX12
loratadine,R06AX13
mebhydrolin,R06AX15
deptropine,R06AX16
ketotifen,R06AX17
acrivastine,R06AX18
azelastine,R06AX19
tritoqualine,R06AX21
ebastine,R06AX22
pimethixene,R06AX23
epinastine,R06AX24
mizolastine,R06AX25
fexofenadine,R06AX26
desloratadine,R06AX27
rupatadine,R06AX28
bilastine,R06AX29
quifenadine,R06AX31
sequifenadine,R06AX32
"thenalidine, combinations",R06AX53
"pyrrobutamine, combinations",R06AX58
aminoalkyl ethers,R06AA
bromazine,R06AA01
diphenhydramine,R06AA02
clemastine,R06AA04
chlorphenoxamine,R06AA06
diphenylpyraline,R06AA07
carbinoxamine,R06AA08
doxylamine,R06AA09
trimethobenzamide,R06AA10
"diphenhydramine, combinations",R06AA52
"clemastine, combinations",R06AA54
"chlorphenoxamine, combinations",R06AA56
"diphenylpyraline, combinations",R06AA57
"doxylamine, combinations",R06AA59
other respiratory system products,R07
other respiratory system products,R07A
respiratory stimulants,R07AB
doxapram,R07AB01
nikethamide,R07AB02
pentetrazol,R07AB03
etamivan,R07AB04
bemegride,R07AB05
prethcamide,R07AB06
almitrine,R07AB07
dimefline,R07AB08
mepixanox,R07AB09
"nikethamide, combinations",R07AB52
"pentetrazol, combinations",R07AB53
other respiratory system products,R07AX
nitric oxide,R07AX01
ivacaftor,R07AX02
ivacaftor and lumacaftor,R07AX30
ivacaftor and tezacaftor,R07AX31
"ivacaftor, tezacaftor and elexacaftor",R07AX32
lung surfactants,R07AA
colfosceril palmitate,R07AA01
natural phospholipids,R07AA02
combinations,R07AA30
sensory organs,S
ophthalmologicals,S01
antiinfectives,S01A
sulfonamides,S01AB
sulfamethizole,S01AB01
sulfafurazole,S01AB02
sulfadicramide,S01AB03
sulfacetamide,S01AB04
sulfafenazol,S01AB05
antivirals,S01AD
idoxuridine,S01AD01
trifluridine,S01AD02
aciclovir,S01AD03
interferon,S01AD05
vidarabine,S01AD06
famciclovir,S01AD07
fomivirsen,S01AD08
ganciclovir,S01AD09
fluoroquinolones,S01AE
ofloxacin,S01AE01
norfloxacin,S01AE02
ciprofloxacin,S01AE03
lomefloxacin,S01AE04
levofloxacin,S01AE05
gatifloxacin,S01AE06
moxifloxacin,S01AE07
besifloxacin,S01AE08
other antiinfectives,S01AX
mercury compounds,S01AX01
silver compounds,S01AX02
zinc compounds,S01AX03
nitrofural,S01AX04
bibrocathol,S01AX05
resorcinol,S01AX06
sodium borate,S01AX07
hexamidine,S01AX08
chlorhexidine,S01AX09
sodium propionate,S01AX10
dibrompropamidine,S01AX14
propamidine,S01AX15
picloxydine,S01AX16
povidone-iodine,S01AX18
antiinflammatory agents,S01B
"corticosteroids, plain",S01BA
dexamethasone,S01BA01
hydrocortisone,S01BA02
cortisone,S01BA03
prednisolone,S01BA04
triamcinolone,S01BA05
betamethasone,S01BA06
fluorometholone,S01BA07
medrysone,S01BA08
clobetasone,S01BA09
alclometasone,S01BA10
desonide,S01BA11
formocortal,S01BA12
rimexolone,S01BA13
loteprednol,S01BA14
fluocinolone acetonide,S01BA15
corticosteroids and mydriatics in combination,S01BB
hydrocortisone and mydriatics,S01BB01
prednisolone and mydriatics,S01BB02
fluorometholone and mydriatics,S01BB03
betamethasone and mydriatics,S01BB04
"antiinflammatory agents, non-steroids",S01BC
indometacin,S01BC01
oxyphenbutazone,S01BC02
diclofenac,S01BC03
flurbiprofen,S01BC04
ketorolac,S01BC05
piroxicam,S01BC06
bendazac,S01BC07
salicylic acid,S01BC08
pranoprofen,S01BC09
nepafenac,S01BC10
bromfenac,S01BC11
antiinflammatory agents and antiinfectives in combination,S01C
corticosteroids and antiinfectives in combination,S01CA
dexamethasone and antiinfectives,S01CA01
prednisolone and antiinfectives,S01CA02
hydrocortisone and antiinfectives,S01CA03
fluocortolone and antiinfectives,S01CA04
betamethasone and antiinfectives,S01CA05
fludrocortisone and antiinfectives,S01CA06
fluorometholone and antiinfectives,S01CA07
methylprednisolone and antiinfectives,S01CA08
chloroprednisone and antiinfectives,S01CA09
fluocinolone acetonide and antiinfectives,S01CA10
clobetasone and antiinfectives,S01CA11
corticosteroids/antiinfectives/mydriatics in combination,S01CB
dexamethasone,S01CB01
prednisolone,S01CB02
hydrocortisone,S01CB03
betamethasone,S01CB04
fluorometholone,S01CB05
"antiinflammatory agents, non-steroids and antiinfectives in combination",S01CC
diclofenac and antiinfectives,S01CC01
indometacin and antiinfectives,S01CC02
antiglaucoma preparations and miotics,S01E
sympathomimetics in glaucoma therapy,S01EA
epinephrine,S01EA01
dipivefrine,S01EA02
apraclonidine,S01EA03
clonidine,S01EA04
brimonidine,S01EA05
"epinephrine, combinations",S01EA51
parasympathomimetics,S01EB
pilocarpine,S01EB01
carbachol,S01EB02
ecothiopate,S01EB03
demecarium,S01EB04
physostigmine,S01EB05
neostigmine,S01EB06
fluostigmine,S01EB07
aceclidine,S01EB08
acetylcholine,S01EB09
paraoxon,S01EB10
"pilocarpine, combinations",S01EB51
"aceclidine, combinations",S01EB58
carbonic anhydrase inhibitors,S01EC
acetazolamide,S01EC01
diclofenamide,S01EC02
dorzolamide,S01EC03
brinzolamide,S01EC04
methazolamide,S01EC05
"brinzolamide, combinations",S01EC54
beta blocking agents,S01ED
timolol,S01ED01
betaxolol,S01ED02
levobunolol,S01ED03
metipranolol,S01ED04
carteolol,S01ED05
befunolol,S01ED06
"timolol, combinations",S01ED51
"betaxolol, combinations",S01ED52
"metipranolol, combinations",S01ED54
"carteolol, combinations",S01ED55
prostaglandin analogues,S01EE
latanoprost,S01EE01
unoprostone,S01EE02
bimatoprost,S01EE03
travoprost,S01EE04
tafluprost,S01EE05
latanoprostene bunod,S01EE06
latanoprost and netarsudil,S01EE51
other antiglaucoma preparations,S01EX
guanethidine,S01EX01
dapiprazole,S01EX02
netarsudil,S01EX05
omidenepag,S01EX06
mydriatics and cycloplegics,S01F
anticholinergics,S01FA
atropine,S01FA01
scopolamine,S01FA02
methylscopolamine,S01FA03
cyclopentolate,S01FA04
homatropine,S01FA05
tropicamide,S01FA06
"cyclopentolate, combinations",S01FA54
"tropicamide, combinations",S01FA56
sympathomimetics excl. antiglaucoma preparations,S01FB
phenylephrine,S01FB01
ephedrine,S01FB02
ibopamine,S01FB03
phenylephrine and ketorolac,S01FB51
decongestants and antiallergics,S01G
sympathomimetics used as decongestants,S01GA
naphazoline,S01GA01
tetryzoline,S01GA02
xylometazoline,S01GA03
oxymetazoline,S01GA04
phenylephrine,S01GA05
oxedrine,S01GA06
brimonidine,S01GA07
"naphazoline, combinations",S01GA51
"tetryzoline, combinations",S01GA52
"xylometazoline, combinations",S01GA53
"phenylephrine, combinations",S01GA55
"oxedrine, combinations",S01GA56
other antiallergics,S01GX
cromoglicic acid,S01GX01
levocabastine,S01GX02
spaglumic acid,S01GX03
nedocromil,S01GX04
lodoxamide,S01GX05
emedastine,S01GX06
azelastine,S01GX07
ketotifen,S01GX08
olopatadine,S01GX09
epinastine,S01GX10
alcaftadine,S01GX11
"cromoglicic acid, combinations",S01GX51
local anesthetics,S01H
local anesthetics,S01HA
cocaine,S01HA01
oxybuprocaine,S01HA02
tetracaine,S01HA03
proxymetacaine,S01HA04
procaine,S01HA05
cinchocaine,S01HA06
lidocaine,S01HA07
combinations,S01HA30
diagnostic agents,S01J
colouring agents,S01JA
fluorescein,S01JA01
rose bengal sodium,S01JA02
"fluorescein, combinations",S01JA51
other ophthalmological diagnostic agents,S01JX
surgical aids,S01K
viscoelastic substances,S01KA
hyaluronic acid,S01KA01
hypromellose,S01KA02
"hyaluronic acid, combinations",S01KA51
other surgical aids,S01KX
chymotrypsin,S01KX01
ocular vascular disorder agents,S01L
antineovascularisation agents,S01LA
verteporfin,S01LA01
anecortave,S01LA02
pegaptanib,S01LA03
ranibizumab,S01LA04
aflibercept,S01LA05
brolucizumab,S01LA06
abicipar pegol,S01LA07
other ophthalmologicals,S01X
other ophthalmologicals,S01XA
guaiazulen,S01XA01
retinol,S01XA02
"sodium chloride, hypertonic",S01XA03
potassium iodide,S01XA04
sodium edetate,S01XA05
ethylmorphine,S01XA06
alum,S01XA07
acetylcysteine,S01XA08
iodoheparinate,S01XA09
inosine,S01XA10
nandrolone,S01XA11
dexpanthenol,S01XA12
alteplase,S01XA13
heparin,S01XA14
ascorbic acid,S01XA15
ciclosporin,S01XA18
"limbal stem cells, autologous",S01XA19
artificial tears and other indifferent preparations,S01XA20
mercaptamine,S01XA21
ocriplasmin,S01XA22
sirolimus,S01XA23
cenegermin,S01XA24
lifitegrast,S01XA25
riboflavin,S01XA26
voretigene neparvovec,S01XA27
antibiotics,S01AA
chloramphenicol,S01AA01
chlortetracycline,S01AA02
neomycin,S01AA03
oxytetracycline,S01AA04
tyrothricin,S01AA05
framycetin,S01AA07
tetracycline,S01AA09
natamycin,S01AA10
gentamicin,S01AA11
tobramycin,S01AA12
fusidic acid,S01AA13
benzylpenicillin,S01AA14
dihydrostreptomycin,S01AA15
rifamycin,S01AA16
erythromycin,S01AA17
polymyxin b,S01AA18
ampicillin,S01AA19
antibiotics in combination with other drugs,S01AA20
amikacin,S01AA21
micronomicin,S01AA22
netilmicin,S01AA23
kanamycin,S01AA24
azidamfenicol,S01AA25
azithromycin,S01AA26
cefuroxime,S01AA27
vancomycin,S01AA28
combinations of different antibiotics,S01AA30
otologicals,S02
antiinfectives,S02A
corticosteroids,S02B
corticosteroids,S02BA
hydrocortisone,S02BA01
prednisolone,S02BA03
dexamethasone,S02BA06
betamethasone,S02BA07
fluocinolone acetonide,S02BA08
corticosteroids and antiinfectives in combination,S02C
corticosteroids and antiinfectives in combination,S02CA
prednisolone and antiinfectives,S02CA01
flumetasone and antiinfectives,S02CA02
hydrocortisone and antiinfectives,S02CA03
triamcinolone and antiinfectives,S02CA04
fluocinolone acetonide and antiinfectives,S02CA05
dexamethasone and antiinfectives,S02CA06
fludrocortisone and antiinfectives,S02CA07
other otologicals,S02D
analgesics and anesthetics,S02DA
lidocaine,S02DA01
cocaine,S02DA02
phenazone,S02DA03
cinchocaine,S02DA04
combinations,S02DA30
indifferent preparations,S02DC
antiinfectives,S02AA
chloramphenicol,S02AA01
nitrofural,S02AA02
boric acid,S02AA03
aluminium acetotartrate,S02AA04
clioquinol,S02AA05
hydrogen peroxide,S02AA06
neomycin,S02AA07
tetracycline,S02AA08
chlorhexidine,S02AA09
acetic acid,S02AA10
polymyxin b,S02AA11
rifamycin,S02AA12
miconazole,S02AA13
gentamicin,S02AA14
ciprofloxacin,S02AA15
ofloxacin,S02AA16
"antiinfectives, combinations",S02AA30
ophthalmological and otological preparations,S03
antiinfectives,S03A
corticosteroids,S03B
corticosteroids,S03BA
dexamethasone,S03BA01
prednisolone,S03BA02
betamethasone,S03BA03
corticosteroids and antiinfectives in combination,S03C
corticosteroids and antiinfectives in combination,S03CA
dexamethasone and antiinfectives,S03CA01
prednisolone and antiinfectives,S03CA02
hydrocortisone and antiinfectives,S03CA04
fludrocortisone and antiinfectives,S03CA05
betamethasone and antiinfectives,S03CA06
other ophthalmological and otological preparations,S03D
antiinfectives,S03AA
neomycin,S03AA01
tetracycline,S03AA02
polymyxin b,S03AA03
chlorhexidine,S03AA04
hexamidine,S03AA05
gentamicin,S03AA06
ciprofloxacin,S03AA07
chloramphenicol,S03AA08
"antiinfectives, combinations",S03AA30
various,V
allergens,V01
allergens,V01A
allergen extracts,V01AA
feather,V01AA01
grass pollen,V01AA02
house dust mites,V01AA03
mould fungus and yeast fungus,V01AA04
tree pollen,V01AA05
insects,V01AA07
food,V01AA08
textiles,V01AA09
flowers,V01AA10
animals,V01AA11
various,V01AA20
all other therapeutic products,V03
all other therapeutic products,V03A
antidotes,V03AB
ipecacuanha,V03AB01
nalorphine,V03AB02
edetates,V03AB03
pralidoxime,V03AB04
prednisolone and promethazine,V03AB05
thiosulfate,V03AB06
sodium nitrite,V03AB08
dimercaprol,V03AB09
obidoxime,V03AB13
protamine,V03AB14
naloxone,V03AB15
ethanol,V03AB16
methylthioninium chloride,V03AB17
potassium permanganate,V03AB18
physostigmine,V03AB19
copper sulfate,V03AB20
potassium iodide,V03AB21
amyl nitrite,V03AB22
acetylcysteine,V03AB23
digitalis antitoxin,V03AB24
flumazenil,V03AB25
methionine,V03AB26
4-dimethylaminophenol,V03AB27
cholinesterase,V03AB29
prussian blue,V03AB31
glutathione,V03AB32
hydroxocobalamin,V03AB33
fomepizole,V03AB34
sugammadex,V03AB35
phentolamine,V03AB36
idarucizumab,V03AB37
andexanet alfa,V03AB38
iron chelating agents,V03AC
deferoxamine,V03AC01
deferiprone,V03AC02
deferasirox,V03AC03
drugs for treatment of hyperkalemia and hyperphosphatemia,V03AE
polystyrene sulfonate,V03AE01
sevelamer,V03AE02
lanthanum carbonate,V03AE03
calcium acetate and magnesium carbonate,V03AE04
sucroferric oxyhydroxide,V03AE05
colestilan,V03AE06
calcium acetate,V03AE07
ferric citrate,V03AE08
patiromer calcium,V03AE09
sodium zirconium cyclosilicate,V03AE10
detoxifying agents for antineoplastic treatment,V03AF
mesna,V03AF01
dexrazoxane,V03AF02
calcium folinate,V03AF03
calcium levofolinate,V03AF04
amifostine,V03AF05
sodium folinate,V03AF06
rasburicase,V03AF07
palifermin,V03AF08
glucarpidase,V03AF09
sodium levofolinate,V03AF10
arginine and lysine,V03AF11
drugs for treatment of hypercalcemia,V03AG
sodium cellulose phosphate,V03AG01
drugs for treatment of hypoglycemia,V03AH
diazoxide,V03AH01
tissue adhesives,V03AK
drugs for embolisation,V03AM
medical gases,V03AN
oxygen,V03AN01
carbon dioxide,V03AN02
helium,V03AN03
nitrogen,V03AN04
medical air,V03AN05
other therapeutic products,V03AX
nalfurafine,V03AX02
cobicistat,V03AX03
nerve depressants,V03AZ
ethanol,V03AZ01
diagnostic agents,V04
urine tests,V04B
other diagnostic agents,V04C
tests for diabetes,V04CA
tolbutamide,V04CA01
glucose,V04CA02
tests for fat absorption,V04CB
vitamin a concentrates,V04CB01
tests for bile duct patency,V04CC
sorbitol,V04CC01
magnesium sulfate,V04CC02
sincalide,V04CC03
ceruletide,V04CC04
tests for pituitary function,V04CD
metyrapone,V04CD01
sermorelin,V04CD03
corticorelin,V04CD04
somatorelin,V04CD05
macimorelin,V04CD06
tests for liver functional capacity,V04CE
galactose,V04CE01
sulfobromophthalein,V04CE02
methacetin (<o>13</o>c),V04CE03
tuberculosis diagnostics,V04CF
tuberculin,V04CF01
tests for gastric secretion,V04CG
cation exchange resins,V04CG01
betazole,V04CG02
histamine phosphate,V04CG03
pentagastrin,V04CG04
methylthioninium chloride,V04CG05
caffeine and sodium benzoate,V04CG30
tests for renal function and ureteral injuries,V04CH
inulin and other polyfructosans,V04CH01
indigo carmine,V04CH02
phenolsulfonphthalein,V04CH03
alsactide,V04CH04
aminohippuric acid,V04CH30
tests for thyreoidea function,V04CJ
thyrotropin,V04CJ01
protirelin,V04CJ02
tests for pancreatic function,V04CK
secretin,V04CK01
pancreozymin (cholecystokinin),V04CK02
bentiromide,V04CK03
tests for allergic diseases,V04CL
tests for fertility disturbances,V04CM
gonadorelin,V04CM01
other diagnostic agents,V04CX
indocyanine green,V04CX01
folic acid,V04CX02
methacholine,V04CX03
mannitol,V04CX04
<o>13</o>c-urea,V04CX05
hexaminolevulinate,V04CX06
edrophonium,V04CX07
carbon monoxide,V04CX08
patent blue,V04CX09
general nutrients,V06
diet formulations for treatment of obesity,V06A
protein supplements,V06B
infant formulas,V06C
nutrients without phenylalanine,V06CA
other nutrients,V06D
"carbohydrates/proteins/minerals/vitamins, combinations",V06DA
"fat/carbohydrates/proteins/minerals/vitamins, combinations",V06DB
carbohydrates,V06DC
glucose,V06DC01
fructose,V06DC02
"amino acids, incl. combinations with polypeptides",V06DD
"amino acids/carbohydrates/minerals/vitamins, combinations",V06DE
milk substitutes,V06DF
other combinations of nutrients,V06DX
low-energy diets,V06AA
all other non-therapeutic products,V07
all other non-therapeutic products,V07A
"solvents and diluting agents, incl. irrigating solutions",V07AB
"blood transfusion, auxiliary products",V07AC
"blood tests, auxiliary products",V07AD
incontinence equipment,V07AN
"sensitivity tests, discs and tablets",V07AR
stomi equipment,V07AS
cosmetics,V07AT
technical disinfectants,V07AV
washing agents etc.,V07AX
other non-therapeutic auxiliary products,V07AY
chemicals and reagents for analysis,V07AZ
plasters,V07AA
contrast media,V08
"x-ray contrast media, iodinated",V08A
"watersoluble, nephrotropic, low osmolar x-ray contrast media",V08AB
metrizamide,V08AB01
iohexol,V08AB02
ioxaglic acid,V08AB03
iopamidol,V08AB04
iopromide,V08AB05
iotrolan,V08AB06
ioversol,V08AB07
iopentol,V08AB08
iodixanol,V08AB09
iomeprol,V08AB10
iobitridol,V08AB11
ioxilan,V08AB12
"watersoluble, hepatotropic x-ray contrast media",V08AC
iodoxamic acid,V08AC01
iotroxic acid,V08AC02
ioglycamic acid,V08AC03
adipiodone,V08AC04
iobenzamic acid,V08AC05
iopanoic acid,V08AC06
iocetamic acid,V08AC07
sodium iopodate,V08AC08
tyropanoic acid,V08AC09
calcium iopodate,V08AC10
non-watersoluble x-ray contrast media,V08AD
ethyl esters of iodised fatty acids,V08AD01
iopydol,V08AD02
propyliodone,V08AD03
iofendylate,V08AD04
"x-ray contrast media, non-iodinated",V08B
barium sulfate containing x-ray contrast media,V08BA
barium sulfate with suspending agents,V08BA01
barium sulfate without suspending agents,V08BA02
magnetic resonance imaging contrast media,V08C
paramagnetic contrast media,V08CA
gadopentetic acid,V08CA01
gadoteric acid,V08CA02
gadodiamide,V08CA03
gadoteridol,V08CA04
mangafodipir,V08CA05
gadoversetamide,V08CA06
ferric ammonium citrate,V08CA07
gadobenic acid,V08CA08
gadobutrol,V08CA09
gadoxetic acid,V08CA10
gadofosveset,V08CA11
superparamagnetic contrast media,V08CB
ferumoxsil,V08CB01
ferristene,V08CB02
"iron oxide, nanoparticles",V08CB03
other magnetic resonance imaging contrast media,V08CX
perflubron,V08CX01
ultrasound contrast media,V08D
ultrasound contrast media,V08DA
"perflutren, human albumin microspheres",V08DA01
microparticles of galactose,V08DA02
perflenapent,V08DA03
"perflutren, phospholipid microspheres",V08DA04
"sulfur hexafluoride, phospholipid microspheres",V08DA05
"perflubutane, phospholipid microspheres",V08DA06
"watersoluble, nephrotropic, high osmolar x-ray contrast media",V08AA
diatrizoic acid,V08AA01
metrizoic acid,V08AA02
iodamide,V08AA03
iotalamic acid,V08AA04
ioxitalamic acid,V08AA05
ioglicic acid,V08AA06
acetrizoic acid,V08AA07
iocarmic acid,V08AA08
methiodal,V08AA09
diodone,V08AA10
diagnostic radiopharmaceuticals,V09
central nervous system,V09A
iodine (<o>123</o>i) compounds,V09AB
iodine iofetamine (<o>123</o>i),V09AB01
iodine iolopride (<o>123</o>i),V09AB02
iodine ioflupane (<o>123</o>i),V09AB03
other central nervous system diagnostic radiopharmaceuticals,V09AX
indium (<o>111</o>in) pentetic acid,V09AX01
iodine (<o>124</o>i) 2beta-carbomethoxy-3beta-(4 iodophenyl)-tropane,V09AX03
flutemetamol (<o>18</o>f),V09AX04
florbetapir (<o>18</o>f),V09AX05
florbetaben (<o>18</o>f),V09AX06
skeleton,V09B
technetium (<o>99m</o>tc) compounds,V09BA
technetium (<o>99m</o>tc) oxidronic acid,V09BA01
technetium (<o>99m</o>tc) medronic acid,V09BA02
technetium (<o>99m</o>tc) pyrophosphate,V09BA03
technetium (<o>99m</o>tc) butedronic acid,V09BA04
renal system,V09C
technetium (<o>99m</o>tc) compounds,V09CA
technetium (<o>99m</o>tc) pentetic acid,V09CA01
technetium (<o>99m</o>tc) succimer,V09CA02
technetium (<o>99m</o>tc) mertiatide,V09CA03
technetium (<o>99m</o>tc) gluceptate,V09CA04
technetium (<o>99m</o>tc) gluconate,V09CA05
technetium (<o>99m</o>tc) ethylenedicysteine,V09CA06
other renal system diagnostic radiopharmaceuticals,V09CX
sodium iodohippurate (<o>123</o>i),V09CX01
sodium iodohippurate (<o>131</o>i),V09CX02
sodium iothalamate (<o>125</o>i),V09CX03
chromium (<o>51</o>cr) edetate,V09CX04
hepatic and reticulo endothelial system,V09D
technetium (<o>99m</o>tc) compounds,V09DA
technetium (<o>99m</o>tc) disofenin,V09DA01
technetium (<o>99m</o>tc) etifenin,V09DA02
technetium (<o>99m</o>tc) lidofenin,V09DA03
technetium (<o>99m</o>tc) mebrofenin,V09DA04
technetium (<o>99m</o>tc) galtifenin,V09DA05
"technetium (<o>99m</o>tc), particles and colloids",V09DB
technetium (<o>99m</o>tc) nanocolloid,V09DB01
technetium (<o>99m</o>tc) microcolloid,V09DB02
technetium (<o>99m</o>tc) millimicrospheres,V09DB03
technetium (<o>99m</o>tc) tin colloid,V09DB04
technetium (<o>99m</o>tc) sulfur colloid,V09DB05
technetium (<o>99m</o>tc) rheniumsulfide colloid,V09DB06
technetium (<o>99m</o>tc) phytate,V09DB07
other hepatic and reticulo endothelial system diagnostic radiopharmaceuticals,V09DX
selenium (<o>75</o>se) tauroselcholic acid,V09DX01
respiratory system,V09E
"technetium (<o>99m</o>tc), inhalants",V09EA
technetium (<o>99m</o>tc) pentetic acid,V09EA01
technetium (<o>99m</o>tc) technegas,V09EA02
technetium (<o>99m</o>tc) nanocolloid,V09EA03
"technetium (<o>99m</o>tc), particles for injection",V09EB
technetium (<o>99m</o>tc) macrosalb,V09EB01
technetium (<o>99m</o>tc) microspheres,V09EB02
other respiratory system diagnostic radiopharmaceuticals,V09EX
krypton (<o>81m</o>kr) gas,V09EX01
xenon (<o>127</o>xe) gas,V09EX02
xenon (<o>133</o>xe) gas,V09EX03
thyroid,V09F
various thyroid diagnostic radiopharmaceuticals,V09FX
technetium (<o>99m</o>tc) pertechnetate,V09FX01
sodium iodide (<o>123</o>i),V09FX02
sodium iodide (<o>131</o>i),V09FX03
sodium iodide (<o>124</o>i),V09FX04
cardiovascular system,V09G
technetium (<o>99m</o>tc) compounds,V09GA
technetium (<o>99m</o>tc) sestamibi,V09GA01
technetium (<o>99m</o>tc) tetrofosmin,V09GA02
technetium (<o>99m</o>tc) teboroxime,V09GA03
technetium (<o>99m</o>tc) human albumin,V09GA04
technetium (<o>99m</o>tc) furifosmin,V09GA05
technetium (<o>99m</o>tc) stannous agent labelled cells,V09GA06
technetium (<o>99m</o>tc) apcitide,V09GA07
iodine (<o>125</o>i) compounds,V09GB
fibrinogen (<o>125</o>i),V09GB01
iodine (<o>125</o>i) human albumin,V09GB02
other cardiovascular system diagnostic radiopharmaceuticals,V09GX
thallium (<o>201</o>tl) chloride,V09GX01
indium (<o>111</o>in) imciromab,V09GX02
chromium (<o>51</o>cr) chromate labelled cells,V09GX03
rubidium (<o>82</o>rb) chloride,V09GX04
inflammation and infection detection,V09H
technetium (<o>99m</o>tc) compounds,V09HA
technetium (<o>99m</o>tc) human immunoglobulin,V09HA01
technetium (<o>99m</o>tc) exametazime labelled cells,V09HA02
technetium (<o>99m</o>tc) antigranulocyte antibody,V09HA03
technetium (<o>99m</o>tc) sulesomab,V09HA04
indium (<o>111</o>in) compounds,V09HB
indium (<o>111</o>in) oxinate labelled cells,V09HB01
indium (<o>111</o>in) tropolonate labelled cells,V09HB02
other diagnostic radiopharmaceuticals for inflammation and infection detection,V09HX
gallium (<o>67</o>ga) citrate,V09HX01
tumour detection,V09I
technetium (<o>99m</o>tc) compounds,V09IA
technetium (<o>99m</o>tc) anticarcinoembryonicantigen antibody,V09IA01
technetium (<o>99m</o>tc) antimelanoma antibody,V09IA02
technetium (<o>99m</o>tc) pentavalent succimer,V09IA03
technetium (<o>99m</o>tc) votumumab,V09IA04
technetium (<o>99m</o>tc) depreotide,V09IA05
technetium (<o>99m</o>tc) arcitumomab,V09IA06
technetium (<o>99m</o>tc) hynic-octreotide,V09IA07
technetium (<o>99m</o>tc) etarfolatide,V09IA08
technetium (<o>99m</o>tc) tilmanocept,V09IA09
indium (<o>111</o>in) compounds,V09IB
indium (<o>111</o>in) pentetreotide,V09IB01
indium (<o>111</o>in) satumomab pendetide,V09IB02
indium (<o>111</o>in) antiovariumcarcinoma antibody,V09IB03
indium (<o>111</o>in) capromab pendetide,V09IB04
other diagnostic radiopharmaceuticals for tumour detection,V09IX
iobenguane (<o>123</o>i),V09IX01
iobenguane (<o>131</o>i),V09IX02
iodine (<o>125</o>i) cc49-monoclonal antibody,V09IX03
fludeoxyglucose (<o>18</o>f),V09IX04
fluorodopa (<o>18</o>f),V09IX05
sodium fluoride (<o>18</o>f),V09IX06
fluorocholine(<o>18</o>f),V09IX07
fluoroethylcholine (<o>18</o>f),V09IX08
gallium (<o>68</o>ga) edotreotide,V09IX09
fluoroethyl-l-tyrosine (<o>18</o>f),V09IX10
fluoroestradiol (<o>18</o>f),V09IX11
fluciclovine (<o>18</o>f),V09IX12
methionine (<o>11</o>c),V09IX13
other diagnostic radiopharmaceuticals,V09X
iodine (<o>131</o>i) compounds,V09XA
iodine (<o>131</o>i) norcholesterol,V09XA01
iodocholesterol (<o>131</o>i),V09XA02
iodine (<o>131</o>i) human albumin,V09XA03
various diagnostic radiopharmaceuticals,V09XX
cobalt (<o>57</o>co) cyanocobalamine,V09XX01
cobalt (<o>58</o>co) cyanocobalamine,V09XX02
selenium (<o>75</o>se) norcholesterol,V09XX03
ferric (<o>59</o>fe) citrate,V09XX04
technetium (<o>99m</o>tc) compounds,V09AA
technetium (<o>99m</o>tc) exametazime,V09AA01
technetium (<o>99m</o>tc) bicisate,V09AA02
therapeutic radiopharmaceuticals,V10
antiinflammatory agents,V10A
other antiinflammatory therapeutic radiopharmaceuticals,V10AX
phosphorous (<o>32</o>p) chromicphosphate colloid,V10AX01
samarium (<o>153</o>sm) hydroxyapatite colloid,V10AX02
dysprosium (<o>165</o>dy) colloid,V10AX03
erbium (<o>169</o>er) citrate colloid,V10AX04
rhenium (<o>186</o>re) sulfide colloid,V10AX05
gold (<o>198</o>au) colloidal,V10AX06
pain palliation (bone seeking agents),V10B
various pain palliation radiopharmaceuticals,V10BX
strontium (<o>89</o>sr) chloride,V10BX01
samarium (<o>153</o>sm) lexidronam,V10BX02
rhenium (<o>186</o>re) etidronic acid,V10BX03
other therapeutic radiopharmaceuticals,V10X
iodine (<o>131</o>i) compounds,V10XA
sodium iodide (<o>131</o>i),V10XA01
iobenguane (<o>131</o>i),V10XA02
tositumomab/iodine (<o>131</o>i) tositumomab,V10XA53
various therapeutic radiopharmaceuticals,V10XX
sodium phosphate (<o>32</o>p),V10XX01
ibritumomab tiuxetan (<o>90</o>y),V10XX02
radium (<o>223</o>ra) dichloride,V10XX03
lutetium (<o>177</o>lu) oxodotreotide,V10XX04
yttrium (<o>90</o>y) compounds,V10AA
yttrium (<o>90</o>y) citrate colloid,V10AA01
yttrium (<o>90</o>y) ferrihydroxide colloid,V10AA02
yttrium (<o>90</o>y) silicate colloid,V10AA03
surgical dressings,V20
